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Under the conditions of transfer hydrogenation employing ortho-cyclometallated 
iridium C,O-benzoate catalysts, selective silylallylation and CF3-allylation were 
developed. In both cases, high levels of catalyst-directed enantioselectivity and 
diastereoselectivity were observed. Column chromatography was then tested as a new 
protocol to purify the iridium precatalyst; this single component precatalyst was proved 
to be more efficient to promote carbonyl crotylation reactions, both diastereo- and 
enantioselectivity were increased. Then, double asymmetric crotylation of 1,3-diols to 
deliver (pseudo-)C2-symmetric adducts with exceptional level of enantioselectivity was 
devised. Implementation of this methodology and other hydrogenative C-C bond 
formations proved to be effective means for the preparation of two known polypropionate 
natural product fragments of C19-C25 of scytophycin C, C19-C27 of rifamycin S and the 
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CHAPTER 1: SYNTHETIC EFFORTS TOWARDS 
ERYTHRONOLIDE FAMILY NATURAL PRODUCTS 
 
1.1 INTRODUCTION  
The erythromycins are a family of polypropinate natural products originally 
isolated from soil bacterial Streptomyces erythreus by Eli Lily back to 1952.1 It was the 
first comertialized macrolide antibiotic, which was used for the treatment of numerous 
infections including, but not limited to, pneumonia, conjunctivitis, and erythrasma.2 
Besides itself, several other semi-synthetic macrolide antibiotics were developed based 
on the 14-membered lactone motif by different companies.  
The structures of the erythromycins were determined by a combination of single-
crystal X-ray diffraction analysis and/or a series of detailed degradation analyses.3,4 All 
erythromycins share several distinctive architectural features, including a 14-membered 
macrolactone, glycosidic linkages at C3 and C5, and polyoxygenated backbone. 
Members of the erythromycin family are differentiated structurally through the absence 
of hydroxy substituents at the C6 and C12 positions and 6-deoxysugar substituent at C3 
and C5 positions. In the later case, the name “erythronolide” was used which referring to 
the polypropinate derived aglycone (Figure 1.1.1). 
 2
 
 Figure 1.1.1: Selected erythromycin family members. 
  
Biogenically, all the erythromycins came from a same precursor, 6-
deoxyerythronolide B. Scientists named this family of natural products polypropionates 
because they were synthesized through sequential aldol condensation reaction of 
propionates in the bacterial. Biosynthetic mechanism of the erythromycins constituted the 
majority of our understanding on the biogenic origin of polyketides. The first polyketide 
synthase genome sequenced was 6-deoxyerythronolide B synthase (DEBS); many other 
Streptomyces synthases sequenced thereafter proved to be both structurally and 
functionally similar to DEBS (Figure 1.1.2).5,6,7 
 3
 
Figure 1.1.2: Proposed biosynthetic scheme of 6-deoxyerythronolide B, figure was 
copied from Cane, Nature, 1995, 378, 263. 
 
Erythromycins and erythronolides were iconic synthetic targets for synthetic 
community. This 14-membered lactone was an inspiration for discovering new synthetic 
methods with wide applications. In 1956, R. B. Woodward first acknowledged the 
synthetic chanllenge of the erythromycins by stating “Erythromycin, with all of our 
advantages, looks at present time quite hopelessly complex, particularly in view of its 
plethora of asymmetric centers.”8 This statement fueled the synthetic community to 
pursue this family of natural products. Ever since E. J. Corey’s first synthetic work of 
erythronolide B in 1978, erythromycin family was “probably the most extensive single 




Figure 1.1.3: Summary of steps count for previous total synthesis effort towards 
erythromycin family natural products. 
  
Due to the space limit, not every single synthesis of each member of erythromycin 
family will be covered in this review; instead, one of each member will be discussed in 
details. Graphic summaries of all the previous completed total and formal synthesises 
will be provided at the end of the chapter. 
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1.2 ERYTHRONOLIDE B BY COREY (1978)  
1.2.1 RETROSYNTHETIC ANALYSIS 
In 1978, Corey and coworkers reported their synthesis of erythronolide B, the first 
total synthesis of any erythromycin family natural products.9 As shown in Scheme 1.2.1, 
in their strategy, the 14-membered macrolide in erythronolide B was assembled through 
Corey-Nicolaou macrolactonization of the corresponding seco-acid 1.2.I, which itself 
was prepared from an intramolecular translactonization of 1.2.II. Installation of the vinyl 
side chain into 1.2.IV was achieved by a thioester alkylation with vinyl iodide 1.2.III. 
Notably, both 1.2.III and 1.2.IV fragments were synthesized as a racemic mixture; chiral 
resolution manipulations were needed to optain enantiopure material. 
 
 
Scheme 1.2.1: Corey’s retrosynthetic strategy for erythronolide B.  
 
1.2.2 SYNTHETIC ROUTE 
Preparation of fragment 2A started from dearomatization of phenol 1.2.1, 
bromolactonization of 1.2.2 fowllowed by recrystallization with chiral amine base 
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provided enantiomeric pure form of 1.2.3, which was the precursor of the epoxide 1.2.4. 
A second round bromolactonization followed by dehalogenation generated a fully 
substituted cyclohexanone 1.2.5. Treatment of 1.2.5 under Baeyer-Villiger oxidation 
condition provide seven-membered lactone 1.2.8, which was activated by forming thio-
ester 2A and ready to couple with the other fragment (Scheme 1.2.2). 
 
 
Scheme 1.2.2: Fragment 2A synthesis. 
 
The iodide 2B was made from enyne 1.2.9. Chemoselective dihydroxylation 
followed by a two-step resolution through forming chiral mandelic ester provided chiral 
tertiary alcohol 1.2.11. After subsequent mercuration and iodination, the iodide 2B was 
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obtained in 11 steps (Scheme 1.2.3). Fragment union was achieved through acylating the 
vinyl lithium reagent generated from 2B via lithium-halogen exchange. After transfer 
lactonization of coupling product 1.2.13, 10-membered lactone 2C was obtained, with 




Scheme 1.2.3: Fragment 2B synthesis.  
 
 
Scheme 1.2.4: Fragment union of 2A and 2B. 
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The end game was carrired out simple and straight forward. 2C was saponified 
and the seco-acid was activated by treating with disulfide 2D to form macrolactonization 
precursor 1.2.16. Heating this thioester provided the macrocyclization product 1.2.17; 
Epoxidation of the double bond followed by allylic oxidation gave 1.2.18. Ring-opening 
epoxide provided 10-epi form of protected erythronolide B, which isomerized to its 
thermodynamically stable form when treated with base. Deprotecting acetonide gave the 
natural product (Scheme 1.2.5). 
 
 




The landmark first total synthesis of erythronolide B by Corey featured 
dearomatization, lactone ring expansion, and Corey-Nicolaou macrolactonization.10 
Successful utilizing this lactonization stragegy had a tremendous impact - all subsequent 
erythromycin family natural products syntheses, except the most recent work published 
by Krische group,11 contain the same bond disconnection. The synthesis contained 33 
longest linear sequence and 47 total steps. One drawback of Corey’s route involved twice 
chiral resolution and advanced intermediates, which suffered a significant loss of overall 
yield (less than 0.5%). 
 
1.3 6-DEOXYERYTHRONOLIDE B BY EVANS (1997) 
1.3.1 RETROSYNTHETIC ANALYSIS 
Corey’s successful disconnection of erythromycin family at the ester bond and 
Woodward’s extensive model study on the macrolatonization established a doctrine for 
synthesizing this family of natutal products. All the following synthetic schemes mainly 
focused on using new methodologies to generate stereotriad and coupling those 
fragments to form the seco-acid. The most successful methodology was Evans aldol 
chemistry.12 In 1997, Evans published by far11 the most concise assembly of 
erythromycin family natural products using stereoselective aldol reaction.13 After 
disconnecting the ester bond, the linear seco-acid 1.3.I could be further disconnected at 
C7-C8, which provided two equally sized fragments 1.3.II and 1.3.III. Both of those two 
fragments came from a same chiral building blocks synthesized from unnatural amino 




Scheme 1.3.1: Evans retrosynthetic analysis. 
 
1.3.2 SYNTHETIC ROUTE 
Both fragments of Evans scheme came from same intermediate Aux. Aux could 
be made from commercial available oxazolidinone 1.3.2; however, the prohibitive price 
for this material normally encouraged synthetic chemistry labs making this compound 
though a five-step sequence (Scheme 1.3.2). 
 
 
Scheme 1.3.2: Common intermediate synthesis. 
 
The starting material Aux showed excellent level of diastereoselectivity for 
introducing new chiral centers at the ethyl terminal. Interestingly, changing the Lewis 
acid core from Sn(II) to Ti(IV) for enolizing the alpha-chiral ketone would also change 
the stereochemical outcome for the aldol reaction; a mechanistic rationale was attributed 
to the different coordination ability of Sn(II) and Ti(IV), since Sn(II) normally 
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coordinated with four monodente ligand, while Ti(IV) would be saturated until six 
ligands on the metal (Scheme 1.3.3).14 
 
 
Scheme 1.3.3: Stereochemical outcome of aldol reaction rationale. 
 
Fragment 3A was synthesized though Ti(IV) mediated aldol reaction of Aux with 
methacrolein. Intramolecular hydride transfer from the chelated zinc intermediate would 
trigger 1,3-syn relationship for the newly generated chiral center. Substrate directed 
hydroboration-oxidation sequence provided primary alcohol 1.3.5, which underwent 
Moffat oxidation to give alpha-chiral aldehyde 3A (Scheme 1.3.4).  
 
 
Scheme 1.3.4: Fragment 3A synthesis. 
 
 12
The other fragment, 3B, was synthesized through same manner. Using Sn(II) as 
Lewis acid to enolize the chiral ketone, an anti stereochemical outcome was observed. 
Using NaBH(OAc)3 as external hydride sourse, 1,3-anti reduction was achieved and 
generated the remaining two chiral centers in this fragment. The oxazolidinone motif was 
replaced with Weinreb amide, followed by mono alkylation to generate alpha-chiral 
ketone 1.3.8. Enolization of 1.3.8 with LiHMDS and TMSOTf gave Mukaiyama aldol 
precursor silyl enol ether 3B in 12 steps (Scheme 1.3.5). 
 
 
Scheme 1.3.5: Fragment 3B synthesis. 
 
The fragment union was achieved through Mukaiyama aldol reaction. Using BF3-
OEt2 as Lewis acid, fully substituted stereopolyad 1.3.9 was obtained in 83% yield. The 
newly generated hydroxyl group needed to be removed to match the structure of the 
natural product; hence a three-step Barton deoxygenation was carried out. The hydrogen 
radical labile PMP-acetal motif survived under optimized reaction condition. After 
hydrogen peroxide facilitated hydrolysis of oxazolidinone auxiliary, the unprotected 
seco-acid 1.3.13 was treated with Yamaguchi lactonization reagent to form macrolactone 
1.3.14. A three-step deprotection sequence, including a Pearlman catalyst promoted 
 13
hydrogenolysis of PMP-acetal, PCC mediated site selective oxidation of diol, and acid 





Key: (a) BF3 OEt2; (b) Zn(BH4)2; (c) DDQ; (d) NaH, then CS2, then MeI; (e) AIBN, Bu3SnH; (f) LiOOH; (g) TBAF; (h) TEA, 2,4,6-trichlorobenzoyl chloride, then DMAP




































































































































Scheme 1.3.6: Fragment union and end game for Evans synthesis. 
 
1.3.3 METHODOLOGY HIGHLIGHT 
Evans chiral oxazolidinone auxiliary was one of the most utilized auxiliaries; it 
ccould be easily hydrolized to get ester or acid, or reduced to aldehyde or alcohol. The 
selectivity for the corresponding aldol reaction was very high for propionate derivatives 
(eqn. 1, Scheme 1.3.7).12a One drawback for Evans aldol reaction was the acetate aldol 
reaction, normally the selectivity was moderate. Several chiral auxiliaries based on Evans 
oxazolidinone structure motif were developed in the last three decades to solve this 
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problem; Crimmins was recently using his own thiazolidinethione auxiliary to synthesize 
advanced intermediate of Evans total synthesis of 6-deoxyerythronolide B in 24 steps 




Scheme 1.3.7: Stereochemical model for Evans aldol reaction. 
 
 
Scheme 1.3.8: Example of Crimmins sequence for modified aldol reaction. 
 
1.3.4 SUMMARY 
The total synthesis of 6-deoxyerythronolide B still remained as a testing standard 
for new total synthesis work of erythromycin family natural products. The synthetic 
scheme was highly convergent; the longest linear sequence was 18 steps from known 
compound, or 23 steps from inexpensive bulk chemicals. Both fragments could be 
obtained from a same precursor, which shorten the total steps required to assembly this 
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molecule. The efficiency to generate chiral centers via Evans aldol reaction was well 
tested in this synthetic enterprise. 
 
1.4 ERYTHROMYCIN A BY WOODWARD (1981) 
1.4.1 RETROSYNTHETIC ANALYSIS 
While installing all the chiral centers across the 14-membered lactone ring was 
already a highly challenging task for synthetic community, glycosidation to introduce two 
sugar motifs into aglycone of erythromycin proved to be more difficult especially in a site 
selective fashion. In 1981, Woodward and his group published the first and only total 
synthesis of erythromycin A.16 By removing two sugar motifs, the aglycone 1.4.I was 
disconnected at the ester bond to provide a second acid 1.4.II. The stereochemistry of 
those chiral centers was controlled by a dithiadecalin 1.4.III as template; the fragments 




Scheme 1.4.1: Woodward’s retrosynthetic analysis. 
 
1.4.2 SYNTHETIC ROUTE 
Starting from dihydrothiopyranone 1.4.1, alpha chlorination with NCS followed 
by nucleophilic substitution gave 4A in 6 steps. Carbonylation at the alpha-position of 
ester generating from acid 1.4.3 provided beta-carbonyl ester 1.4.4; subsequent 




Scheme 1.4.2: Dithiadecalin precursors synthesis. 
 
Alkylation of 4B at the mesylate terminal coupled 4A and 4B together as the 
precursor for the dithiadecalin. A proline catalyzed intramolecular aldol reaction, which 
was so-called Harjos-Parrish reaction, was carried out to generate 1.4.6. Beta-hydroxyl 
dehydration followed by stereoselective carbonyl reduction and further elaboration 
provided the common intermediate 4P; successfully identifying this piece as a repeating 
unit in the molecule helped to reduce the total steps count for erythromycin A synthesis. 
After desulforation with Raney-Ni, alpha-chiral aldehyde 4D was obtained in 18 steps 




Scheme 1.4.3: Dithiadecalin as the template to control stereochemistry. 
 
4C and 4D were coupled though carbonyl alkylation followed by oxidation to 
form 1,3-dicarbonyl compound 1.4.9. A three-step sequence was used to site-selectively 
remove oxygen on more stereically hindered dithiadecalin motif and generated 
alpha,beta-unsaturated ketone 1.4.10. Benzyl thiol was added to this enone motif from the 
canvex face of the ring system, which helped to define the stereochemistry at C8 of 
1.4.11. Subsequent desulforation and aldol reaction with thioester generated all the 
carbon skeleton of the seco-acid. Substrate steering isomerization promoted by base 
corrected the stereochemistry at C2 position of 1.4.14. Suponification of thioester and 
acetate followed by esterification provided the key intermediate 4E in 34 steps (Scheme 
1.4.4, Figure 1.4.1). 
 19
 
Scheme 1.4.4: Seco ester 4E synthesis. 
 
 
Figure 1.4.1: Dithiadecalin directed face selective reduction of ketone. 
 
Although there were previous example using macrocyclization to construct the 
lacone motif of erythromycin family natural products before,17 Woodward provided a 
first systematic study on the transannular steric effect for assemblying this specific 
molecule. He proposed a well-accepted doctrine based on extensive experimental studies 
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of different model systems, that in order to form the ring, C9 must be S configuration and 
both C9-C11 and C3-C5 sopposed to be protected by cyclic protecting groups such as 
acetonide and/or carbonate. In order to match the stereochemical requirement for the 
macrocyclization, mesylate on C9 was replaced with amine to invert the stereochemistry. 
After protecting C9-C11 with carbamate and C3-C5 with acetal, the seco ester 1.4.18 was 
suponified and the corresponding acid was activated with thio chloroformate to form 
thioester, which cyclize upon heating and treating with PPh3 to form macrocyclic 




Key: (a) LiN3, HMPA; (b) PtO2, H2; (c) Na2CO3; (d) NH2OH-HCl, KH2PO4; (e) TEA; (f) meityl-CH(OMe)2, CSA;

























































































(43 steps in LLS)
Woodward's doctr ine:
1. The configuration at C9 must be S









Scheme 1.4.5: Macrocyclization and Woodward’s doctrine. 
 
While the idea that preorganization was required for macrocylization was 
accepted by the synthetic community for nearly three decades, there were exceptions in 
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the literature. In 1995, Danishefsky published a synthetic work towards 6-
deoxyerythronolide B; although the stereochemical requirement matched with 
Woodward’s statement, the macrocyclization only provided 18% yield.18 In 1997, Martin 
reported the first and only total synthesis of erythromycin B. In this study, C3-C5 
dihydroxyl motif was not protected as cyclic precursor, but the macrocyclization went 
smoothly.19 In 2011, White restudied this process and conformed that preorganization 
was not only necessary but even detrimental in certain cases for macrocyclization 
(Scheme 1.4.6).20  
 
Scheme 1.4.6: White’s observation for macrocyclization. 
 
The macrocyclization proved to be challenging for this synthesis; however, the 
sugar motifs were even more stepy to be made; this was also the normal drawback of 
making chiral building blocks from sugars, since the polyoxegenated system often 
suffering from low site-selectivity, hence requiring extensive protection-deprotection 
manipulations (Scheme 1.4.7).   
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Scheme 1.4.7: Glycosidation reagent synthesis. 
 
With macrocyclization product 4F in hand, Woodward attempted the 
glycosidation. After deprotecting C3-C5 acetal with TFA under buffered condition, 
region-selective glycosidation with S1 to penta-ol 1.4.21 was carried out; the reagent 
became standard glycosidation protocol later. Second-round glycosidation with S2 
provided all the backbone of erythromycin A. This core, 1.4.23, was further elaborated to 
introduce carbonyl motif at C9 position in three steps hence finished the first total 




Scheme 1.4.8: Glycosidation and end game for erythromycin A synthesis. 
 
1.4.3 METHODOLOGY HIGHLIGHT 
Woodward’s synthesis of erythromycin featured the glycosidation and extensive 
study on preorganization requirement for macrocyclozation, which had been discussed 
above. Notably, the intramolecular proline catalyzed aldol reaction, which was so-called 
Harjos-Parrish reaction, was utilized neatly to introduce chirality in the reaction 
sequence. Harjos reported this reaction back to 1974,21 and the mechanistic study for the 
stereochemical outcome was carried out by Houk (Eqn.2).22 Using congested ring system 
as template to develop substrate controlled stereochemical introduction was another show 
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The disconnection strategy of erythromycin in this work was based on identifying 
repeating stereochemistry assignment in the molecule, and the insight of preorganization 
provided remarkable consideration to the synthetic community for ring construction. The 
synthesis was 55 steps longest linear sequence, with overall yield 0.0089%. 
Glycosidation method was developed in the sequence; however, the last ten steps which 
were required by glycosidation only provided 1.54% yield. While published two years 
after Woodward passing away, this synthetic enterprise represented the end of 
“Woodwardian Era”. 
 
1.5 ERYTHROMYCIN B BY MARTIN (1998) 
1.5.1 RETROSYNTHETIC ANALYSIS 
Erythromycin B, which was the precursor of erythromycin A in soil bacteria 
fermentation process, was first synthesized by Martin in 1997.24 The first generation 
approach was a mimic of biotic synthesizing sequence, which starting from seco-acid 
generation, macrolactonization, and glycosidation to finish the total synthesis. In 2003, 
Martin published the second generation synthesis of erythromycin;19 the synthetic scheme 
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set glycosidation prior to macrolactonization, which in principal would limit protection-
deprotection manipulations. Acturally, this new strategy proved to be the most concise 
total synthesis of erythromycins, to date. In the retrosynthetic analysis, erythromycin was 
disconnected at the ester bond, which provided a glycosidated seco-acid 1.5.I; further 
disconnection provided a retro-aldol reaction motif. 
  
 
Scheme 1.5.1: Retrosynthetic analysis of Martin. 
 
1.5.2 SYNTHETIC ROUTE 
The synthetic scheme started with an auxiliary promoted enatioselective aldol 
reaction towards furyl aldehyde to generate Evans aldol product 1.5.2. Although this 
chiral auxiliary was commercial available, the price for it was prohibitive, hence a two 





Scheme 1.5.2: Chiral auxiliary A synthesis. 
 
Reductive cleavage of the chiral auxiliary followed by treating the diol with 
bromine broke the aromaticity of furan to generate [3,3,1]-fused ring system 1.5.3. 
Cuperate mediated 1,4-Michael addition followed by cerium promoted carbonyl addition 
with methium lithium generated substituted dioxabicyclo[3.3.1]nonane, which underwent 
PPTS promoted ketal opening and dithiane formation wo provide linear stereopolyad 
1.5.4. This strategy was neat and efficient, avoiding using stepy one-dimensional chain 
elongation strategy which commonly seen in the total synthesis of polyketides. Carbonate 
protection of 1,2-diol motif and TBS protection of primary hydroxyl group followed by 
dithiane cleavage generated aldol precursor 1.5.5. The coupling partner, B, which itself 
needed three steps to make, was reacted with corrospnding lithium enolate of 1.5.5, 
through substrate directed carbonyl addition to give fragment union product 1.5.6. This 
also provided majority of carbon atoms on the lactone backbone of erythromycin B. 




Scheme 1.5.3: Fragment 5A synthesis. 
 
Altough not using exactly the same compounds, the glycosidation reagents S1 and 
S2 which Martin used in his total synthesis were quite similar to what Woodward had 
developed before. In Woodward synthesis, C5-C6 diol could be selectively glycosidated 
at the C5 position without touching C6 hydroxyl group. However, this selectivity proved 
to be case dependent, as Martin only observed 1.2:1 ratio favored to the desired one; 
futurnately, those two regioisomers could be separated easily. After obtaining alpha-
chiral aldehyde 1.5.9, allylstannane mediated Sakurai type crotylation reaction was 
proceeded to introduce the two last carbon atoms in the seco-acid. Oxidative cleavage of 
olefin 1.5.10 with OsO4 in DMF generated beta-hydroxyl acid,
25 which underwent 
Yamaguchi lactonization smoothly to give macrolactone 1.5.11. It was quite impressive 
at this step, since the macrolactonization proceeded without matching preorganization 
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required postulated by Woodward, also the complete selectivity of C13-hydroxyl group 
over C3-hydroxyl group. The unprotected hydroxyl group reacted with S2 for the second 
glycosidation, and the product, 1.5.13, was only steps away from the final natural 








Key: (a) AgOTf, 2,6-tBu2Py; (b) TBAF; (c) TESOTf, iPr2NEt; (d) (COCl)2, DMSO, TEA; (e) BF3-OEt2; (f) OsO4, Oxone, NaHCO3; (g) Pd/C, HClO4;








































































































































































Martin provided two elegant total synthesis schemes of erythromycin B. Both of 
these two synthesis were featured the application of dearomatization of furan ring, aldol 
coupling and late stage glycosidations. The second synthesis, which avoiding adopting 
biomimic synthetic pathway, showed the power of synthetic planning and provided 
synthetic community an oppoturnity to re-think about well-accepted doctrine of 
Woodward’s postulation. Comparing with Woodward’s erythromycin A synthsis, 
Martin’s scheme was much shorter; it was only 28 steps in the longest linear sequence, 
which was only a half of Woodward’s work. 
 
1.6 ERYTHRONOLIDE A BY CARREIRA (2005) 
1.6.1 RETROSYNTHETIC ANALYSIS 
Unlike erythronolide B and 6-deoxyerythronolide B, erythronolide A, the 
aglycone form of natural product erythromycin A, was not observed in bacteria culture. 
Oxidation at the C12 position of erythronolide backbone seemed to be unlikely prior to 
glycosidation, it was believed that erythromycin A came through oxidation of 
erythromycin B, which itself came from oxidation at C6 position followed by 
glycosidation of C3 and C5 hydroxyl groups on the precursor 6-deoxyerythronolide B.5,6 
Although this compound was not isolated from natural, the interesting structure motif of 
highly oxygenated 14-membered lactone still drew considerable attention from synthetic 
community; the first total synthesis of erythronolide was carried out by Corey in 1979, 
right after his landmark first total synthesis of erythronolide B, which required 39 longest 
linear sequence and 50 total steps.17a 
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In 2005,26 Carreira was able to synthesize erythronolide A through iterative 
utilization of nitrile oxide [3+2] cyclo addition.27 The 14-membered lactone was 
disconnected at the ester bond as all the previous work did, to provide the seco-acid 1.6.I. 
A novel Mg promoted nitrile oxide [3+2] cycloaddition strategy was used to combine two 
fragments, 1.6.II and 1.6.III, together in high yield and selectivity. The nitrile oxide 
piece 1.6.III was obtained though another [3+2] cycloaddition from 1.6.IV (Scheme 
1.6.1). 
 
Scheme 1.6.1: Retrosynthetic analysis of Carreira’s synthesis. 
 
1.6.2 SYNTHETIC ROUTE 
The synthesis began with modification of commercial available chiral building 
block Roche ester 1.6.1. Synthesis of fragment 6A, which was in the longest linear 
sequence of the whole synthetic plan, needed three steps. The coupling partner 6B was 
prepared by Noyori asymmetric hydrogenation of acetylenic ketone 1.6.4. The third piece 
bromide 6C, which also came from Roche ester 1.6.1, was prepared through simple 




Scheme 1.6.2: Synthesis of fragment 6A, 6B and 6C. 
 
Fragment 6A underwent smooth Mg-promoted [3+2] cycloaddition with 
enantiomerically pure allylic alcohol 6B to form 1.6.6 in good yield and selectivity. 
Oxidative cleavage followed by carbonyl addition with the Grignard reagent generated 
from 6C through Felkin-Anh controled provided stereopolyad 1.6.8. This tertiary alcohol 
was also obtained in high diastereoselectivity. Reductive cleavage of the N-O bond in the 
dihydroisoxazole motif with Raney-Ni followed by zinc borohydride mediated 1,3-
induction hydride transfer provided tertiary alkyl silyl ether 1.6.10; since the highly steric 
demanding environment where the silyl group sit on, the protecting group was stable in 




Key: (a) tBuOCl; (b) iPrOH, ErMgBr; (c) TPAP, NMO; (d) THF; (e) TESOTf, 2,6-lutidine; (f) Raney-Ni, B(OH)3, H2;
























































Scheme 1.6.3: Fragment union to generate 6D. 
 
Fragment 6D underwent second interative [3+2] cycloaddition with allylic alcohol 
6B to form 1.6.11; notably, for system as complicated as 6D and 6B, this cycloaddition 
still went smoothly and provided excellent level of diastereoselectivity. Oxidizing the 
alcohol 1.6.11 to form a ketone, followed by Wittig homologation and stereoselective 
dihydroxylation provide diol 1.6.12. Subsequent manipulation including chemoselective 
oxidation of primary alcohol to form carboxylic acid 1.6.13 and Yamaguchi 
macrolactonization to close the 14-membered lactone ring 1.6.14. The dihydroisoxazole 
motif was reduced followed by Pd(OAc)2 promoted hydrogenolysis of benzylic 
protecting group provided erythronolide A. 
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Scheme 1.6.4: End game of Carreira’s synthesis. 
  
1.6.3 METHODOLOGY HIGHLIGHT 
Nitrile oxide cycloaddition proved to be a highly selective method in organic 
synthesis to construct hetereocyclic compounds as masked 1,3-dioxygenated motif. 
Normally, the solvent polarity had little effect on the regioselectivity; instead, steric 
effects generally dominated.28 The first successful metal coordination controled 1,3-
dipolar cycloadditions of this type was reported by Kanemasa back to 1994.29 In 2001, 
Carriera developed a novel strategy to generate stereopolyad based on Kanemasa’s work, 
and this methodology proved to be very efficient and successful.27 Ever since the 
development of this strategy, several polyketide natural products, including epothilone A 
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and B,30 erythronolide A and bafilomycin A,31 were synthesized by Carriera’s group 
utilizing this methodology. 
 
1.6.4 SUMMARY 
Carreira developed the most concised assembly of erythronolide A, the aglycone 
form of erythromycin A, to date. The synthetic route constituted of 26 steps in longest 
linear sequence and 33 total steps from Roche ester. The whole synthetic scheme featured 
iterative application of nitrile oxide [3+2] cycloaddition to control stereochemistry and 
substrate directed carbonyl addtions. The application of chiral building block Roche ester 
helped to avoid using stoichmetric amount of chiral auxiliaries, which enhance the atomic 
economy of the whole synthetic scheme. The efficiency of this [3+2] cycloaddition was 
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CHAPTER 2: TRANSITION METAL CATALYZED ANTI-




Carbonly silylallylation reaction has been attracted for many years because the 
product is a very important synthetic intermediate in organic reaction (Scheme 2.1).2  For 
example, Roush utilized (E)-γ-(alkoxysilyl)allyl boronate for the construction of diol. 
Since then, various reagents have been developed from the same group to increase the 
selectivity. Recently, chiral silyl allyl Titinium reagent was used to give β-
hydroxyallylsilanes with high reactivity and selectivity. These types of reagents share 
common drawbacks such as generating stoichiometric amount of byproducts and 
requiring multiple steps for preparation. 
 
Scheme 2.1 Representative examples of chirally modified metal reagents for use in 
enantioselective carbonyl silylallylation. 
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In connection with studies aimed at the discovery of hydrogen-mediated reductive 
C-C bond formations beyond hydroformylation, a broad family of C-C bond forming 
transfer hydrogenations promoted by iridium catalyst was reported.3 A remarkable feature 
of these processes resides in the ability to achieve carbonyl addition from the aldehyde or 
alcohol oxidation level. In the former case, isopropanol or formic acid mediate reductive 
C-C coupling. In the latter case, dehydrogenation of the primary alcohol reactants 
generates aldehyde electrophiles, while simultaneously driving reductive generation of 
nucleophilic organometallics from unsaturated reactants.  Unlike conventional methods 
for carbonyl allylation, these processes circumvent use of premetallated nucleophiles and 
metallic reductants. In this fashion, α-(trimethylsilyl)allyl acetate can serve as a 
alternative to previously reported silicon-containing 1,3- or 1,1-bimetallic allyl transfer 
agents.  
 
2.2 REACTION OPTIMIZATION 
Our study began with the attempted (trimethylsilyl)allylation of alcohol 2.2a. 
Using the ortho-cyclometallated catalyst generated in situ from [Ir(cod)Cl]2, 4-cyano-3-
nitrobenzoic acid, BIPHEP and allyl acetate, neither the desired (trimethylsilyl)allylation 




Using the isolated π-allyl iridium precatalyst (BIPHEP)-I in the presence of 
cesium carbonate (eqn. 2), the desired (trimethylsilyl)allylation product 2.2a was formed 




Based on previous observations that the substituent para to the carboxylic group 
in our preformed cyclometallated catalyst plays an important role to affect the reaction 
outcome, we first screened different catalysts bearing various groups at this position. Our 
best result was obtained with cyano group on the para position of the acid moiety. In 
order to neutralize the acetic acid generated during C-C bond formation, a stoichiometric 
amount of base was added. This additive increased the conversion significantly. 
Additionally, due to the fact that the product tends to undergo Peterson type elimination 
under basic conditions, milder base such as NaHCO3 was employed, and the yield 
increased dramatically, with excellent diastereoselectivity. Unfortunately, these 
conditions were not suitable for aromatic substrates (Table 2.1). 
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Table 2.1 Optimization of inorganic base and substituents on Ir-complex. 
 
Based on these result, we used p-bromobenzyl alcohol 2.2d as a model substrate. 
We were pleased to find that K3PO4 also provided great enhancement of catalytic activity 
in our system. This helped us to carry out the reactions at lower temperature to achieve 




Table 2.2 Optimization of inorganic base, solvents and temperature. 
 
When screening phosphates as base additives, we found an interesting 
observation: different methods for drying base additives provided different reaction 
outcomes. For example, drying the base in oven for three days provided good yield and 
excellent diastereoselectivity. However, when we used flame dried base additive, only a 
trace amount of desired product was obtained and significant amount of Peterson 
Olefination by-product had been formed. Based on the hygroscopic nature of K3PO4, we 
hypothesized that the oven-dried base was contaminated with some water. Hence we used 
water as an additive in our catalytic system, and started to screen water loading. Finally, 
when 500 mol% water was added to the reaction mixture, the desired product was 
obtained in 78% yield, with > 20:1 anti:syn d.r. (Table 2.3). Later study showed that 
water could also help other iridium catalyzed carbon-carbon bond formation reactions 
using the o-cyclometallated iridium C,O-benzoate as catalyst. The origin of this water 
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effect has not yet been fully investigated; it might be that water helped to modify the pH 
in the reaction mixture, increase the solubility of the inorganic base and/or work as a 
proton shuttle to increase the turnover rate. 
 
Table 2.3 Observation of Water Effect. 
 
After successfully designing iridium catalyzed diastereoselective carbonyl 
silylallylation, we applied (R)-Segphos modified preformed ortho-cyclometallated 
iridium C,O-benzoate instead of the racemic Biphep complex in our reactions, after 
changing the concentration from 0.5 M to 1.0 M, a yield with 72%, > 20:1 anti:syn d.r., 
95% e.e. was achieved (Table 2.4). 
 
Table 2.4 Optimization for enantioselectivity. 
 
 64
With the optimized condition in hand, the scope of this transformation was tested. 
Diverse substituted benzyl alcohols, hetero aromatic alcohols, allylic alcohols and, 
unactivated aliphatic alcohols all showed good reactivity in this system, having an 
excellent level of anti-diastereo- and enantioselectivity. Carbonyl silylallylation from the 
aldehyde oxidation level employing isopropanol as the terminal reductant has also been 
explored. Under identical condition, but in the presence of isopropanol, corresponding 
aldehydes were converted to silylallylation products in good yield and high levels of anti-
diastereoselectivity with exceptional levels of enantioselectivity (Table 2.5). 
 
 
Table 2.5 Enantioselective α-(trimethylsilyl)allylation. 
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A plausible catalytic cycle is shown below. In order to activate the preformed 
iridium allyl complex, various pathways are possible. Protonolysis of the metal-allyl 
bond by alcohol presented (Pathway A), or transferring the allyl group to aldehyde 
(Pathway B) should be most plausible to generate the iridium hydride. Deprotonation of 
the iridium hydride with base generates a nucleophilic iridium anion, which coordinates 
to silylallyl acetate. Ionization of the silylallyl acetete through an SN2’ pathway gives the 
kinetically favored cis-π-silylallyl complex, which is in fast equilibrium with the (E)-
silylallyl complex and opens a vacant site on the metal center. (Scheme 2.2) 
 
Scheme 2.2 Proposed Catalytic Mechanisms and Model Accounting for Observed 
Stereocontrol. 
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At this stage, the aldehyde coordinates with iridium and carbon-carbon bond 
formation occurs through a six-membered chair-like transition state. This proposed 
transition state model is necessary to achieve a high level of stereocontrol. The newly 
formed iridium homoallylic alkoxide is a hexa-coordinated 18-electon complex, which 
suppresses the β-hydride elimination pathway. Another molecule of alcohol comes in to 
hydrolyze this complex, releases the desired product and, regenerates the iridium hydride 
to finish the catalytic cycle (Scheme 2.2). The absolute stereochemistry of the adducts 
has been confirmed by comparing the optical rotation with literature reported compound 
(See Supporting Information). 
By far, we have developed a highly stereoselective silylallylation method under 
iridium catalyzed transfer hydrogenation conditions. Notably, the manipulation of pre-
activation is dramatically shorter than previously reported methods, the reaction is not 
moisture sensitive and, excellent levels of regio-, anti-diastereo- and enantioselectivity 
are achieved using chiral catalyst under relatively easy-to-handle temperatures. 
 
2.3 APPLICATIONS OF ADDUCTS 
To evaluate the utility of the coupling products 2.3a-2.3i, adducts 2.3a, 2.3c, 2.3f 
and 2.3g were subjected to DMDO-mediated oxidative elimination.1m,n The 1,4-ene-diols 
2.5a, 2.5c, 2.5f and 2.5g were produced in excellent yield with high levels of E:Z 
selectivity (Table 2.6). 
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Table 2.6 Dioxirane mediated oxidative desilylation of adducts to furnish the 
corresponding 1,4-ene-diols. 
 
Proto-desilylation was attempted next. Under nearly all conditions assayed, 
exclusive formation of Peterson olefination products was observed. However, upon 
exposure of adduct 2.3g to TiCl4 in the presence of exogenous aldehyde, the product of 
proto-desilylation 2.6g is generated in 73% yield with complete E:Z selectivity (Scheme 
2.3). In the absence of aldehyde, Peterson olefination is again the exclusive reaction 
product, suggesting exogenous aldehyde protects the hydroxyl moiety of 2.3g through 
formation of a titanium bound hemi-acetal. Notably, compound 2.6g was previously 
prepared in 7-steps from malic acid.4 Thus far, the protodesilylation is most efficient for 
the benzyl ether-containing adduct 2.6g. 
 
 
Scheme 2.3 Protodesilylation of requires exogenous aldehyde. 
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Finally, under condition similar to those described by Woerpel,5 exposure of 2.5g-
OAc to chlorosulfonyl isocyanate delivers the product of [3+2] cycloaddition, the 4,5-
trans-disubstituted pyrrolidinone 2.7g, as a single diastereomer. Lactone formation was 
not observed. Formation of the 2.7g suggests a mechanism involving stereoselective 
addition of chlorosulfonyl isocyanate to the allylsilane anti-periplanar with respect to the 
silyl group to generate the indicated β-silyl carbocation. Exclusive N-cyclization 
accompanied by 1,2-silyl migration delivers the 4,5-trans-substituted pyrrolidinone 2.7g. 
In the absence of NaHCO3, a mixture of lactone and lactam products are observed. These 
data suggest that partitioning of the N- and O-cyclization pathways is not dictated 
primarily by steric factors as proposed by Woerpel,5b but that the acidity of the medium 
plays a dominant role (Scheme 2.4) 
 
 
Scheme 2.4 Reaction of adduct with chlorosulfonyl isocyanate to furnish the product of 
formal [3+2] cycloaddition 
 
2.4 SUMMARY 
We report a method for highly anti-diastereo- and enantioselective carbonyl 
silylallylation under the conditions of iridium catalyzed transfer hydrogenation from both 
aldehyde and alcohol oxidation levels. Substituted 1,4-ene-diols, five-membered lactam, 
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and formal vinylation products can be obtained after simple manipulations. The 
corresponding reaction using ruthenium based catalyst and allenylsilanes as allyl donors 
is still under way. 
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2.5 EXPERIMENTAL SECTION 
 
General Methods 
All reactions were run under an atmosphere of Argon. Tetrahydrofuran (THF) and 
toluene were obtained from Pure-Solv MD-5 Solvent Purification System (Innovative 
Technology). Anhydrous solvents were transferred by an oven-dried syringe. Sealed 
tubes (13x100 mm) were purchased from Fischer Scientific and were dried in an oven 
overnight and cooled under a stream of nitrogen prior to use. Commercially available 
allyl acetate (Aldrich) was purified by distillation prior to use. Cesium carbonate was 
purchased from Alfa Aesar and was used directly without further purification. 
Isopropanol (Fisher) was purified by distillation prior to use. Analytical thin-layer 
chromatography (TLC) was carried out using 0.2-mm commercial silica gel plates (DC-
Fertigplatten Kieselgel 60 F254). Infrared spectra were recorded on a Perkin-Elmer 1600 
spectrometer. High-resolution mass spectra (HRMS) were obtained on a Karatos MS9 
and are reported as m/z (relative intensity). Accurate masses are reported for the 
molecular ion (M+H, M or M-H) or a suitable fragment ion. Nuclear magnetic resonance 
spectra (1H NMR and 13C NMR) spectra were recorded with a Varian Gemini (400 MHz) 
spectrometer for CDCl3 solutions and chemical shifts are reported as parts per million 
(ppm) relative to residual CHCl3 δH (7.26 ppm) and CDCl3 δC (77.0 ppm), respectively, 
as internal standards. Coupling constants are reported in Hertz (Hz). 
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Preparation of (R)-I 
To a mixture of [Ir(cod)Cl]2 (87.3 mg, 0.13 mmol, 100 mol%), (R)-SEGPHOS (159 mg, 
0.26 mmol, 200 mol%), Cs2CO3 (169 mg, 0.52 mmol, 400 mol%), 4-CN-3-NO2BzOH 
(100 mg, 0.52 mmol, 400 mol%) and allyl acetate (65 mg, 0.65 mmol, 500 mol%) in a 
sealed tube under N2 atmosphere was added THF (2.6 mL, 0.05 M). The reaction mixture 
was stirred for 30 min at ambient temperature and heated for 1.5 hr at 80 oC, at which 
point the reaction mixture was allowed to cool to ambient temperature. The reaction 
mixture was filtered and washed with THF (10 mL). The filtrate was concentrated in 
vacuo and desolved in THF (2 mL), then hexanes (50 mL) was added. A yellow 
precipitate formed, which was collected by filtration and dried under vacuum (101 mg, 
0.098 mmol, 75% yield).  
 
Preparation of (R)-C3-TUNEPHOS 
To a mixture of [Ir(cod)Cl]2 (87.3 mg, 0.13 mmol, 100 mol%), (R)-C3-TUNEPHOS (155 
mg, 0.26 mmol, 200 mol%), Cs2CO3 (169 mg, 0.52 mmol, 400 mol%), 4-CN-3-
NO2BzOH (100 mg, 0.52 mmol, 400 mol%) and allyl acetate (65 mg, 0.65 mmol, 500 
mol%) in a sealed tube under N2 atmosphere was added THF (2.6 mL, 0.05 M). The 
reaction mixture was stirred for 30 min at ambient temperature and heated for 1.5 hr at 80 
oC, at which point the reaction mixture was allowed to cool to ambient temperature. The 
reaction mixture was filtered and washed with THF (10 mL). The filtrate was 
concentrated in vacuo and desolved in THF (2 mL), then hexanes (50 mL) was added. A 
yellow precipitate formed, which was collected by filtration and dried under vacuum (103 
mg, 0.101 mmol, 78% yield).  
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In accordane with a modified literature procedure,6 tirmethylsilyl allyl ether (10.0 g, 
0.076 mol, 100 mol%) was dissolved in THF (250 mL, 0.3 M), and then cooled to -78 oC. 
1.7 M solution of t-butyllithium in pentane (51 mL, 0.087 mol, 115 mol%) was added 
dropwise over 15 min and the resulting bright yellow solution was stirred for 2 hr at -78 
oC. The reaction mixture was quenched with acetic anhydride (8.025 g, 0.079 mol, 105 
mol%) at -78 oC and then stirred at ambient temperature overnight. Thre resulting 
mixture was diluted with water (50 mL) and pentane (100 mL).  The organic phase was 
separated and washed with water (3 times) and brine. The resulting solution was dried 
over Na2SO4, filtered and concentrated in vacuo. Purification of the residue by column 
chromatography (SiO2; Pentane: Ether, 20:1) provied 2.1 (9.2 g, 0.053 mmol) as a pale 
yellow oil in 70% yield. 
 
TLC (SiO2): Rf = 0.6 (ethyl acetate: hexanes, 1:30). 
 
1H NMR (400 MHz, CDCl3): δ 5.88-5.80 (m, 1H), 5.18 (dt, J = 5.6, 2.0 Hz, 1H), 5.00 
(dt, J = 8.4, 2.0 Hz, 1H), 4.97-4.95 (m, 1H), 2.09 (s, 3H), 0.05 (s, 9H). 
 
13C NMR (100 MHz, CDCl3): δ 170.7, 134.9, 111.2, 70.5, 21.0, -4.1. 
 
FTIR (neat): υ 2960, 1739, 1634, 1408, 1369, 1230, 1159, 1086, 1017, 991, 901, 839, 











An oven-dried sealed tube under one atmosphere of nitrogen gas was charged with 
benzaldehyde 2.4e (21.2 mg, 0.20 mmol, 100 mol%), (R)-I (10.3 mg, 0.01 mmol, 5 
mol%), K3PO4 (43 mg, 0.20 mmol, 100 mol%). THF (0.2 mL, 1.0 M), H2O (18 L, 1.0 
mmol, 500 mol%), isopropanol (24 mg, 0.4 mmol, 200 mol%)  and  α-
(trimethylsilyl)allyl acetate (103 mg, 0.60 mmol, 300 mol%) were added and the mixture 
was stirred at ambient temperature for 0.5 hr. The reaction mixture was allowed to stir at 
70 oC for 48 hr, at which point the reaction mixture was concentrated in vacuo. 
Purification of the residue by column chromatography (SiO2; ethyl acetate: hexanes, 1:20 
with 0.1% TEA) provided 2.3e (31.3 mg, 0.142 mmol) as a colorless oil in 71% yield. 
 
TLC (SiO2): Rf = 0.3 (ethyl acetate: hexanes, 1:10). 
 
1H NMR (400 MHz, CDCl3): δ 7.36-7.24 (m, 5H), 5.86 (dt, J = 17.2, 10.4 Hz, 1H), 5.11 
(dd, J = 10.4, 1.6 Hz, 1H), 5.05-5.00 (m, 1H), 4.80 (dd, J = 8.4, 1.6 Hz, 1H), 2.21 (d, J = 
1.6 Hz, 1H), 2.10-2.05 (m, 1H), -0.20 (s, 9H). 
 
13C NMR (100 MHz, CDCl3): δ 143.6, 136.6, 128.4, 127.8, 126.9, 116.0, 74.5, 45.6, -2.4. 
 
HPLC: (Chiralcel OJ-H column, hexanes:i-PrOH = 95:5, 0.5 mL/min, 210 nm), tminor = 
11.0 min, tmajor = 11.6 min; ee = 96%. 
 
[]D25= +47.01 (c =2.8, CHCl3). To corroborate the assignement of absolute 
stereochemistry, the optical rotation was correlated with a known compound7 
 
FTIR (neat): υ 3426, 2953, 2896, 1626, 1494, 1455, 1386, 1247, 1196, 1153, 1089, 1050, 
1028, 988, 906, 835, 786, 763, 718, 698 cm-1. 
 
HRMS (CI) Calcd. for C13H21OSi [M+H]














An oven-dried sealed tube under one atmosphere of nitrogen gas was charged with 4-
bromobenzaldehyde 2.4d (37.0 mg, 0.20 mmol, 100 mol%), (R)-I (10.3 mg, 0.01 mmol, 
5 mol%), K3PO4 (43 mg, 0.20 mmol, 100 mol%). THF (0.2 mL, 1.0 M), H2O (18 L, 1.0 
mmol, 500 mol%), isopropanol (24 mg, 0.4 mmol, 200 mol%)  and α-(trimethylsilyl)allyl 
acetate (103 mg, 0.60 mmol, 300 mol%) were added and the mixture was stirred at 
ambient temperature for 0.5 hr. The reaction mixture was allowed to stir at 70 oC for 48 
hr, at which point the reaction mixture was concentrated in vacuo. Purification of the 
residue by column chromatography (SiO2; ethyl acetate: hexanes, 1:20 with 0.1% TEA) 
provided 2.3d (43.7 mg, 0.146 mmol) as a colorless oil in 73% yield. 
 
TLC (SiO2): Rf = 0.3 (ethyl acetate: hexanes, 1:10). 
 
1H NMR (400 MHz, CDCl3): δ 7.46 (d, J = 8.4, 2H),  7.46 (d, J = 8.4, 2H), 5.82 (dt, J = 
17.2, 10.4 Hz, 1H), 5.10 (dd, J = 10.4, 1.6 Hz, 1H), 5.03 (d, J = 17.2 Hz, 1H), 4.78 (d, J = 
7.6 Hz, 1H), 2.20 (br, 1H), 2.02-1.97 (m, 1H), -0.16 (s, 9H). 
 
13C NMR (100 MHz, CDCl3): δ 142.8, 135.9, 131.4, 128.5, 121.4, 116.3, 73.8, 45.5, -2.6. 
 
HPLC: (Chiralcel OJ-H column, hexanes:i-PrOH = 95:5, 1.0 mL/min, 210 nm), tminor = 
11.9 min, tmajor = 12.9 min; ee = 98%. 
 
[]D25= +37.4 (c =0.62, CH2Cl2). 
 
FTIR (neat): υ 3430, 2953, 1625, 1592, 1485, 1408, 1247, 1191, 1155, 1088, 1070, 1010, 
908, 833, 785, 753, 737, 691 cm-1. 
 
HRMS (CI) Calcd. for C13H20BrOSi [M+H]
















An oven-dried sealed tube under one atmosphere of nitrogen gas was charged with 
methyl 4-formylbenzoate 2.4e (32.8 mg, 0.20 mmol, 100 mol%), (R)-I (10.3 mg, 0.01 
mmol, 5 mol%), K3PO4 (43 mg, 0.20 mmol, 100 mol%). THF (0.2 mL, 1.0 M), H2O (18 
L, 1.0 mmol, 500 mol%), isopropanol (24 mg, 0.4 mmol, 200 mol%)  and α-
(trimethylsilyl)allyl acetate (103 mg, 0.60 mmol, 300 mol%) were added and the mixture 
was stirred at ambient temperature for 0.5 hr. The reaction mixture was allowed to stir at 
70 oC for 48 hr, at which point the reaction mixture was concentrated in vacuo. 
Purification of the residue by column chromatography (SiO2; ethyl acetate: hexanes, 1:20 
with 0.1% TEA) provided 2.3e (43.4 mg, 0.156 mmol) as a colorless oil in 78% yield. 
 
TLC (SiO2): Rf = 0.2 (ethyl acetate: hexanes, 1:10). 
 
1H NMR (400 MHz, CDCl3): δ 8.01-7.99 (m, 2H), 7.41-7.39 (m, 2H), 5.83 (dt, J = 16.8, 
10.4 Hz, 1H), 5.08 (dd, J = 10.4, 1.6 Hz, 1H), 4.99-4.94 (m, 1H), 4.88 (d, J = 7.6 Hz, 
1H), 3.91 (s, 3H), 2.27 (br, 1H), 2.04-2.00 (m, 1H), -0.15 (s, 9H). 
 
13C NMR (100 MHz, CDCl3): δ 166.9, 149.0, 135.7, 129.7, 129.4, 126.7, 116.4, 74.1, 
52.1, 45.5, -2.4. 
 
HPLC: (Chiralcel OD-H column, hexanes:i-PrOH = 95:5, 1.0 mL/min, 230 nm), tminor = 
12.7 min, tmajor = 14.3 min; ee = 98%. 
 
[]D25= +16.1 (c =0.23, CH2Cl2). 
 
FTIR (neat): υ 3501, 2954, 2889, 1698, 1624, 1609, 1433, 1390, 1346, 1307, 1155,  
1018, 1005, 977, 955, 895, 835, 784, 772, 729, 702 cm-1. 
 
HRMS (CI) Calcd. for C15H23O3Si [M+H]


















An oven-dried sealed tube under one atmosphere of nitrogen gas was charged with 
cinnamaldehyde 2.4b (26.4 mg, 0.20 mmol, 100 mol%), (R)-I (10.3 mg, 0.01 mmol, 5 
mol%), K3PO4 (43 mg, 0.20 mmol, 100 mol%). THF (0.2 mL, 1.0 M), H2O (18 L, 1.0 
mmol, 500 mol%), isopropanol (24 mg, 0.4 mmol, 200 mol%)  and α-(trimethylsilyl)allyl 
acetate (103 mg, 0.60 mmol, 300 mol%) were added and the mixture was stirred at 
ambient temperature for 0.5 hr. The reaction mixture was allowed to stir at 70 oC for 48 
hr, at which point the reaction mixture was concentrated in vacuo. Purification of the 
residue by column chromatography (SiO2; ethyl acetate: hexanes, 1:20 with 0.1% TEA) 
provided 2.3b (36.5 mg, 0.148 mmol) as a colorless oil in 74% yield. 
 
TLC (SiO2): Rf = 0.2 (ethyl acetate:hexanes, 1:10). 
 
1H NMR (400 MHz, CDCl3): δ 7.39-7.22 (m, 5H),  6.58 (d, J = 15.6 Hz, 1H), 6.22 (dd, J 
= 15.6, 7.6 Hz, 1H), 5.84 (dt, J = 16.8, 10.4 Hz, 1H), 5.10 (dd, J = 10.0, 2.0 Hz, 1H), 5.02 
(ddd, J = 16.8, 2.0, 0.8 Hz, 1H), 4.43 (td, J = 7.6, 1.2 Hz, 1H), 1.90-1.86 (m, 2H),  0.05 
(s, 9H). 
 
13C NMR (100 MHz, CDCl3): δ 136.6, 136.1, 131.9, 130.8, 128.6, 127.7, 126.5, 115.7, 
73.2, 44.1, -1.9. 
 
HPLC: (Chiralcel OJ-H column, hexanes:i-PrOH = 95:5, 0.5 mL/min, 210 nm), tminor = 
13.6 min, tmajor = 14.8 min; ee = 94%. 
 
[]D25= +38.8 (c =0.21, CH2Cl2). 
 
FTIR (neat): υ 3428, 3026, 2954, 1625, 1494, 1449, 1379, 1246, 1105, 1035, 1003, 964, 
897, 860, 853, 784, 748, 724, 691 cm-1. 
 
HRMS (CI) Calcd. for C15H23OSi [M+H]
















An oven-dried sealed tube under one atmosphere of nitrogen gas was charged with 6-
bromopicolinaldehyde 2.4i (37.2 mg, 0.20 mmol, 100 mol%), (R)-I (10.3 mg, 0.01 mmol, 
5 mol%), K3PO4 (43 mg, 0.20 mmol, 100 mol%). THF (0.2 mL, 1.0 M), H2O (18 L, 1.0 
mmol, 500 mol%), isopropanol (24 mg, 0.4 mmol, 200 mol%)  and α-(trimethylsilyl)allyl 
acetate (103 mg, 0.60 mmol, 300 mol%) were added and the mixture was stirred at 
ambient temperature for 0.5 hr. The reaction mixture was allowed to stir at 70 oC for 48 
hr, at which point the reaction mixture was concentrated in vacuo. Purification of the 
residue by column chromatography (SiO2; ethyl acetate: hexanes, 1:20 with 0.1% TEA) 
provided 2.3i (39.6 mg, 0.132 mmol) as a colorless oil in 66% yield. 
 
TLC (SiO2): Rf = 0.2 (ethyl acetate:hexanes, 1:10). 
 
1H NMR (400 MHz, CDCl3): δ 7.51 (t, J = 7.6 Hz, 1H), 7.34 (dd, J = 7.6, 0.4 Hz, 1H), 
7.20 (dt, J = 7.6, 0.4 Hz, 1H), 5.71 (dt, J = 17.2, 10.4 Hz, 1H), 4.94 (t, J = 4.4 Hz, 1H), 
4.85 (dd, J = 10.4, 2.4 Hz, 1H), 4.76 (ddd, J = 17.2, 2.4, 0.8 Hz, 1H), 3.59 (d, J = 4.4 Hz, 
1H), 2.07 (dd, J = 10.4, 4.4 Hz, 1H), 0.05 (s, 9H). 
 
13C NMR (100 MHz, CDCl3): δ 164.1, 140.7, 138.8, 134.7, 126.3, 119.6, 114.9, 73.0, 
43.4, -2.3. 
 
HPLC: (Chiralcel OD-H column, hexanes:i-PrOH = 98:2, 1.0 mL/min, 254 nm), tmajor = 
6.6 min , tminor = 7.9 min; ee = 99%. 
 
[]D25= -44.6 (c =0.40, CH2Cl2). 
 
FTIR (neat): υ 3348, 2922, 1583, 1556, 1441, 1406, 1377, 1286, 1241, 1163, 1212, 1080, 
1057, 999, 930, 903, 838, 806, 779, 748, 677. 
 
HRMS (CI) Calcd. for C12H19NOBrSi [M+H]













An oven-dried sealed tube under one atmosphere of nitrogen gas was charged with 3-
phenylpropanal 2.4a (26.8 mg, 0.20 mmol, 100 mol%), (R)-I (10.3 mg, 0.01 mmol, 5 
mol%), K3PO4 (43 mg, 0.20 mmol, 100 mol%). THF (0.2 mL, 1.0 M), H2O (18 L, 1.0 
mmol, 500 mol%), isopropanol (24 mg, 0.4 mmol, 200 mol%)  and α-(trimethylsilyl)allyl 
acetate (103 mg, 0.60 mmol, 300 mol%) were added and the mixture was stirred at 
ambient temperature for 0.5 hr. The reaction mixture was allowed to stir at 70 oC for 48 
hr, at which point the reaction mixture was concentrated in vacuo. Purification of the 
residue by column chromatography (SiO2; ethyl acetate: hexanes, 1:20 with 0.1% TEA) 
provided 2.3a (34.3 mg, 0.138 mmol) as a colorless oil in 69% yield. 
 
TLC (SiO2): Rf = 0.3 (ethyl acetate:hexanes, 1:10). 
 
1H NMR (400 MHz, CDCl3): δ 7.30-7.26 (m, 2H), 7.20-7.17 (m, 3H), 5.79 (dt, J = 17.2, 
10.8 Hz, 1H), 5.06 (dd, J = 10.4, 2.0 Hz, 1H), 4.95 (dd, J = 17.2, 2.0 Hz, 1H), 3.84-3.82 
(m, 1H), 2.76-2.63 (m, 2H), 1.84-1.71 (m, 3H), 0.04 (s, 9H). 
 
13C NMR (100 MHz, CDCl3): δ 142.1, 135.7, 128.4, 128.3, 125.8, 115.3, 71.0, 42.7, 
39.1, 32.3,   -2.0. 
 
HPLC: (Chiralcel OD-H column, hexanes:i-PrOH = 95:5, 0.5 mL/min, 210 nm), tmajor = 
12.1 min, tminor = 16.8 min ; ee = 98%. 
 
[]D25= +13.3 (c =0.60, CH2Cl2). 
 
FTIR (neat): υ 3448, 3027, 2951, 1624, 1603, 1495, 1454, 1414, 1246, 1167, 1098, 1044, 
999, 897, 835, 748, 698. 
 
HRMS (CI) Calcd. for C15H23OSi [M-H]














An oven-dried sealed tube under one atmosphere of nitrogen gas was charged with 3-
(benzyloxy)propanal 2.4g (32.8 mg, 0.20 mmol, 100 mol%), (R)-I (10.3 mg, 0.01 mmol, 
5 mol%), K3PO4 (43 mg, 0.20 mmol, 100 mol%). THF (0.2 mL, 1.0 M), H2O (18 L, 1.0 
mmol, 500 mol%), isopropanol (24 mg, 0.4 mmol, 200 mol%)  and α-(trimethylsilyl)allyl 
acetate (103 mg, 0.60 mmol, 300 mol%) were added and the mixture was stirred at 
ambient temperature for 0.5 hr. The reaction mixture was allowed to stir at 70 oC for 48 
hr, at which point the reaction mixture was concentrated in vacuo. Purification of the 
residue by column chromatography (SiO2; ethyl acetate: hexanes, 1:20 with 0.1% TEA) 
provided 2.3g (35.1 mg, 0.126 mmol) as a colorless oil in 63% yield (4:1 dr). 
 
TLC (SiO2): Rf = 0.3 (ethyl acetate:hexanes, 1:10). 
 
1H NMR (400 MHz, CDCl3): δ 7.37-7.29 (m, 5H), 5.90 (dt, J = 17.2, 10.4 Hz, 1H), 4.99 
(dd, J = 10.4, 2.4 Hz, 1H), 4.87 (ddd, J = 17.2, 2.4, 0.8 Hz, 1H), 4.52 (s, 2H), 4.08-4.01 
(m, 1H), 3.72-3.61 (m, 2H),  2.74-2.73 (m, 1H), 1.95-1.85 (m, 1H),  1.65-1.58 (m, 2H), 
0.05 (s, 9H). 
 
13C NMR (100 MHz, CDCl3): δ 138.0, 136.1, 128.4, 127.7, 127.6, 114.1, 73.2, 71.3, 
69.4, 43.2, 36.8, -2.1. 
 
HPLC: (Chiralcel OJ-H column, hexanes:i-PrOH = 97.5:2.5, 0.5 mL/min, 210 nm), tmajor 
= 11.8 min, tminor = 13.3 min; ee = 98%. 
 
[]D25= +26.7 (c =0.64, CH2Cl2). 
 
FTIR (neat): υ 3511, 2951, 2860, 1623,1496, 1454, 1414, 1362, 1244, 1205, 1088, 1027, 
1004, 896, 835, 780, 733, 696. 
 
HRMS (CI) Calcd. for C16H25O2Si [M-H]















An oven-dried sealed tube under one atmosphere of nitrogen gas was charged with ). 4-
(benzyloxy)butana 2.4h (35.6 mg, 0.20 mmol, 100 mol%), (R)-I (10.3 mg, 0.01 mmol, 5 
mol%), K3PO4 (43 mg, 0.20 mmol, 100 mol%). THF (0.2 mL, 1.0 M), H2O (18 L, 1.0 
mmol, 500 mol%), isopropanol (24 mg, 0.4 mmol, 200 mol%)  and α-(trimethylsilyl)allyl 
acetate (103 mg, 0.60 mmol, 300 mol%) were added and the mixture was stirred at 
ambient temperature for 0.5 hr. The reaction mixture was allowed to stir at 70 oC for 48 
hr, at which point the reaction mixture was concentrated in vacuo. Purification of the 
residue by column chromatography (SiO2; ethyl acetate: hexanes, 1:20 with 0.1% TEA) 
provided 2.3h (40.4 mg, 0.138 mmol) as a colorless oil in 69% yield. 
 
TLC (SiO2): Rf = 0.4 (ethyl acetate:hexanes, 1:10). 
 
1H NMR (400 MHz, CDCl3): δ 7.37-7.26 (m, 5H), 5.83 (dt, J = 16.8, 10.4 Hz, 1H), 5.02 
(dd, J = 10.4, 2.4 Hz, 1H), 4.91 (ddd, J = 16.8, 2.4, 0.8 Hz, 1H), 4.52 (m, 2H), 3.86-3.80 
(m, 1H), 3.52-3.48 (m, 2H),  2.13 (d, J = 4.0 Hz, 1H), 1.75-1.49 (m, 5H), 0.04 (s, 9H). 
 
13C NMR (100 MHz, CDCl3): δ 138.3, 136.0, 128.4, 127.6, 127.5, 114.7, 72.9, 71.2, 
70.4, 42.8, 34.5, 26.4, -2.1. 
 
HPLC: (Chiralcel OD-H column, hexanes:i-PrOH = 95:5, 0.5 mL/min, 210 nm), tminor = 
10.9 min, tmajor = 12.2 min; ee = 98%. 
 
[]D25= +41.2 (c =0.63, CH2Cl2). 
 
FTIR (neat): υ 3448, 2950, 2857, 1624, 1496, 1454, 1362, 1244, 1204, 1097, 1028, 950, 
895, 835, 782, 734, 696. 
 
HRMS (CI) Calcd. for C17H27O2Si [M-H]

















An oven-dried sealed tube under one atmosphere of nitrogen gas was charged with 
nonanal 2.4c (28.4 mg, 0.20 mmol, 100 mol%), (R)-I (10.3 mg, 0.01 mmol, 5 mol%), 
K3PO4 (43 mg, 0.20 mmol, 100 mol%). THF (0.2 mL, 1.0 M), H2O (18 L, 1.0 mmol, 
500 mol%), isopropanol (24 mg, 0.4 mmol, 200 mol%)  and α-(trimethylsilyl)allyl 
acetate (103 mg, 0.60 mmol, 300 mol%) were added and the mixture was stirred at 
ambient temperature for 0.5 hr. The reaction mixture was allowed to stir at 70 oC for 48 
hr, at which point the reaction mixture was concentrated in vacuo. Purification of the 
residue by column chromatography (SiO2; ethyl acetate: hexanes, 1:20 with 0.1% TEA) 
provided 2.3c (36.9 mg, 0.144 mmol) as a colorless oil in 72% yield. 
 
TLC (SiO2): Rf = 0.4 (ethyl acetate:hexanes, 1:10). 
 
1H NMR (400 MHz, CDCl3): δ 5.79 (dt, J = 17.2, 10.4 Hz, 1H), 5.03 (d, J = 10.4 Hz, 
1H), 4.92 (d, J = 17.2 Hz, 1H), 3.84-3.74 (m, 1H), 1.69-1.65 (m, 1H), 1.49-1.26 (m, 
15H), 0.88 (t, J = 6.8 Hz, 3H),  0.04 (s, 9H). 
 
13C NMR (100 MHz, CDCl3): δ 135.9, 115.0, 71.5, 42.6, 37.3, 31.9, 29.6, 29.3, 25.8, 
22.7, 14.1, -2.0. 
 
HPLC: Enantiomeric excess was determined by HPLC analysis of the 3,5-nitrobenzoate 
derivative of the product (Chiralcel OD-H column, hexanes:i-PrOH = 95:5, 0.5 mL/min, 
254 nm), tminor = 10.7 min, tmajor = 11.3 min; ee = 90%. 
 
[]D25= +21.2 (c =0.57, CH2Cl2). 
 
FTIR (neat): υ 3463, 2955, 2924, 2854, 1716, 1624, 1465, 1378, 1246, 1167, 1049, 1004, 
895, 836, 750, 723, 690. 
 
HRMS (CI) Calcd. for C15H31OSi [M-H]














An oven-dried sealed tube under one atmosphere of nitrogen gas was charged with 
benzyl alcohol 2.2f (21.6 mg, 0.20 mmol, 100 mol%), (R)-I (10.3 mg, 0.01 mmol, 5 
mol%), K3PO4 (43 mg, 0.20 mmol, 100 mol%). THF (0.2 mL, 1.0 M), H2O (18 L, 1.0 
mmol, 500 mol%) and α-(trimethylsilyl)allyl acetate (103 mg, 0.60 mmol, 300 mol%) 
were added and the mixture was stirred at ambient temperature for 0.5 hr. The reaction 
mixture was allowed to stir at 70 oC for 48 hr, at which point the reaction mixture was 
concentrated in vacuo. Purification of the residue by column chromatography (SiO2; ethyl 
acetate: hexanes, 1:20 to 1:10 with 0.1% TEA) provided 2.3f (30.4 mg, 0.138 mmol) as a 
colorless oil in 69% yield. 
 
HPLC: (Chiralcel OJ-H column, hexanes:i-PrOH = 95:5, 0.5 mL/min, 210 nm), tminor = 













An oven-dried sealed tube under one atmosphere of nitrogen gas was charged with 4-
bromobenzyl alcohol 2.2d (37.4 mg, 0.20 mmol, 100 mol%), (R)-I (10.3 mg, 0.01 mmol, 
5 mol%), K3PO4 (43 mg, 0.20 mmol, 100 mol%). THF (0.2 mL, 1.0 M), H2O (18 L, 1.0 
mmol, 500 mol%) and α-(trimethylsilyl)allyl acetate (103 mg, 0.60 mmol, 300 mol%) 
were added and the mixture was stirred at ambient temperature for 0.5 hr. The reaction 
mixture was allowed to stir at 70 oC for 48 hr, at which point the reaction mixture was 
concentrated in vacuo. Purification of the residue by column chromatography (SiO2; ethyl 
acetate: hexanes, 1:20 with 0.1% TEA) provided 2.3d (43.1 mg, 0.144 mmol) as a 
colorless oil in 72% yield. 
 
HPLC: (Chiralcel OJ-H column, hexanes:i-PrOH = 95:5, 1.0 mL/min, 210 nm), tminor = 












An oven-dried sealed tube under one atmosphere of nitrogen gas was charged with 
methyl 4-(hydroxymethyl)benzoate 2.2e (33.2 mg, 0.20 mmol, 100 mol%), (R)-I (10.3 
mg, 0.01 mmol, 5 mol%), K3PO4 (43 mg, 0.20 mmol, 100 mol%). THF (0.2 mL, 1.0 M), 
H2O (18 L, 1.0 mmol, 500 mol%) and α-(trimethylsilyl)allyl acetate (103 mg, 0.60 
mmol, 300 mol%) were added and the mixture was stirred at ambient temperature for 0.5 
hr. The reaction mixture was allowed to stir at 70 oC for 48 hr, at which point the reaction 
mixture was concentrated in vacuo. Purification of the residue by column 
chromatography (SiO2; ethyl acetate: hexanes, 1:20 with 0.1% TEA) provided 2.3e (41.8 
mg, 0.150 mmol) as a colorless oil in 75% yield. 
 
HPLC: (Chiralcel OD-H column, hexanes:i-PrOH = 95:5, 1.0 mL/min, 230 nm), tminor = 













An oven-dried sealed tube under one atmosphere of nitrogen gas was charged with 
cinnamyl alcohol 2.2b (26.8 mg, 0.20 mmol, 100 mol%), (R)-C3-TUNEPHOS (10.2 mg, 
0.01 mmol, 5 mol%), K3PO4 (43 mg, 0.20 mmol, 100 mol%). THF (0.2 mL, 1.0 M), H2O 
(18 L, 1.0 mmol, 500 mol%) and α-(trimethylsilyl)allyl acetate (103 mg, 0.60 mmol, 
300 mol%) were added and the mixture was stirred at ambient temperature for 0.5 hr. The 
reaction mixture was allowed to stir at 70 oC for 48 hr, at which point the reaction 
mixture was concentrated in vacuo. Purification of the residue by column 
chromatography (SiO2; ethyl acetate: hexanes, 1:20 with 0.1% TEA) provided 2.3b (34.5 
mg, 0.140 mmol) as a colorless oil in 70% yield. 
 
HPLC: (Chiralcel OJ-H column, hexanes:i-PrOH = 95:5, 0.5 mL/min, 210 nm), tminor = 














An oven-dried sealed tube under one atmosphere of nitrogen gas was charged with (6-
bromopyridin-2-yl)methanol 2.2i (37.6 mg, 0.20 mmol, 100 mol%), (R)-I (10.3 mg, 0.01 
mmol, 5 mol%), K3PO4 (43 mg, 0.20 mmol, 100 mol%). THF (0.2 mL, 1.0 M), H2O (18 
L, 1.0 mmol, 500 mol%) and α-(trimethylsilyl)allyl acetate (103 mg, 0.60 mmol, 300 
mol%) were added and the mixture was stirred at ambient temperature for 0.5 hr. The 
reaction mixture was allowed to stir at 70 oC for 48 hr, at which point the reaction 
mixture was concentrated in vacuo. Purification of the residue by column 
chromatography (SiO2; ethyl acetate: hexanes, 1:20 with 0.1% TEA) provided 2.3i (34.8 
mg, 0.116 mmol) as a colorless oil in 58% yield. 
 
HPLC: (Chiralcel OD-H column, hexanes:i-PrOH = 98:2, 1.0 mL/min, 254 nm), tmajor = 












An oven-dried sealed tube under one atmosphere of nitrogen gas was charged with 3-
phenylpropan-1-ol 2.2a (27.2 mg, 0.20 mmol, 100 mol%), (R)-I (10.3 mg, 0.01 mmol, 5 
mol%), K3PO4 (43 mg, 0.20 mmol, 100 mol%). THF (0.2 mL, 1.0 M), H2O (18 L, 1.0 
mmol, 500 mol%) and α-(trimethylsilyl)allyl acetate (103 mg, 0.60 mmol, 300 mol%) 
were added and the mixture was stirred at ambient temperature for 0.5 hr. The reaction 
mixture was allowed to stir at 70 oC for 48 hr, at which point the reaction mixture was 
concentrated in vacuo. Purification of the residue by column chromatography (SiO2; ethyl 
acetate: hexanes, 1:20 with 0.1% TEA) provided 2.3a (32.3 mg, 0.130 mmol) as a 
colorless oil in 65% yield. 
 
HPLC: (Chiralcel OD-H column, hexanes:i-PrOH = 95:5, 0.5 mL/min, 210 nm), tmajor = 












An oven-dried sealed tube under one atmosphere of nitrogen gas was charged with 3-
(benzyloxy)propan-1-ol 2.2g (33.2 mg, 0.20 mmol, 100 mol%), (R)-I (10.3 mg, 0.01 
mmol, 5 mol%), K3PO4 (43 mg, 0.20 mmol, 100 mol%). THF (0.2 mL, 1.0 M), H2O (18 
L, 1.0 mmol, 500 mol%) and α-(trimethylsilyl)allyl acetate (103 mg, 0.60 mmol, 300 
mol%) were added and the mixture was stirred at ambient temperature for 0.5 hr. The 
reaction mixture was allowed to stir at 70 oC for 48 hr, at which point the reaction 
mixture was concentrated in vacuo. Purification of the residue by column 
chromatography (SiO2; ethyl acetate: hexanes, 1:20 with 0.1% TEA) provided 2.3g (34.0 
mg, 0.122 mmol) as a colorless oil in 61% yield. 
 
HPLC: (Chiralcel OJ-H column, hexanes:i-PrOH = 97.5:2.5, 0.5 mL/min, 210 nm), tmajor 












An oven-dried sealed tube under one atmosphere of nitrogen gas was charged with 4-
(benzyloxy)butan-1-ol 2.2h (36.0 mg, 0.20 mmol, 100 mol%), (R)-I (10.3 mg, 0.01 
mmol, 5 mol%), K3PO4 (43 mg, 0.20 mmol, 100 mol%). THF (0.2 mL, 1.0 M), H2O (18 
L, 1.0 mmol, 500 mol%) and α-(trimethylsilyl)allyl acetate (103 mg, 0.60 mmol, 300 
mol%) were added and the mixture was stirred at ambient temperature for 0.5 hr. The 
reaction mixture was allowed to stir at 70 oC for 48 hr, at which point the reaction 
mixture was concentrated in vacuo. Purification of the residue by column 
chromatography (SiO2; ethyl acetate: hexanes, 1:20 with 0.1% TEA) provided 2.3h (40.4 
mg, 0.138 mmol) as a colorless oil in 69% yield. 
 
HPLC: (Chiralcel OD-H column, hexanes:i-PrOH = 95:5, 0.5 mL/min, 210 nm), tminor = 













An oven-dried sealed tube under one atmosphere of nitrogen gas was charged with 
nonan-1-ol 2.2c (28.9 mg, 0.20 mmol, 100 mol%), (R)-I (10.3 mg, 0.01 mmol, 5 mol%), 
K3PO4 (43 mg, 0.20 mmol, 100 mol%). THF (0.2 mL, 1.0 M), H2O (18 L, 1.0 mmol, 
500 mol%) and α-(trimethylsilyl)allyl acetate (103 mg, 0.60 mmol, 300 mol%) were 
added and the mixture was stirred at ambient temperature for 0.5 hr. The reaction mixture 
was allowed to stir at 70 oC for 48 hr, at which point the reaction mixture was 
concentrated in vacuo. Purification of the residue by column chromatography (SiO2; ethyl 
acetate: hexanes, 1:20 with 0.1% TEA) provided 2.3c (34.4 mg, 0.134 mmol) as a 
colorless oil in 67% yield. 
 
HPLC: Enantiomeric excess was determined by HPLC analysis of the 3,5-nitrobenzoate 
derivative of the product (Chiralcel OD-H column, hexanes:i-PrOH = 95:5, 0.5 mL/min, 











A flask was charged with 2.3f (33.1 mg, 0.15 mmol, 100 mol%), K2CO3 (103.7 mg, 0.75 
mmol, 500 mol%) and acetone (1.25 mL). The mixture was cooled to -20 oC, and then 
0.08 M solution of dimethyl dioxirane in acetone (3.75 mL, 0.3 mmol, 200 mol%) was 
added. The resulting mixture was warmed to 0 oC and stirred until no starting material 
left (checked by TLC). The mixture was filtered through a pad of celite, concentrated, 
and treated with a solution of HOAc (0.5 mL) in MeOH (3 mL) for 30 min. The solution 
was diluted with ether and washed with sat’d aqueous NaHCO3 solution. The aqueous 
layer was extracted with ether. The combined organic layers was dried over Na2SO4, 
filtered and concentrated in vacuo. Purification of the residue by column chromatography 
(SiO2; ether) provided 2.5f (19.5 mg, 0.119 mmol) as a colorless oil in 79% yield. (E:Z = 
5:1) 
 
TLC (SiO2): Rf = 0.4 (ethyl acetate:ether, 1:40). 
 
1H NMR for the major product (400 MHz, CDCl3): δ 7.37-7.27 (m, 5H), 5.93-5.92 (m, 
2H), 5.25-5.20 (m, 1H), 4.15 (d, J = 2.0 Hz, 2H), 2.32 (br, 1H), 1.77 (br, 1H). 
 
13C NMR for the major product (100 MHz, CDCl3): δ 142.7, 133.4, 130.2, 128.6, 127.8, 
126.2, 74.8, 63.1. 
 
FTIR (neat): υ 3304, 3029, 2859, 1492, 1452, 1261, 1193, 1086, 970, 912, 846, 751. 
 
HRMS (CI) Calcd. for C10H11O2 [M-H]
+: 163.0759, Found: 163.0760. 
 













A flask was charged with 2.3a (37.3 mg, 0.15 mmol, 100 mol%), K2CO3 (103.7 mg, 0.75 
mmol, 500 mol%) and acetone (1.25 mL).  The mixture was cooled to -20 oC, and then 
0.08 M solution of dimethyl dioxirane in acetone (3.75 mL, 0.3 mmol, 200 mol%) was 
added. The resulting mixture was warmed to 0 oC and stirred until no starting material 
left (checked by TLC). The mixture was filtered through a pad of celite, concentrated, 
and treated with a solution of HOAc (0.5 mL) in MeOH (3 mL) for 30 min. The solution 
was diluted with ether and washed with sat’d aqueous NaHCO3 solution. The aqueous 
layer was extracted with ether. The combined organic layers was dried over Na2SO4, 
filtered and concentrated in vacuo. Purification of the residue by column chromatography 
(SiO2; ether) provided 2.5a (24.2 mg, 0.126 mmol) as a colorless oil in 84% yield. (E:Z = 
10:1) 
 
TLC (SiO2): Rf = 0.4 (ethyl acetate:ether, 1:40). 
 
1H NMR (400 MHz, CDCl3): δ 7.36-7.31 (m, 2H), 7.26-7.22 (m, 2H), 5.93-5.87 (m, 1H), 
5.84-5.78 (m, 1H), 4.24-4.19 (m, 3H), 2.84-2.70 (m, 2H), 1.99-1.86 (m, 2H), 1.85 (br, 
1H), 1.71 (br, 1H). 
 
13C NMR (100 MHz, CDCl3): δ 141.7, 134.1, 130.0, 128.4, 128.4, 125.9, 71.6, 62.9, 
38.6, 31.6. 
 
FTIR (neat): υ 3323, 3026, 2924, 2859, 1496, 1454, 1093, 998, 972, 912, 746, 699. 
 
HRMS (CI) Calcd. for C12H16O2 [M]












A flask was charged with 2.3g (41.8 mg, 0.15 mmol, 100 mol%), K2CO3 (103.7 mg, 0.75 
mmol, 500 mol%) and acetone (1.25 mL).  The mixture was cooled to -20 oC, and then 
0.08 M solution of dimethyl dioxirane in acetone (3.75 mL, 0.3 mmol, 200 mol%) was 
added. The resulting mixture was warmed to 0 oC and stirred until no starting material 
left (checked by TLC). The mixture was filtered through a pad of celite, concentrated, 
and treated with a solution of HOAc (0.5 mL) in MeOH (3 mL) for 30 min. The solution 
was diluted with ether and washed with sat’d aqueous NaHCO3 solution. The aqueous 
layer was extracted with ether. The combined organic layers was dried over Na2SO4, 
filtered and concentrated in vacuo. Purification of the residue by column chromatography 
(SiO2; ether) provided 2.5g (29.3 mg, 0.132 mmol) as a colorless oil in 88% yield. (E:Z = 
≥20:1) 
 
TLC (SiO2): Rf = 0.4 (ethyl acetate:ether, 1:40). 
 
1H NMR (400 MHz, CDCl3): δ 7.83-7.30 (m, 5H), 5.87 (dtd, J = 15.6, 5.2, 1.2 Hz, 1H), 
5.74 (ddt, J = 15.6, 6.0, 1.2 Hz, 1H), 4.52 (s, 2H), 4.41-4.34 (m, 1H), 4.17-4.12 (m, 2H), 
3.74-3.61 (m, 2H), 3.00 (d, J = 3.6 Hz, 1H), 1.88-1.79 (m, 2H), 1.46 (br, 1H). 
 
13C NMR (100 MHz, CDCl3): δ 137.8, 133.6, 129.5, 128.5, 127.8, 127.7, 73.3, 71.2, 
68.4, 63.0, 36.4. 
 
FTIR (neat): υ 3346, 2921, 2860, 1496, 1454, 1414, 1364, 1310, 1206, 1072, 1004, 969, 
909, 802, 736. 
 
HRMS (CI) Calcd. for C13H17O3 [M-H]












A flask was charged with 2.3c (38.5 mg, 0.15 mmol, 100 mol%), K2CO3 (103.7 mg, 0.75 
mmol, 500 mol%) and acetone (1.25 mL).  The mixture was cooled to -20 oC, and then 
0.08 M solution of dimethyl dioxirane in acetone (3.75 mL, 0.3 mmol, 200 mol%) was 
added. The resulting mixture was warmed to 0 oC and stirred until no starting material 
left (checked by TLC). The mixture was filtered through a pad of celite, concentrated, 
and treated with a solution of HOAc (0.5 mL) in MeOH (3 mL) for 30 min. The solution 
was diluted with ether and washed with sat’d aqueous NaHCO3 solution. The aqueous 
layer was extracted with ether. The combined organic layers was dried over Na2SO4, 
filtered and concentrated in vacuo. Purification of the residue by column chromatography 
(SiO2; ether) provided 2.5c (26.1 mg, 0.131 mmol) as a colorless oil in 87% yield. (E:Z = 
10:1) 
 
TLC (SiO2): Rf = 0.5 (ethyl acetate:ether, 1:40). 
 
1H NMR (400 MHz, CDCl3): δ 5.89-5.79 (m, 1H), 5.76-5.69 (m, 1H), 4.15-4.09 (m, 3H), 
1.90 (br, 2H), 1.57-1.45 (m, 2H), 1.33-1.20  (m, 12H), 0.87 (t, J = 6.8 Hz, 3H). 
 
13C NMR (100 MHz, CDCl3): δ 134.5, 129.7, 72.3, 62.9, 37.2, 31.8, 29.5, 29.2, 25.4, 
25.3, 22.6, 14.1. 
 
FTIR (neat): υ 3332, 2854, 1465, 1085, 1005, 971, 722. 
 
HRMS (CI) Calcd. for C12H23O2 [M-H]













A flask was charged with 2.3g (30.2 mg, 0.11 mmol, 100 mol%), 4-nitrobenzaldehyde 
(18.1 mg, 0.12 mmol, 110 mol%) and DCM (1.2 mL, 0.9 M). The mixture was cooled to 
-78 oC, and then 1.0 M solution of TiCl4 in DCM (0.14 mL, 0.14 mmol, 130 mol%) was 
added dropwise over 3 min. The resulting mixture was stirred until no starting material 
left (checked by TLC). The mixture was quenched with sat’d aqueous ammonium 
chloride solution (3 mL) at -78 oC, and then diluted with DCM (3 mL). The resulting 
biphasic solution was warmed to ambient temperature and stirred for 10 min. The organic 
phase was separated and the aqueous was washed with DCM. The combined organic 
layers was dried over Na2SO4, filtered and concentrated in vacuo. Purification of the 
residue by column chromatography (SiO2; ether:hexanes, 1:4) provided 2.6g (16.6 mg, 
0.08 mmol) as a colorless oil in 73% yield.  
 
TLC (SiO2): Rf = 0.15 (ethyl acetate:hexanes, 1:4). 
 
1H NMR (400 MHz, CDCl3): δ 7.28-7.37 (m, 5H), 5.67 (dqd, J = 15.2, 6.4, 0.8 Hz, 1H), 
5.49 (dqd, J = 15.2, 6.4, 1.6 Hz, 1H), 4.52 (s, 2H), 4.25-4.31 (m, 1H), 3.72-3.66 (m, 1H), 
3.65-3.59 (m, 1H), 2.67 (d, J = 3.2 Hz, 1H), 1.85-1.75 (m, 2H), 1.69 (ddd, J = 6.8, 1.6, 
0.8 Hz, 3H). 
 
13C NMR (100 MHz, CDCl3): δ 138.0, 133.5, 128.4, 127.7, 127.6, 126.4, 73.2, 71.8, 
68.4, 36.7, 17.7. 
 
FTIR (neat): υ 3414, 3029, 2916, 2857, 1496, 1453, 1364, 1309, 1205, 1096, 966, 923, 
801, 736. 
 
HRMS (CI) Calcd. for C13H17O2 [M-H]
+: 205.1229, Found: 205.1227. 
 















To a cooled (0 oC) suspension of 2.3g (100 mg, 0.36 mmol, 100 mol%), DMAP (4.4 mg, 
0.036 mmol, 10 mol%) and Et3N (72.9 mg, 0.72 mmol, 200 mol%)  in DCM (4.0 mL, 
0.09 M) was added acetic anhydride (73.8 mg, 0.72 mmol, 200 mol%). The reaction 
mixture was allowed to warm to ambient temperature and stirred overnight. The mixture 
was washed with sat’d aqueous NaHCO3, dried over MgSO4, filtered and concentrated in 
vacuo. Purification of the residue by column chromatography (SiO2; ethyl acetate: 
hexanes, 1:30 with 0.1% TEA) provided 2.3g-OAc (114.2 mg, 0.36 mmol) as a colorless 
oil in 99% yield.  
 
TLC (SiO2): Rf = 0.70 (ethyl acetate:hexanes, 1:10). 
 
1H NMR (400 MHz, CDCl3): δ 7.37-7.25 (m, 5H), 5.80 (dt, J = 17.2, 10.4 Hz, 1H), 5.28 
(dq, J = 6.0, 3.6 Hz, 1H), 5.00 (dd, J = 10.4, 2.0 Hz, 1H), 4.85 (ddd, J = 17.2, 2.0, 0.4 Hz, 
1H), 4.51 (d, J = 12.0 Hz, 1H), 4.43 (d, J = 12.0 Hz, 1H), 3.45 (t,  J = 6.4 Hz, 2H), 2.05-
1.92 (m, 1H), 2.00 (s, 3H), 1.84-1.74 (m, 2H), 0.01 (s, 9H). 
 
13C NMR (100 MHz, CDCl3): δ 170.3, 138.4, 135.0, 128.3, 127.8, 127.5, 115.2, 72.9, 
71.9, 66.7, 40.0, 34.3, 21.3, -2.4. 
 
FTIR (neat): υ 3031, 2954, 2860, 1737, 1626, 1496, 1454, 1370, 1236, 1102, 1019, 953, 













To a cooled (0 oC) suspension of 2.3g-OAc (15 mg, 0.047 mmol, 100 mol%) and 
NaHCO3 (10 mg, 0.12 mmol, 250 mol%) in toluene (0.5 mL, 0.1 M) was added 
chlorosulfonyl isocynate (10.9 mg, 0.071 mmol, 150 mol%). The reaction mixture was 
warmed slowly to ambient temperature and stirred for 10 hr. Sat’d aqueous NaHSO3 (0.5 
mL) was added and stirred 16 hr, at which point the layers were separated and the 
aqueous was extracted with EtOAc. The combined organic layers was dried over Na2SO4, 
filtered and concentrated in vacuo. Purification of the residue by column chromatography 
(SiO2; ethyl acetate: hexanes, 1:2.5) provided 2.7g (13.3 mg, 0.037 mmol) as a colorless 
oil in 78% yield.  
 
TLC (SiO2): Rf = 0.2 (ethyl acetate:hexanes, 1:1). 
 
1H NMR (400 MHz, CDCl3): δ 7.36-7.27 (m, 5H), 6.41 (br, 1H), 4.95-4.91 (m, 1H), 4.49 
(d, J = 12.0 Hz, 1H), 4.44 (d, J = 12.0 Hz, 1H), 3.63 (t, J = 4.0 Hz, 1H), 3.56-3.42 (m, 
2H), 2.55 (dd, J = 17.6, 11.2 Hz, 1H), 2.10 (dd, J = 17.6, 4.8, 1H), 2.04 (s, 3H), 1.94-1.81 
(m, 2H), 1.32 (ddd, J = 11.2, 4.8, 4.0 Hz, 1H), 0.01 (s, 9H). 
 
13C NMR (100 MHz, CDCl3): δ 178.2, 170.6, 137.8, 128.4, 127.9, 127.8, 73.8, 73.4, 
66.1, 57.7, 31.4, 31.3, 22.0, 21.1, -3.8. 
 
FTIR (neat): υ 3211, 2953, 1737, 1691, 1496, 1454, 1370, 1232, 1096, 1027, 964, 837, 
738, 698. 
 
HRMS (CI) Calcd. for C19H30NO4Si [M+H]
+: 364.1944, Found: 364.1946. 
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NOE experiment was performed for 7g using a pure sample. 
TMS irradiated: Ha (0.62%), HC (1.03%). 
(Note: The observation of nOe between TMS and Hc and the absence of nOe between 
TMS and the OAc suggest a 1,2 trans configuration which is corresponding to the 














It is estimated that 20% of approved pharmaceutical agents and 30-40% of 
commercially available agrochemicals contain one or more fluorine atoms.2 Additionally, 
in 2006, 80% of the small molecule drugs entering the market were estimated to contain 
one or more chiral centers.3 These facts underscore the importance of developing 
enantioselective methods for the preparation of organofluorine compounds.3,4 Toward 
this end, highly enantioselective nucleophilic trifluoromethylations of aldehydes and 
ketones have been developed.4,5 Nucleophilic (α-trifluoromethyl)allylation might also 
serve to establish absolute stereochemistry at CF3-bearing carbon centers.
6  Yet despite 
persistent efforts aimed at the development of asymmetric carbonyl allylation protocols,7 
enantioselective carbonyl (α-trifluoromethyl)allylation remains an unmet challenge.5,6 
Here, under the conditions of C-C bond forming transfer hydrogenation,8 we report the 
first examples of enantioselective carbonyl (α-trifluoromethyl)allylation: a process in 
which carbonyl addition occurs with equal facility from the alcohol or aldehyde oxidation 
level. (Figure 3.1) 
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Figure 3.1 Selected Example of Pharmeceuticals bearing F and/or CF3. 
 
3.2 REACTION OPTIMIZATION 
Our approach takes advantage of carbonyl allylation protocols recently developed 
in our laboratory, wherein primary alcohol dehydrogenation triggers reductive generation 
of allyliridium nucleophiles, enabling carbonyl allylation from the alcohol oxidation 
level.8,9 In initial experiments, carbonyl (α-trifluoromethyl)allylation was attempted using 
the ortho-cyclometallated catalyst generated in situ from [Ir(cod)Cl]2, various 4-
substituted-3-nitrobenzoic acids, BIPHEP (2,2'-bis(diphenylphosphino)biphenyl) and α-
trifluoromethyl allyl benzoate 3.1 in THF (1 M). However, C-C coupling products were 
not observed in reactions involving in situ catalyst generation. Rather, products of 
transesterification, the benzoates 3.8d derived from alcohols 3.2d, were obtained (eqn. 1). 
Eventually, it was found that transesterification is suppressed for reactions employing the 
isolated π-allyl iridium C,O-benzoate modified by BIPHEP and 4-cyano-3-nitrobenzoic 
acid in THF (0.2 M) (eqn. 2). As observed in related (α-trimethylsilyl)allylations,9k the 
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presence of water (200 mol%) improved conversion and suppressed byproduct formation, 





At this point, an assay of chiral ligands was undertaken and it was found that the 
iridium complex modified by (R)-Cl,MeO-BIPHEP, designated “(R)-I”, provided the 
highest levels of enantiomeric enrichment.(Table 3.1) 
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Table 3.1 Ligand optimization for enantioselective reactions. 
 
Thus, upon exposure of primary alcohols 1a-1i to α-trifluoromethyl allyl benzoate 
in the presence of (R)-I, Na2CO3 (100 mol%) and water (200 mol%) in THF (0.2 M) at 
70 oC, the desired products of (α-trifluoromethyl)allylation 3.3a-3.3i were generated in 




Table 3.2 anti-Diastereo- and enantioselective carbonyl (α-trifluoromethyl)allylation 
from the alcohol oxidation level. 
 
Notably, in the presence of isopropanol, but under otherwise equivalent 
conditions, an identical set of adducts 3.3a-3.3i are generated from aldehydes 3.9a-3.9i 




Table 3.3 anti-Diastereo- and enantioselective carbonyl (α-trifluoromethyl)allylation 
from the aldehyde oxidation level. 
 
Exposure of optically enriched alcohol 3.2j to standard conditions for anti-
diastereo- and enantioselective (α-trifluoromethyl)allylation employing (R)-I as the 
precatalyst produces compound 3.3j as a single stereoisomer, as determined by 1H and 
19F NMR analysis. Similarly, using (S)-I as the precatalyst, alcohol 3.2j is converted to 
the isomeric adduct iso-3.3j as a single stereoisomer, as determined by 1H and 19F NMR 
analysis. Using the catalyst modified by the achiral ligand, BIPHEP, compounds 3.3j and 
iso-3.3j are produced in a 1:1.5 ratio, respectively. These data illustrate how the present 
methodology enables incorporation of CF3-groups into polyketide substructures with high 
levels of catalyst directed stereoselectivity (Scheme 3.1).10 
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Scheme 3.1 Catalyst directed diastereoselectivity. 
 
3.3 APPLICATION OF ADDUCTS 
To further illustrate the utility of the coupling products, compound 3.3i was 
subjected to ozonolysis conditions involving NaBH4-mediated decomposition of the 
ozonide. The resulting β-trifluoromethyl alcohol 3.4i was produced in 94% isolated yield. 
The primary alcohol of diol 3.4i was converted chemoselectively to the primary p-
toluenesulfonate 3.5i in 99% isolated yield. Conversion of p-toluenesulfonate 3.5i to 
piperidine 3.6i was accomplished in analogy to an established procedure.11 Alternatively, 
elimination of p-toluenesulfonate 3.5i followed by hydrogenation of the resulting 
terminal olefin provides the syn-1,1,1-trifluoroisopropyl secondary alcohol 3.7 as a single 








3.4i, 94% Yield (R = H)




























2) Ru(OAc)2(rac-BINAP) (5 mol%)
EtOAc, DIPEA, 25 oC
30 atm H2  
Scheme 3.2 Elaboration of carbonyl (α-trifluoromethyl)allylation products. 
 
3.4 SUMMARY 
In summary, we report the first protocol for anti-diastereo- and enantioselective 
carbonyl (α-trifluoromethyl)allylation. Notably, through the use of C-C bond forming 
transfer hydrogenation, carbonyl addition is possible from the alcohol oxidation level, 
bypassing discrete alcohol oxidation and use of stoichiometric organometallic reagents 
and, hence, molar metallic byproducts. 
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All reactions were run under an atmosphere of Argon. Tetrahydrofuran (THF) and 
toluene were obtained from Pure-Solv MD-5 Solvent Purification System (Innovative 
Technology). Anhydrous solvents were transferred by an oven-dried syringe. Sealed 
tubes (13x100 mm) were purchased from Fischer Scientific and were dried in an oven 
overnight and cooled under a stream of nitrogen prior to use. Commercially available 
allyl acetate (Aldrich) was purified by distillation prior to use. Cesium carbonate was 
purchased from Alfa Aesar and was used directly without further purification. 
Isopropanol (Fisher) was purified by distillation prior to use. Analytical thin-layer 
chromatography (TLC) was carried out using 0.2-mm commercial silica gel plates (DC-
Fertigplatten Kieselgel 60 F254). Infrared spectra were recorded on a Perkin-Elmer 1600 
spectrometer. High-resolution mass spectra (HRMS) were obtained on a Karatos MS9 
and are reported as m/z (relative intensity). Accurate masses are reported for the 
molecular ion (M+H, M or M-H) or a suitable fragment ion. Nuclear magnetic resonance 
spectra (1H NMR and 13C NMR) spectra were recorded with a Varian Gemini (400 MHz) 
spectrometer for CDCl3 solutions and chemical shifts are reported as parts per million 
(ppm) relative to residual CHCl3 δH (7.26 ppm) and CDCl3 δC (77.0 ppm), respectively, 
as internal standards. Coupling constants are reported in Hertz (Hz).  
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Preparation of (R)-I 
 
To a mixture of [Ir(cod)Cl]2 (87.3 mg, 0.13 mmol, 100 mol%), (R)-Cl,MeO-BIPHEP 
(169 mg, 0.26 mmol, 200 mol%), Cs2CO3 (169 mg, 0.52 mmol, 400 mol%), 4-CN-3-
NO2BzOH (100 mg, 0.52 mmol, 400 mol%) and allyl acetate (65 mg, 0.65 mmol, 500 
mol%) in a sealed tube under an atmosphere of N2 was added THF (2.6 mL, 0.05 M). The 
reaction mixture was stirred for 30 minutes at ambient temperature and heated for 1.5 
hours at 80 oC, at which point the reaction mixture was allowed to cool to ambient 
temperature. The reaction mixture was filtered with the aid of THF (10 mL). The filtrate 
was concentrated in vacuo and desolved in THF (2 mL). Hexanes (50 mL) was added. A 
yellow precipitate formed, which was collected by filtration and dried under vacuum to 
provide (R)-I (238 mg, 0.221 mmol) in 85% yield.  
 
 
Preparation of (S)-I 
 
To a mixture of [Ir(cod)Cl]2 (87.3 mg, 0.13 mmol, 100 mol%), (S)-Cl,MeO-BIPHEP (169 
mg, 0.26 mmol, 200 mol%), Cs2CO3 (169 mg, 0.52 mmol, 400 mol%), 4-CN-3-
NO2BzOH (100 mg, 0.52 mmol, 400 mol%) and allyl acetate (65 mg, 0.65 mmol, 500 
mol%) in a sealed tube under an atmosphere of N2 was added THF (2.6 mL, 0.05 M). The 
reaction mixture was stirred for 30 minutes at ambient temperature and heated for 1.5 
hours at 80 oC, at which point the reaction mixture was allowed to cool to ambient 
temperature. The reaction mixture was filtered with the aid of THF (10 mL). The filtrate 
was concentrated in vacuo and desolved in THF (2 mL). Hexanes (50 mL) was added. A 
yellow precipitate formed, which was collected by filtration and dried under vacuum to 








In accordane with a modified literature procedure,13 trifluoroacetaldehyde hydrate (10.6 
g, 90 mmol, 100 mol%) was added dropwise to a mixture of H2SO4 (20 mL) and P2O5 (3 
g) at 100 oC. The trifluoroacetaldehyde thus generated was transferred via cannula to a 
cooled flask (CO2/acetone). Once all the gaseous aldehyde was collected, THF (45 mL) 
was added and the reaction vessel was placed in an ice bath. To the stirred solution of 
aldehyde at 0 oC was added a THF solution of vinylmagnesium bromide (110 mL, 1.0 M, 
110 mmol, 110 mol%). After addition was complete, the reaction mixture was stirred at 0 
oC for 3 h, at which point the reaction was NH4Cl (aq.) (20 mL). The reaction mixture 
was filtered with the aid of ether. Triethylamine (18.2 g, 180 mmol, 200 mol%) was 
added to the etheral solution, followed by benzoyl chloride (19.0 g, 135 mmol, 150 
mol%). The reaction mixture was stirred at ambient temperature overnight. A saturated 
NaHCO3 (aq.) was added and the organic phase was separated and washed with water 
and brine. The resulting solution was dried (Na2SO4), filtered and concentrated in vacuo. 
Purification of the residue by column chromatography (SiO2; hexane:ether, 10:1) provied 
title compound (11.0 g, 48 mmol) as a colorless oil in 53% yield. 
 
TLC (SiO2): Rf = 0.7 (ethyl acetate: hexanes, 1:4). 
 
1H NMR (400 MHz, CDCl3): δ 8.12-8.09 (m, 2H), 7.65-7.60 (m, 1H), 7.51-7.47 (m, 2H), 
5.99-5.88 (m, 2H), 5.69-5.63 (m, 1H), 5.58-5.54 (m, 1H). 
 
13C NMR (100 MHz, CDCl3): δ 164.4, 133.8, 130.0, 128.6, 126.9, 123.3, 123.1 (q, J = 
278.3 Hz), 71.3 (q, J = 33.5 Hz). 
 
19F NMR (376 MHz, CDCl3): δ -76.6 (d, J = 6.4 Hz). 
 
FTIR (neat): 3321, 2941, 1737, 1453, 1317, 1258, 1178, 1125, 1091, 1028, 985, 949, 
899, 707, 685 cm-1. 
 
HRMS (CI) Calcd. for C11H10O2F3 [M+H]











An oven-dried sealed tube under an atmosphere of N2 was charged with (6-bromopyridin-
2-yl)methanol 3.1a (37.6 mg, 0.20 mmol, 100 mol%), (R)-I (10.3 mg, 0.01 mmol, 5 
mol%), K3PO4 (43 mg, 0.20 mmol, 100 mol%), THF (0.2 mL, 1.0 M), H2O (18 μL, 1.0 
mmol, 500 mol%). α-(Trifluoromethyl)allyl benzoate (92.1 mg, 0.40 mmol, 200 mol%) 
was added and the mixture was allowed to stir at ambient temperature for 0.5 hr, at which 
point the reaction vessel was placed in an oil bath at 70 oC and was allowed to stir for 72 
hr. The reaction mixture was concentrated in vacuo. Purification of the residue by column 
chromatography (SiO2; ethyl acetate: hexanes, 1:10 with 0.1% TEA) provided 3.3a (35.6 
mg, 0.120 mmol) as a colorless oil in 60% yield (>20:1 dr). 
 
TLC (SiO2): Rf = 0.3 (ethyl acetate: hexanes, 1:5). 
 
1H NMR (400 MHz, CDCl3): δ 7.58 (t, J = 8.0 Hz, 1H), 7.41 (d, J = 8.0 Hz, 1H), 7.34 
(dt, J = 8.0, 0.8 Hz, 1H), 5.80 (dtd, J = 17.2, 10.4, 0.8 Hz, 1H), 5.25-5.23 (m, 2H), 5.02 
(d, J = 17.2 Hz, 1H), 3.37-3.27 (m, 2H). 
 
13C NMR (100 MHz, CDCl3): δ 160.5, 141.1, 139.1, 127.1, 126.1 (q, J = 280.5 Hz), 
126.0, 123.7, 119.6, 70.4, 54.0 (q, J = 25.4 Hz). 
 
19F NMR (376 MHz, CDCl3): δ -67.71 (d, J = 9.6 Hz). 
 
HPLC: (Chiralcel OD-H column, hexanes:i-PrOH = 97:3, 1 mL/min, 254 nm), tmajor = 
9.2 min, tminor = 10.9 min; ee = 95%. 
 
[ α ]D
25 = -29.55 (c =2.2, CH2Cl2).  
 
FTIR (neat): 3398, 1558, 1434, 1124, 1101, 987, 936, 758, 686 cm-1. 
 
HRMS (CI) Calcd. for C10H10NOF3 [M+H]



















An oven-dried sealed tube under an atmosphere of N2 was charged with furan-2-
ylmethanol 3.1b (19.6 mg, 0.20 mmol, 100 mol%), (R)-I (10.3 mg, 0.01 mmol, 5 mol%), 
Na2CO3 (21.2 mg, 0.20 mmol, 100 mol%). THF (1.0 mL, 0.2 M), H2O (7.2 μL, 0.4 
mmol, 200 mol%), and α-(trifluoromethyl)allyl benzoate (92.1 mg, 0.40 mmol, 200 
mol%) was added and the mixture was allowed to stir at ambient temperature for 0.5 hr, 
at which point the reaction vessel was placed in an oil bath at 70 oC and was allowed to 
stir for 72 hr. The reaction mixture was concentrated in vacuo. Purification of the residue 
by column chromatography (SiO2; ethyl acetate: hexanes, 1:10 with 0.1% TEA) provided 
3.3b (28.9 mg, 0.140 mmol) as a colorless oil in 70% yield (>20:1 dr). 
 
TLC (SiO2): Rf = 0.4 (ethyl acetate: hexanes, 1:5). 
 
1H NMR (400 MHz, CDCl3): δ 7.39 (dt, J = 2.0, 0.8, 1H), 6.35 (dd, J = 3.6, 2.0 Hz, 1H), 
6.32 (dt, J = 3.6, 0.8 Hz, 1H), 5.90 (dtd, J = 17.2, 10.4, 1.2 Hz, 1H), 5.43 (d, J = 10.4 Hz, 
1H), 5.29 (d, J = 17.2 Hz, 1H), 5.17 (d, J = 6.0 Hz, 1H), 3.29 (pd, J = 9.2, 4.0 Hz, 1H), 
2.17 (br, 1H). 
 
13C NMR (100 MHz, CDCl3): δ 153.0, 142.3, 126.9, 125.8 (q, J = 279.8 Hz,), 123.8, 
110.4, 107.4, 65.8, 52.4 (q, J = 34.7 Hz). 
 
19F NMR (376 MHz, CDCl3): δ -68.02 (d, J = 10.0 Hz). 
 
HPLC: (Chiralcel OD-H column, hexanes:i-PrOH = 95:5, 1 mL/min, 210 nm), tminor = 
6.0 min, tmajor = 6.8 min; ee = 94%. 
 
[ α ]D
25 = +15.00 (c =1.2, CH2Cl2). 
 
FTIR (neat): 3408, 2918, 1506, 1352, 1172, 1257, 1152, 1132, 1010, 937, 739 cm-1. 
 
HRMS (CI) Calcd. for C9H10F3O2 [M+H]



















An oven-dried sealed tube under an atmosphere of N2 was charged with trans-cinnamyl 
alcohol 3.1c (26.8 mg, 0.20 mmol, 100 mol%), (R)-I (10.3 mg, 0.01 mmol, 5 mol%), 
Na2CO3 (21.2 mg, 0.20 mmol, 100 mol%). THF (1.0 mL, 0.2 M), H2O (7.2 μL, 0.4 
mmol, 200 mol%), and α-(trifluoromethyl)allyl benzoate (92.1 mg, 0.40 mmol, 200 
mol%) was added and the mixture was allowed to stir at ambient temperature for 0.5 hr, 
at which point the reaction vessel was placed in an oil bath at 70 oC and was allowed to 
stir for 72 hr. The reaction mixture was concentrated in vacuo. Purification of the residue 
by column chromatography (SiO2; ethyl acetate: hexanes, 1:10 with 0.1% TEA) provided 
3.3c (29.1 mg, 0.120 mmol) as a colorless oil in 60% yield (>20:1 dr). 
 
TLC (SiO2): Rf = 0.5 (ethyl acetate: hexanes, 1:5). 
 
1H NMR (400 MHz, CDCl3): δ 7.40-7.25 (m, 5H), 6.67 (d, J = 16.0 Hz, 1H), 5.19 (ddd, J 
= 16.0, 6.8, 0.4 Hz, 1H), 5.92 (dtd, J = 17.2, 10.4, 0.8 Hz, 1H), 5.49 (d, J = 10.4 Hz, 1H), 
5.47 (d, J = 17.2 Hz, 1H), 4.74-4.71 (m, 1H), 2.92 (pd, J = 8.4, 3.2 Hz, 1H), 1.9 (br, 1H). 
 
13C NMR (100 MHz, CDCl3): δ 136.1, 132.4, 128.6, 128.1, 128.0 (q, J = 272.2 Hz), 
126.6, 123.6, 70.2, 54.2 (q, J = 24.7 Hz). 
 
19F NMR (376 MHz, CDCl3): δ -67.31 (d, J = 10.0 Hz). 
 
HPLC: (Chiralcel OB-H column, hexanes:i-PrOH = 95:5, 1 mL/min, 254 nm), tmajor = 
7.0 min, tminor = 7.8 min; ee = 87%. 
 
[ α ]D
25 = -23.64 (c =1.1, CH2Cl2). 
 
FTIR (neat): 3426, 2953, 2896, 1626, 1494, 1455, 1386, 1247, 1196, 1153, 1089, 1050, 
1028, 988, 906, 835, 786, 763, 718, 698 cm-1. 
 
HRMS (CI) Calcd. for C13H14OF3 [M+H]




















An oven-dried sealed tube under an atmosphere of N2 was charged with 3-phenylpropan-
1-ol 3.1d (27.2 mg, 0.20 mmol, 100 mol%), (R)-I (10.3 mg, 0.01 mmol, 5 mol%), 
Na2CO3 (21.2 mg, 0.20 mmol, 100 mol%). THF (1.0 mL, 0.2 M), H2O (7.2 μL, 0.4 
mmol, 200 mol%), and α-(trifluoromethyl)allyl benzoate (92.1 mg, 0.40 mmol, 200 
mol%) were added and the mixture was allowed to stir at ambient temperature for 0.5 hr, 
at which point the reaction vessel was placed in an oil bath at 70 oC and was allowed to 
stir for 72 hr. The reaction mixture was concentrated in vacuo. Purification of the residue 
by column chromatography (SiO2; ethyl acetate: hexanes, 1:10 with 0.1% TEA) provided 
3.3d (29.8 mg, 0.121 mmol) as a colorless oil in 61% yield (>20:1 dr). 
 
TLC (SiO2): Rf = 0.5 (ethyl acetate: hexanes, 1:5). 
 
1H NMR (400 MHz, CDCl3): δ 7.31-7.28 (m, 2H), 7.22-7.18 (m, 3H), 5.88 (dt, J = 17.2, 
10.4 Hz, 1H), 5.46 (d, J = 10.4 Hz, 1H), 5.34 (d, J = 17.2 Hz, 1H), 4.11-4.05 (m, 1H), 
2.86-2.71 (m, 1H), 2.70-2.63 (m, 2H), 1.89-1.82 (m, 1H), 1.77-1.68 (m. 1H), 1.72 (d, J = 
6.0 Hz, 1H). 
 
13C NMR (100 MHz, CDCl3): δ 141.2, 128.5, 128.4, 127.2, 126.3 (q, J = 272.8 Hz), 
126.1, 123.6, 68.1, 53.7 (q, J = 37.0 Hz), 36.5, 31.9. 
 
19F NMR (376 MHz, CDCl3): δ -67.61 (d, J = 9.8 Hz). 
 
HPLC: (Chiralcel OB-H column, hexanes:i-PrOH = 95:5, 1 mL/min, 210 nm), tminor = 
5.8 min, tmajor = 6.4 min; ee = 94%. 
 
[ α ]D
25 = -15.01 (c =0.4, CH2Cl2). 
 
FTIR (neat): 3424, 3028, 2924, 2856, 1604, 1455, 1327, 1253, 1146, 1102, 998, 936, 
749, 719, 699 cm-1. 
 
HRMS (CI) Calcd. for C13H16OF3 [M+H]


















An oven-dried sealed tube under an atmosphere of N2 was charged with nonan-1-ol 3.1e 
(28.8 mg, 0.20 mmol, 100 mol%), (R)-I (10.3 mg, 0.01 mmol, 5 mol%), Na2CO3 (21.2 
mg, 0.20 mmol, 100 mol%). THF (1.0 mL, 0.2 M), H2O (7.2 μL, 0.4 mmol, 200 mol%), 
and α-(trifluoromethyl)allyl benzoate (92.1 mg, 0.40 mmol, 200 mol%) were added and 
the mixture was allowed to stir at ambient temperature for 0.5 hr, at which point the 
reaction vessel was placed in an oil bath at 70 oC and was allowed to stir for 72 hr. The 
reaction mixture was concentrated in vacuo. Purification of the residue by column 
chromatography (SiO2; ethyl acetate: hexanes, 1:15 with 0.1% TEA) provided 3.3e (32.3 
mg, 0.128 mmol) as a colorless oil in 64% yield (>10:1 dr). 
 
TLC (SiO2): Rf = 0.6 (ethyl acetate: hexanes, 1:5). 
 
1H NMR (400 MHz, CDCl3): δ 5.87 (dt, J = 17.6, 10.0 Hz, 1H), 5.46 (d, J = 10.0 Hz, 
1H), 5.34 (d, J = 17.6 Hz, 1H), 4.07-4.04 (m, 1H), 2.71 (pd, J = 10.2, 2.4 Hz, 1H), 1.64 
(d, J = 4.8 Hz, 1H), 1.57-1.27 (m, 14H), 0.88 (t, J = 6.8 Hz, 3H). 
 
13C NMR (100 MHz, CDCl3): δ 127.3, 126.5 (q, J = 279.0 Hz), 123.4, 68.7, 53.4 (q, J = 
24.5 Hz), 34.8, 31.8, 29.5, 29.4, 29.2, 25.5, 22.6, 14.1. 
 
19F NMR (376 MHz, CDCl3): δ -67.72 (d, J = 10.4 Hz). 
 
HPLC: Enantiomeric excess was determined by HPLC analysis of the 4-nitrobenzoate 
derivative of the product (Chiralcel OJ-H column, hexanes:i-PrOH = 99:1, 0.75 mL/min, 
254 nm), tminor = 28.4 min, tmajor = 36.1 min; ee = 92%. 
 
[ α ]D
25 = -29.29 (c =1.4, CH2Cl2). 
 
FTIR (neat): 3463, 2955, 2924, 2854, 1716, 1624, 1465, 1378, 1246, 1167, 1103, 962, 
740, 727, 640. cm-1. 
 
HRMS (CI) Calcd. for C13H22OF3 [M-H]



















An oven-dried sealed tube under an atmosphere of N2 was charged with 
cyclohexylmethanol 3.1f (22.8 mg, 0.20 mmol, 100 mol%), (R)-I (10.3 mg, 0.01 mmol, 5 
mol%), K3PO4 (43 mg, 0.20 mmol, 100 mol%). THF (0.2 mL, 1.0 M), H2O (18 μL, 1.0 
mmol, 500 mol%), and α-(trifluoromethyl)allyl benzoate (92 mg, 0.40 mmol, 200 mol%) 
were added and the mixture was allowed to stir at ambient temperature for 0.5 hr, at 
which point the reaction vessel was placed in an oil bath at 70 oC and was allowed to stir 
for 72 hr. The reaction mixture was concentrated in vacuo. Purification of the residue by 
column chromatography (SiO2; ethyl acetate: hexanes, 1:20 with 0.1% TEA) provided 
3.3f (38.9 mg, 0.154 mmol) as a colorless oil in 77% yield. 
 
TLC (SiO2): Rf = 0.6 (ethyl acetate:hexanes, 1:5). 
 
1H NMR (400 MHz, CDCl3): δ 5.89 (dt, J = 17.2, 10.4 Hz, 1H), 5.44 (d, J = 10.4 Hz, 
1H), 5.45 (d, J = 17.2 Hz, 1H), 3.73-3.69 (m, 1H), 2.94 (pd, J = 9.6, 2.4 Hz, 1H), 1.78-
0.94 (m, 11H). To corroborate the assignement of relative stereochemistry, the chemical 
shift and coupling constant were correlated with a known compound. 
 
13C NMR (100 MHz, CDCl3): δ 127.4, 126.7 (q, J = 279.8 Hz), 123.1, 72.9, 50.3 (q, J = 
23.8 Hz), 40.4, 28.8, 28.8, 26.2, 25.8, 25.6. 
 
19F NMR (376 MHz, CDCl3): δ -67.63 (d, J = 9.8 Hz). 
 
HPLC: Enantiomeric excess was determined by HPLC analysis of the 4-nitrobenzoate 
derivative of the product (Chiralcel OJ-H column, hexanes:i-PrOH = 98:2, 0.75 mL/min, 
254 nm), tminor = 6.8 min, tmajor = 7.6 min; ee = 91%. 
 
[ α ]D
25 = -27.35 (c =1.7, CH2Cl2). 
 
FTIR (neat): 3410, 2926, 2854, 1451, 1328, 1257, 1145, 1103, 962, 744, 720 cm-1. 
 
HRMS (CI) Calcd. for C11H18OF3 [M+H]



















An oven-dried sealed tube under an atmosphere of N2 was charged with 2-
(benzyloxy)ethanol 3.1g (30.4 mg, 0.20 mmol, 100 mol%), (R)-I (10.3 mg, 0.01 mmol, 5 
mol%), Na2CO3 (21.2 mg, 0.20 mmol, 100 mol%). THF (1.0 mL, 0.2 M), H2O (7.2 μL, 
0.4 mmol, 200 mol%), and α-(trifluoromethyl)allyl benzoate (92.1 mg, 0.40 mmol, 200 
mol%) were added and the mixture was allowed to stir at ambient temperature for 0.5 hr, 
at which point the reaction vessel was placed in an oil bath at 70 oC and was allowed to 
stir for 72 hr. The reaction mixture was concentrated in vacuo. Purification of the residue 
by column chromatography (SiO2; ethyl acetate: hexanes, 1:10 with 0.1% TEA) provided 
3.3g (29.7 mg, 0.114 mmol) as a colorless oil in 57% yield (>20:1 dr). 
 
TLC (SiO2): Rf = 0.4 (ethyl acetate: hexanes, 1:5). 
 
1H NMR (400 MHz, CDCl3): δ 7.39-7.29 (m, 5H), 5.88 (dt, J = 17.2, 9.6 Hz, 1H), 5.42 
(d, J = 9.6 Hz, 1H), 5.40 (d, J = 17.2 Hz, 1H), 4.58-4.51 (m, 2H), 4.28-4.24 (m, 1H), 3.46 
(d, J = 5.6 Hz, 2H), 2.91 (pd, J = 10.6, 2.8 Hz, 1H), 2.24 (br, 1H). 
 
13C NMR (100 MHz, CDCl3): δ 137.5, 128.5, 128.0, 127.8, 127.3, 126.2 (q, J = 278.3 
Hz), 123.4, 73.4, 71.4, 67.2, 50.5 (q, J = 26.0 Hz). 
 
19F NMR (376 MHz, CDCl3): δ -67.83 (d, J = 10.0 Hz). 
 
HPLC: (Chiralcel OB-H column, hexanes:i-PrOH = 95:5, 1 mL/min, 210 nm), tmajor = 
8.3 min, tminor = 11.8 min; ee = 99%. 
 
[ α ]D
25 = -10.67 (c =1.5, CH2Cl2). 
 
FTIR (neat): 3454, 2919, 2851, 1454, 1258, 1097, 908, 730, 697 cm-1. 
 
HRMS (CI) Calcd. for C13H15O2F3 [M]




















An oven-dried sealed tube under an atmosphere of N2 was charged with 3-(4-
methoxybenzyloxy)propan-1-ol 3.1h (39.2 mg, 0.20 mmol, 100 mol%), (R)-I (10.3 mg, 
0.01 mmol, 5 mol%), Na2CO3 (21.2 mg, 0.20 mmol, 100 mol%). THF (1.0 mL, 0.2 M), 
H2O (7.2 μL, 0.4 mmol, 200 mol%), and α-(trifluoromethyl)allyl benzoate (92.1 mg, 0.40 
mmol, 200 mol%) were added and the mixture was allowed to stir at ambient temperature 
for 0.5 hr, at which point the reaction vessel was placed in an oil bath at 70 oC and was 
allowed to stir for 72 hr. The reaction mixture was concentrated in vacuo. Purification of 
the residue by column chromatography (SiO2; ethyl acetate: hexanes, 1:10 with 0.1% 
TEA) provided 3.3h (38.4 mg, 0.126 mmol) as a colorless oil in 63% yield (10:1 dr). 
 
TLC (SiO2): Rf = 0.4 (ethyl acetate: hexanes, 1:5). 
 
1H NMR (400 MHz, CDCl3): δ 7.26-7.22 (m, 2H), 6.90-6.86 (m, 2H), 5.91 (dt, J = 17.2, 
10.0 Hz, 1H), 5.42 (d, J = 10.0 Hz, 1H), 5.30 (d, J = 17.2 Hz, 1H), 4.44 (s, 2H), 4.31-4.27 
(m, 1H), 3.80 (s, 3H), 3.72-3.60 (m, 2H), 3.00 (d, J = 2.4, 1H), 2.68 (pd, J = 9.6, 2.8 Hz, 
1H), 1.92-1.82 (m, 1H), 1.66-1.59 (m, 1H). 
 
13C NMR (100 MHz, CDCl3): δ 159.3, 129.7, 129.4, 127.8, 126.2 (q, J = 279.1 Hz), 
123.0, 113.9, 73.1, 68.2, 68.1, 55.3, 53.8 (q, J = 25.3 Hz), 34.4. 
 
19F NMR (376 MHz, CDCl3): δ -67.70 (d, J = 10.2 Hz). 
 
HPLC: (Chiralcel OB-H column, hexanes:i-PrOH = 95:5, 1 mL/min, 230 nm), tmajor = 
14.4 min, tminor = 21.1 min; ee = 94%. 
 
[ α ]D
25 = -22.50 (c =2.0, CH2Cl2). 
 
FTIR (neat): 3486, 2935, 2868, 1513, 1250, 1173, 1096, 1033, 819 cm-1. 
 
HRMS (CI) Calcd. for C15H19O3F3 [M]















tert-butyl (3S,4R)-3-hydroxy-4-(trifluoromethyl)hex-5-enylcarbamate 3.3i 
 
 
An oven-dried sealed tube under an atmosphere of N2 was charged with tert-butyl 3-
hydroxypropylcarbamate 3.1i (175.2 mg, 1.0 mmol, 100 mol%), (R)-I (51.5 mg, 0.05 
mmol, 5 mol%), K3PO4 (215 mg, 1.0 mmol, 100 mol%). THF (1.0 mL, 1.0 M), H2O (90 
μL, 5.0 mmol, 500 mol%), and α-(trifluoromethyl)allyl benzoate (460 mg, 2.0 mmol, 200 
mol%) were added and the mixture was allowed to stir at ambient temperature for 0.5 hr, 
at which point the reaction vessel was placed in an oil bath at 70 oC and was allowed to 
stir for 72 hr. The reaction mixture was concentrated in vacuo. Purification of the residue 
by column chromatography (SiO2; ethyl acetate: hexanes, 1:10 with 0.1% TEA) provided 
3.3i (206.8 mg, 0.730 mmol) as a colorless oil in 73% yield. 
 
TLC (SiO2): Rf = 0.5 (ethyl acetate:hexanes, 1:3). 
 
1H NMR (400 MHz, CDCl3): δ 5.90 (dt, J = 17.2, 10.0 Hz, 1H), 5.44 (d, J = 10.0 Hz, 
1H), 5.32 (d, J = 17.2 Hz, 1H), 4.79 (br, 1H), 4.09 (d, J = 10.8 Hz, 1H), 3.49-3.42 (m, 
1H), 3.36 (br, 1H), 3.14-3.08 (m, 1H), 2.67 (pd, J = 10.6, 2.8 Hz, 1H), 1.69-1.60 (m, 1H), 
1.59-1.43 (m, 1H), 1.44 (s, 9H). 
 
13C NMR (100 MHz, CDCl3): δ 157.2, 127.8, 126.2 (q, J = 279 Hz), 123.2, 79.9, 65.5, 
53.8 (q, J = 25.3 Hz), 36.8, 35.8, 28.3. 
 
19F NMR (376 MHz, CDCl3): δ -67.88 (d, J = 10.3 Hz). 
 
HPLC: Enantiomeric excess was determined by HPLC analysis of the 4-nitrobenzoate 
derivative of the product (Chiralcel OJ-H column, hexanes:i-PrOH = 98:2, 0.75 mL/min, 
254 nm), tmajor = 20.5 min, tminor = 24.8 min; ee = 96%. 
 
[ α ]D
25 = -7.14 (c =1.4, CH2Cl2). 
 
FTIR (neat): 3350, 2925, 1682, 1517, 1367, 1252, 1169, 1147, 1105, 934, 861, 719 cm-1. 
 
HRMS (CI) Calcd. for C12H20OF3Na [M+Na]



















An oven-dried sealed tube under an atmosphere of N2 was charged with 6-
bromopicolinaldehyde 3.9a (37.2 mg, 0.20 mmol, 100 mol%), (R)-I (10.3 mg, 0.01 
mmol, 5 mol%), K3PO4 (43 mg, 0.20 mmol, 100 mol%). THF (0.2 mL, 1.0 M), H2O (18 
μL, 1.0 mmol, 500 mol%), isopropanol (31 μL, 0.4 mmol, 200 mol%), and α-
(trifluoromethyl)allyl benzoate (92.1 mg, 0.40 mmol, 200 mol%) were added and the 
mixture was allowed to stir at ambient temperature for 0.5 hr, at which point the reaction 
vessel was placed in an oil bath at 70 oC and was allowed to stir for 72 hr. The reaction 
mixture was concentrated in vacuo. Purification of the residue by column 
chromatography (SiO2; ethyl acetate: hexanes, 1:10 with 0.1% TEA) provided 3.3a (42.6 
mg, 0.144 mmol) as a colorless oil in 72% yield (>20:1 dr). 
 
HPLC: (Chiralcel OD-H column, hexanes:i-PrOH = 97:3, 1 mL/min, 254 nm), tmajor = 















An oven-dried sealed tube under an atmosphere of N2 was charged with furan-2-
carbaldehyde 3.9b (19.2 mg, 0.20 mmol, 100 mol%), (R)-I (10.3 mg, 0.01 mmol, 5 
mol%), Na2CO3 (21.2 mg, 0.20 mmol, 100 mol%). THF (1.0 mL, 0.2 M), H2O (7.2 μL, 
0.4 mmol, 200 mol%), isopropanol (31 μL, 0.4 mmol, 200 mol%), and α-
(trifluoromethyl)allyl benzoate (92.1 mg, 0.40 mmol, 200 mol%) were added and the 
mixture was allowed to stir at ambient temperature for 0.5 hr, at which point the reaction 
vessel was placed in an oil bath at 70 oC and was allowed to stir for 72 hr. The reaction 
mixture was concentrated in vacuo. Purification of the residue by column 
chromatography (SiO2; ethyl acetate: hexanes, 1:10 with 0.1% TEA) provided 3.3b (28.8 
mg, 0.139 mmol) as a colorless oil in 69% yield (>20:1 dr). 
 
 
HPLC: (Chiralcel OD-H column, hexanes:i-PrOH = 95:5, 1 mL/min, 210 nm), tminor = 


















An oven-dried sealed tube under an atmosphere of N2 was charged with trans-cinnamyl 
alcohol 3.9c (26.8 mg, 0.20 mmol, 100 mol%), (R)-I (10.3 mg, 0.01 mmol, 5 mol%), 
Na2CO3 (21.2 mg, 0.20 mmol, 100 mol%). THF (1.0 mL, 0.2 M), H2O (7.2 μL, 0.4 
mmol, 200 mol%), and α-(trifluoromethyl)allyl benzoate (92.1 mg, 0.40 mmol, 200 
mol%) were added and the mixture was allowed to stir at ambient temperature for 0.5 hr, 
at which point the reaction vessel was placed in an oil bath at 70 oC and was allowed to 
stir for 72 hr. The reaction mixture was concentrated in vacuo. Purification of the residue 
by column chromatography (SiO2; ethyl acetate: hexanes, 1:10 with 0.1% TEA) provided 
3.3c (29.1 mg, 0.120 mmol) as a colorless oil in 60% yield (>20:1 dr). 
 
 
HPLC: (Chiralcel OB-H column, hexanes:i-PrOH = 95:5, 1 mL/min, 254 nm), tmajor = 























An oven-dried sealed tube under an atmosphere of N2 was charged with 3-
phenylpropanal 3.9d (26.8 mg, 0.20 mmol, 100 mol%), (R)-I (10.3 mg, 0.01 mmol, 5 
mol%), Na2CO3 (21.2 mg, 0.20 mmol, 100 mol%). THF (1.0 mL, 0.2 M), H2O (7.2 μL, 
0.4 mmol, 200 mol%), isopropanol (31 μL, 0.4 mmol, 200 mol%), and α-
(trifluoromethyl)allyl benzoate (92.1 mg, 0.40 mmol, 200 mol%) were added and the 
mixture was allowed to stir at ambient temperature for 0.5 hr, at which point the reaction 
vessel was placed in an oil bath at 70 oC and was allowed to stir for 72 hr. The reaction 
mixture was concentrated in vacuo. Purification of the residue by column 
chromatography (SiO2; ethyl acetate: hexanes, 1:10 with 0.1% TEA) provided 3.3d (31.8 
mg, 0.138 mmol) as a colorless oil in 69% yield (>20:1 dr). 
 
HPLC: (Chiralcel OB-H column, hexanes:i-PrOH = 95:5, 1 mL/min, 210 nm), tminor = 














An oven-dried sealed tube under an atmosphere of N2 was charged with nonanal 3.9e 
(28.4 mg, 0.20 mmol, 100 mol%), (R)-I (10.3 mg, 0.01 mmol, 5 mol%), Na2CO3 (21.2 
mg, 0.20 mmol, 100 mol%). THF (1.0 mL, 0.2 M), H2O (7.2 μL, 0.4 mmol, 200 mol%), 
isopropanol (31 μL, 0.4 mmol, 200 mol%), and α-(trifluoromethyl)allyl benzoate (92.1 
mg, 0.40 mmol, 200 mol%) were added and the mixture was allowed to stir at ambient 
temperature for 0.5 hr, at which point the reaction vessel was placed in an oil bath at 70 
oC and was allowed to stir for 72 hr. The reaction mixture was concentrated in vacuo. 
Purification of the residue by column chromatography (SiO2; ethyl acetate: hexanes, 1:15 
with 0.1% TEA) provided 3.3e (34.8 mg, 0.138 mmol) as a colorless oil in 69% yield 
(10:1 dr). 
 
HPLC: Enantiomeric excess was determined by HPLC analysis of the 4-nitrobenzoate 
derivative of the product (Chiralcel OJ-H column, hexanes:i-PrOH = 99:1, 0.75 mL/min, 














An oven-dried sealed tube under an atmosphere of N2 was charged with 
cyclohexanecarbaldehyde 3.9f (22.4 mg, 0.20 mmol, 100 mol%), (R)-I (10.3 mg, 0.01 
mmol, 5 mol%), K3PO4 (43 mg, 0.20 mmol, 100 mol%). THF (0.2 mL, 1.0 M), H2O (18 
μL, 1.0 mmol, 500 mol%), isopropanol (31 μL, 0.4 mmol, 200 mol%), and α-
(trifluoromethyl)allyl benzoate (92 mg, 0.40 mmol, 200 mol%) were added and the 
mixture was allowed to stir at ambient temperature for 0.5 hr, at which point the reaction 
vessel was placed in an oil bath at 70 oC and was allowed to stir for 72 hr. The reaction 
mixture was concentrated in vacuo. Purification of the residue by column 
chromatography (SiO2; ethyl acetate: hexanes, 1:20 with 0.1% TEA) provided 3.3f (36.0 
mg, 0.162 mmol) as a colorless oil in 81% yield. 
 
HPLC: Enantiomeric excess was determined by HPLC analysis of the 4-nitrobenzoate 
derivative of the product (Chiralcel OJ-H column, hexanes:i-PrOH = 98:2, 0.75 mL/min, 

















An oven-dried sealed tube under an atmosphere of N2 was charged with 2-
(benzyloxy)acetaldehyde 3.9g (30.0 mg, 0.20 mmol, 100 mol%), (R)-I (10.3 mg, 0.01 
mmol, 5 mol%), Na2CO3 (21.2 mg, 0.20 mmol, 100 mol%). THF (1.0 mL, 0.2 M), H2O 
(7.2 μL, 0.4 mmol, 200 mol%), isopropanol (31 μL, 0.4 mmol, 200 mol%), and α-
(trifluoromethyl)allyl benzoate (92.1 mg, 0.40 mmol, 200 mol%) were added and the 
mixture was allowed to stir at ambient temperature for 0.5 hr, at which point the reaction 
vessel was placed in an oil bath at 70 oC and was allowed to stir for 72 hr. The reaction 
mixture was concentrated in vacuo. Purification of the residue by column 
chromatography (SiO2; ethyl acetate: hexanes, 1:10 with 0.1% TEA) provided 3.3g (28.6 
mg, 0.110 mmol) as a colorless oil in 55% yield (>20:1 dr). 
 
HPLC: (Chiralcel OB-H column, hexanes:i-PrOH = 95:5, 1 mL/min, 210 nm), tmajor = 



















An oven-dried sealed tube under an atmosphere of N2 was charged with 3-(4-
methoxybenzyloxy)propanal 3.9h (38.8 mg, 0.20 mmol, 100 mol%), (R)-I (10.3 mg, 0.01 
mmol, 5 mol%), Na2CO3 (21.2 mg, 0.20 mmol, 100 mol%). THF (1.0 mL, 0.2 M), H2O 
(7.2 μL, 0.4 mmol, 200 mol%), isopropanol (31 μL, 0.4 mmol, 200 mol%), and α-
(trifluoromethyl)allyl benzoate (92.1 mg, 0.40 mmol, 200 mol%) were added and the 
mixture was allowed to stir at ambient temperature for 0.5 hr, at which point the reaction 
vessel was placed in an oil bath at 70 oC and was allowed to stir for 72 hr. The reaction 
mixture was concentrated in vacuo. Purification of the residue by column 
chromatography (SiO2; ethyl acetate: hexanes, 1:10 with 0.1% TEA) provided 3.3h (40.8 
mg, 0.134 mmol) as a colorless oil in 67% yield (10:1 dr). 
 
HPLC: (Chiralcel OB-H column, hexanes:i-PrOH = 95:5, 1 mL/min, 230 nm), tmajor = 


















An oven-dried sealed tube under an atmosphere of N2 was charged with tert-butyl 3-
oxopropylcarbamate 3.9i (34.7 mg, 0.2 mmol, 100 mol%), (R)-I (10.3 mg, 0.01 mmol, 5 
mol%), K3PO4 (43 mg, 0.2 mmol, 100 mol%). THF (0.2 mL, 1.0 M), H2O (18 μL, 5.0 
mmol, 500 mol%), isopropanol (31 μL, 0.4 mmol, 200 mol%), and α-
(trifluoromethyl)allyl benzoate (92.1 mg, 0.4 mmol, 200 mol%) were added and the 
mixture was allowed to stir at ambient temperature for 0.5 hr, at which point the reaction 
vessel was placed in an oil bath at 70 oC and was allowed to stir for 72 hr. The reaction 
mixture was concentrated in vacuo. Purification of the residue by column 
chromatography (SiO2; ethyl acetate: hexanes, 1:10 with 0.1% TEA) provided 3.3i (39.7 
mg, 0.140 mmol) as a colorless oil in 70% yield (>20:1 dr). 
 
HPLC: Enantiomeric excess was determined by HPLC analysis of the 4-nitrobenzoate 
derivative of the product (Chiralcel OJ-H column, hexanes:i-PrOH = 98:2, 0.75 mL/min, 


















An oven-dried sealed tube under an atmosphere of N2 was charged with 3-(4-
methoxybenzyloxy)propan-1-ol (750 mg, 3.94 mmol, 100 mol%), (S)-I (203 mg, 0.197 
mmol, 5 mol%), Cs2CO3 (128.5 mg, 0.394 mmol, 10 mol%). THF (20.0 mL, 0.2 M) and 
allyl acetate (858 μL, 7.9 mmol, 200 mol%) were added and the mixture was stirred at 
120 oC for 22 hr, The reaction mixture was concentrated in vacuo. Purification of the 
residue by column chromatography (SiO2; ethyl acetate: hexanes, 1:10 with 0.1% TEA) 
provided (S)-1-(4-methoxybenzyloxy)hex-5-en-3-ol (763.5 mg, 3.23 mmol) as a colorless 
oil in 82% yield, 96% ee. 
 
Followed by the TBS-protection/Ozonolysis sequence reported by the same group,15 the 
title compund 3.1j was obtained (989 mg, 2.79 mmol) as a colorless oil in 86% yield over 
two steps. 
 
TLC (SiO2): Rf = 0.3 (ethyl acetate:hexanes, 1:2). 
 
1H NMR (400 MHz, CDCl3): δ7.26-7.24 (m, 2H), 6.89-6.87 (m, 2H), 4.45-4.37 (m, 2H), 
4.12-4.07 (m, 1H), 3.87-3.80 (m, 1H), 3.81 (s, 3H), 3.75-3.68 (m, 1H), 3.49 (t, J = 6.4 
Hz, 2H), 2.38 (br, 1H), 1.91-1.76 (m, 3H), 1.69-1.61 (m, 1H), 0.88 (s, 9H), 0.09 (s, 3H), 
0.07 (s, 3H). 
 
13C NMR (100 MHz, CDCl3): δ 159.1, 130.5, 129.3, 113.8, 72.7, 69.1, 66.5, 60.1, 55.3, 
38.2, 36.7, 25.8, 17.9, -4.7. 
 
[ α ]D
25 = -5.38 (c =1.3, CH2Cl2). 
 
FTIR (neat): 3413, 2928, 2856, 1586, 1513, 1464, 1360, 1247, 1089, 1035, 838, 774, 
1028, 988, 906, 835, 786, 763, 718, 698 cm-1. 
 
HRMS (CI) Calcd. for C19H34O4NaSi [M+Na]



















CF3   
An oven-dried sealed tube under an atmosphere of N2 was charged with (S)-3-(tert-
butyldimethylsilyloxy)-5-(4-methoxybenzyloxy)pentan-1-ol 3.1j (70.9 mg, 0.20 mmol, 
100 mol%), (R)-I (10.3 mg, 0.01 mmol, 5 mol%), Na2CO3 (21.2 mg, 0.20 mmol, 100 
mol%). THF (1.0 mL, 0.2 M), H2O (7.2 μL, 0.4 mmol, 200 mol%), and α-
(trifluoromethyl)allyl benzoate (92.1 mg, 0.40 mmol, 200 mol%) were added and the 
mixture was allowed to stir at ambient temperature for 0.5 hr, at which point the reaction 
vessel was placed in an oil bath at 70 oC and was allowed to stir for 72 hr. The reaction 
mixture was concentrated in vacuo. Purification of the residue by column 
chromatography (SiO2; ethyl acetate: hexanes, 1:10 with 0.1% TEA) provided 3.3j (66.6 
mg, 0.144 mmol) as a colorless oil in 72% yield (>20:1 dr). 
 
TLC (SiO2): Rf = 0.4 (ethyl acetate: hexanes, 1:5). 
 
1H NMR (400 MHz, CDCl3): δ 7.25-7.23 (m, 2H), 6.89-6.87 (m, 2H), 5.88 (dt, J = 17.2, 
9.6 Hz, 1H), 5.41 (d, J = 9.6 Hz, 1H), 5.27 (d, J = 17.2 Hz, 1H), 4.45-4.36 (m, 3H), 4.21-
4.15 (m, 1H), 3.81 (s, 3H), 3.49 (t, J = 6.0 Hz, 2H), 3.42 (d, J = 2.4 Hz, 1H), 2.52 (pd, J = 
9.6, 2.0 Hz, 1H), 1.99-1.75 (m, 3H), 1.41 (ddd, J = 14.4, 4.8, 2.4 Hz, 1H), 0.88 (s, 9H), 
0.09 (s, 3H), 0.07 (s, 3H). 
 
13C NMR (100 MHz, CDCl3): δ 159.2, 130.3, 129.3, 128.0, 126.2 (q, J = 279.7 Hz), 
122.9, 113.8, 72.7, 68.6, 66.2, 65.7, 55.3, 54.1 (q, J = 24.5 Hz), 39.6, 36.0, 25.7, 17.9, -
4.8, -4.8. 
 
19F NMR (376 MHz, CDCl3): δ -67.66 (d, J = 10.0 Hz). 
 
FTIR (neat): 3455, 2953, 2930, 2857, 1613, 1514, 1464, 1302, 1250, 1172, 1094, 1037, 
932, 836, 776 cm-1. 
 
HRMS (CI) Calcd. for C23H38O4F3Si [M+H]














An oven-dried sealed tube under an atmosphere of N2 was charged with (S)-3-(tert-
butyldimethylsilyloxy)-5-(4-methoxybenzyloxy)pentan-1-ol 3.1j (70.9 mg, 0.20 mmol, 
100 mol%), (S)-I (10.3 mg, 0.01 mmol, 5 mol%), Na2CO3 (21.2 mg, 0.20 mmol, 100 
mol%). THF (1.0 mL, 0.2 M), H2O (7.2 μL, 0.4 mmol, 200 mol%), and α-
(trifluoromethyl)allyl benzoate (92.1 mg, 0.40 mmol, 200 mol%) were added and the 
mixture was allowed to stir at ambient temperature for 0.5 hr, at which point the reaction 
vessel was placed in an oil bath at 70 oC and was allowed to stir for 72 hr. The reaction 
mixture was concentrated in vacuo. Purification of the residue by column 
chromatography (SiO2; ethyl acetate: hexanes, 1:10 with 0.1% TEA) provided iso-3.3j 
(73.1 mg, 0.158 mmol) as a colorless oil in 79% yield (>20:1 dr). 
 
TLC (SiO2): Rf = 0.4 (ethyl acetate: hexanes, 1:5). 
 
1H NMR (400 MHz, CDCl3): δ 7.26-7.22 (m, 2H), 6.90-6.86 (m, 2H), 5.87 (dtd, J = 
17.2, 9.6, 0.8 Hz, 1H), 5.40 (dd, J = 9.6, 0.8 Hz, 1H), 5.27 (d, J = 17.2 Hz, 1H), 4.44-4.36 
(m, 2H), 4.23 (dq, J = 9.6, 2.8 Hz 1H), 4.09-4.03 (m, 1H), 3.80 (s, 3H), 3.47 (t, J = 6.08 
Hz, 2H), 3.00 (d, J = 2.4 Hz, 1H), 2.59 (pd, J = 9.6, 2.4 Hz, 1H), 1.89-1.75 (m, 2H), 1.69-
1.61 (m, 1H), 1.51 (ddd, J = 14.4, 4.8, 2.8 Hz, 1H), 0.88 (s, 9H), 0.10 (s, 3H), 0.09 (s, 
3H). 
 
13C NMR (100 MHz, CDCl3): δ 159.2, 130.2, 129.3, 127.9, 126.2 (q, J = 279.0 Hz), 
122.8, 113.7, 72.7, 69.8, 67.2, 66.1, 55.2, 54.1 (q, J = 24.6 Hz), 41.1, 37.5, 25.8, 17.9, -
4.3, -4.9. 
 
19F NMR (376 MHz, CDCl3): δ -67.65 (d, J = 10.0 Hz). 
 
FTIR (neat): 3454, 2954, 2920, 2850, 1623, 1534, 1474, 1291, 1250, 1172, 1094, 1037, 
932, 836, 780 cm-1. 
 
HRMS (CI) Calcd. for C23H38O4F3Si [M+H]












Because the configuration of the β-chiral center derived from (S)-I was known based on 
previous work,16 also the anti relationship of the two newly formed chiral centers has 
been determined by comparison with reported racemic compounds, the absolute 
stereochemistry outcome could be identified by studying the relative stereochemistry of 
the newly formed chiral centers with the existed β-chiral center. 
 
Desilylation of 3j which comes from the reaction using (R)-I as catalyst and iso-3j which 
comes from the reaction using (S)-I as catalyst, followed by acetonide formation in one-
pot, provided the anti- and syn-cyclic acetal as single diastereomer, repectively. This 
observation suggested the configuration of the two newly formed chiral centers in 3j was 
(3R, 4S), and (3S, 4R) in iso-3j. Hence the absolute stereochemistry outcome has been 
identified. 
 
(Note: The absence of nOe between Ha and Hb in acetonide derivitive of 3j suggests a 1,3 
trans configuration of the two side chains on the cyclic acetal; and the observation of nOe 
between Ha and Hb in acetonide derivitive of iso-3j suggest a 1,3 cis configuration of the 















tert-butyl (3S,4R)-5,5,5-trifluoro-3-hydroxy-4-(hydroxymethyl)pentylcarbamate 3.4i 
 
 
An oven-dried round bottom flask under atmosphere of N2 was charged with tert-butyl 
(3S,4R)-3-hydroxy-4-(trifluoromethyl)hex-5-enylcarbamate 3.3i (206.8 mg, 0.730 mmol, 
100 mol%). DCM (14.6 mL, 0.05 M) was added and the mixture was stirred at -78 oC 
with ozone bubbled through until TLC showed full consumption of 3i. A solution of 
NaBH4 (276.2 mg, 7.3 mmol, 1000 mol%) in ethanol (50 mL, 0.95) and water (5 mL) 
was added dropwise and the reaction mixture was stirred at 0 oC  for one hour and slowly 
warmed up to ambient temperature  and stirred overnight. The reaction mixture was 
concentrated in vacuo, and the product was extracted with ethyl acetate (30 mL/3 times). 
After removing the solvent, purification of the residue by column chromatography (SiO2; 
ethyl acetate: hexanes, 1:1 with 0.1% TEA) provided 3.4i (197.1 mg, 0.686 mmol) as a 
colorless oil in 94% yield as a single diastereomer.17 
 
TLC (SiO2): Rf = 0.15 (ethyl acetate:hexanes, 1:1). 
 
1H NMR (400 MHz, CDCl3): δ 4.87 (br, 1H), 4.81 (br, 1H), 4.11-3.87 (m, 3H), 3.58-3.53 
(m, 1H), 3.31-3.24 (m, 1H), 3.12-3.08 (m, 1H), 2.28-2.20 (m, 1H), 1.79-1.65 (m, 1H), 
1.44 (s, 9H). 
 
13C NMR (100 MHz, CDCl3): δ 158.0, 126.6 (q, J = 279.0 Hz), 80.4, 66.2, 59.0, 49.6 (q, 
J = 23.8 Hz), 37.4, 36.5, 28.2. 
 
19F NMR (376 MHz, CDCl3): δ -66.87 (d, J = 10.0 Hz). 
 
FTIR (neat): 3350, 2979, 1685, 1522, 1368, 1253, 1166, 1129, 866 cm-1. 
 
HRMS (CI) Calcd. for C11H21NO4F3 [M+H]














An oven-dried round bottom flask under atmosphere of N2 was charged with tert-butyl 
(3S,4R)-5,5,5-trifluoro-3-hydroxy-4-(hydroxymethyl)pentylcarbamate 3.4i (299 mg, 1.04 
mmol, 100 mol%) and TsCl (337 mg, 1.77 mmol, 170 mol%). Pyridine (5 mL, 0.2 M) 
was added and the mixture was stirred at ambient temperature overnight. After all starting 
material consumped, the reaction mixture was diluted with 30 mL ethyl acetate, washed 
with saturated CuSO4 solution to remove pyridine, and washed with brine. After 
removing the solvent, 3.5i was obtained as a pale yellow oil in 99% yield and used 
without further purification. 
 
TLC (SiO2): Rf = 0.35 (ethyl acetate:hexanes, 1:2). 
 
1H NMR (400 MHz, CDCl3): δ 7.78 (d, J = 8.0 Hz, 2H), 7.35 (d, J = 8.0 Hz, 2H), 4.84 
(br, 1H), 3.51-3.44 (m, 1H), 3.09-3.04 (m, 1H), 2.45 (s, 3H), 2.47-2.39 (m, 1H), 1.68-
1.55 (m, 2H), 1.43 (s, 9H). 
 
13C NMR (100 MHz, CDCl3): δ 157.8, 145.2, 132.2, 129.9, 128.0, 125.8 (q, J = 279.8 
Hz), 80.3, 64.2, 63.2, 48.5 (q, J = 24.6 Hz), 36.5, 36.2, 28.2, 21.6. 
 
19F NMR (376 MHz, CDCl3): δ -66.62 (d, J = 9.0 Hz). 
 
FTIR (neat): 3413, 2929, 1686, 1523, 1367, 1252, 1176, 1137, 984, 816, 664 cm-1. 
 
HRMS (CI) Calcd. for C18H27NSO6F3 [M+H]












An oven-dried round bottom flask under atmosphere of N2 was charged with 3.5i (46.1 
mg, 0.104 mmol, 100 mol%). Trifluoroacetic acid (0.5 mL, 0.2 M) was added and the 
mixture was stirred at ambient temperature for 15 minutes. After all starting material 
consumped, the reaction mixture was concentrated in vacuo. Acetonitrile (5 mL, 0.02 M) 
was added, and freshly distilled diisopropylethylamine (80.7 mg, 0.624 mmol, 600 
mol%) was injected dropwisely. The reaction mixture was stirred at ambient temperature 
overnight, followed by adding di-tert-butyl dicarbonate (36.2 mg, 0.208 mmol, 200 
mol%) and stirred fro another 8 hours. After removing the solvent, purification of the 
residue by column chromatography (SiO2; ethyl acetate: hexanes, 1:4 with 0.1% TEA) 
provided 3.6 (22.7 mg, 0.084 mmol) as colorless oil in 81% yield.18 
 
TLC (SiO2): Rf = 0.45 (ethyl acetate:hexanes, 1:2). 
 
1H NMR (500 MHz, DMSO, 120 oC): δ 4.69 (br, 1H), 4.20 (s, 1H), 3.84 (dd, J = 13.0, 
4.0 Hz, 1H), 3.69-3.64 (m, 1H), 3.27 (dd, J = 13.0, 11.0 Hz, 1H), 3.19 (ddd, J = 13.5, 
11.5, 3.5 Hz, 1H), 2.43-2.37 (m, 1H), 1.68-1.55 (m, 1H), 1.42 (s, 9H). 
 
13C NMR (125 MHz, DMSO, 120 oC): δ 153.4, 125.7 (q, J = 279.3 Hz), 78.5, 60.9 (q, J 
= 2.4 Hz), 43.7 (q, J = 23.8 Hz), 37.8, 37.2 (q, J = 2.8 Hz), 31.3, 27.5. 
 
19F NMR (470 MHz, DMSO, 120 oC): δ -66.61 (d, J = 9.4 Hz). 
 
FTIR (neat): 3427, 2926, 1671, 1430, 1259, 1240, 1155, 1111, 1029, 862, 842, 797,706  
cm-1. 
 
HRMS (CI) Calcd. for C11H18NOF3Na [M+Na]
















An oven-dried round bottom flask under atmosphere of N2 was charged with 3.5i (44.1 
mg, 0.1 mmol, 100 mol%). Freshly made NaOMe (1.0 M in MeOH, 0.5 mL, 0.2 M) was 
added under 0 oC and the mixture was stirred at ambient temperature overnight. After all 
starting material consumped, solvent was removed and the residue was extracted with 30 
mL ethyl acetate, washed with brine, concentrated in vacuo. Purification of the residue by 
column chromatography (SiO2; ethyl acetate: hexanes, 1:3 with 0.1% TEA) provided (S)-
tert-butyl 3-hydroxy-4-(trifluoromethyl)pent-4-enylcarbamate (24.8 mg, 0.094 mmol) as 
a colorless oil in 94% yield. 
 
TLC (SiO2): Rf = 0.5 (ethyl acetate:hexanes, 1:2). 
 
1H NMR (400 MHz, CDCl3): δ 5.83 (d, J = 0.8 Hz, 1H), 5.83-5.82 (m, 1H), 4.83 (br, 
1H), 4.37 (d, J = 9.6 Hz, 1H), 3.91 (s, 1H), 3.56-3.54 (m, 1H), 3.17-3.10 (m, 1H), 1.88-
1.82 (m, 1H), 1.67-1.61 (m, 1H), 1.45 (s, 9H). 
 
13C NMR (100 MHz, CDCl3): δ 157.4, 141.1 (q, J = 29.0 Hz), 123.4 (q, J = 271.6 Hz), 
118.8 (q, J = 5.9 Hz), 80.1, 65.5, 37.3, 36.8, 28.3. 
 
19F NMR (376 MHz, CDCl3): δ -66.65. 
 
FTIR (neat): 3345, 2979, 1685, 1516, 1368, 1280, 1165, 1122, 1086, 953, 863, 782 cm-1. 
 
HRMS (CI) Calcd. for C11H18NOF3Na [M+Na]


















To a mixture of (S)-tert-butyl 3-hydroxy-4-(trifluoromethyl)pent-4-enylcarbamate (24.8 
mg, 0.094 mmol, 100 mol%) and Ru(racBINAP)(OAc)2
19 (4.1mg, 0.005 mmol, 5 mol%) 
was added dry methanol (4 mL, 0.025 M) in autoclave and then the reaction mixture was 
stirred under an hydrogen pressure of 30 atm at room temperature overnight. After 
finishing the reaction, the mixture was concentrated in vacuo. The residue was purified 
by silica gel column chromatography (SiO2; ethyl acetate: hexanes, 1:3 with 0.1% TEA) 
to afford 3.7 (24.9 mg, 0.086 mmol) as a colorless oil in 92% yield.20 
 
TLC (SiO2): Rf = 0.5 (ethyl acetate:hexanes, 1:2). 
 
1H NMR (400 MHz, CDCl3): δ 4.81 (br, 1H), 3.97 (d, J = 10.0 Hz, 1H), 3.52-3.47 (m, 
1H), 3.30 (br, 1H), 3.16-3.10 (m, 1H), 2.22-2.14 (m, 1H), 1.70-1.46 (m, 1H), 1.44 (s, 
9H), 1.18 (d, J = 6.8 Hz, 3H). 
 
13C NMR (100 MHz, CDCl3): δ 157.2, 127.8 (q, J = 279.0 Hz), 79.9, 65.8, 43.1 (q, J = 
23.8 Hz), 37.1, 35.6, 28.3, 7.4. 
 
19F NMR (376 MHz, CDCl3): δ -70.06 (d, J = 9.6 Hz). 
 
FTIR (neat): 3350, 2981, 2928, 1685, 1520, 1458, 1368, 1271, 1172, 1145, 1075, 1007, 
861, 681 cm-1. 
 
HRMS (CI) Calcd. for C11H21NOF3Na [M+H]










CHAPTER 4: ENHANCED IRIDIUM CATALYZED CARBONYL 
CROTYLATION AND DOUBLE CROTYLATION: BEYOND 








In the course of developing C-C bond forming hydrogenations and transfer 
hydrogenations,2 it was found that ortho-cyclometallated iridium C,O-benzoates serve as 
catalysts for diverse carbonyl allylation processes whereinprimary alcohol 
dehydrogenation triggers reductive generation of allyliridium nucleophiles from allylic 
carboxylates, thus enabling asymmetric carbonyl allylation directly from the alcohol 
oxidation level.Under nearly identical conditions, carbonyl allylation is achievedfrom the 
aldehyde oxidation level employing isopropanol as terminal reductant.3 Notably, by 
harnessing the reductive capability of alcohol mediated transfer hydrogenation, 
asymmetric carbonyl allylationis achieved in the absence of stoichiometric allylmetal 
reagents or metallic reductants, representing a significant departure from conventional 
carbonyl allylation protocols.4,5,6 
 
 247
4.1.2 REACTION OPTIMIZATION 
Our initial investigations into stereoselective carbonyl crotylation employing α-
methyl allyl acetate as the crotyl donor were achieved using the ortho-cyclometallated 
iridium C,O-benzoateprepared in situfrom [Ir(cod)Cl]2, allyl acetate, 4-cyano-3-
nitrobenzoic acid and the chiral phosphine ligand (S)-SEGPHOS.3c,7,8 Although in situ 
assembly of the catalyst proved convenient and exceptional enantioselectivities typically 
wereobserved (>95% ee), only moderate levels ofanti-diastereoselectivity were evident 
(5:1 – 11:1 dr). In subsequent work, conditions for preparation of thediscreteortho-
cyclometallated iridium C,O-benzoate precatalyst and its isolation via precipitation were 
identified.3d Notably, using such single component precatalysts, alcohol mediated 
carbonyl allylation processeswere found to proceed atconsiderably lower temperatures. 
This fact prompted the present reinvestigation of alcohol mediated carbonyl crotylation. 
Here, we report that the ortho-cyclometallated iridium C,O-benzoate derived from 
[Ir(cod)Cl]2, allyl acetate, 4-cyano-3-nitrobenzoic acid and (S)-SEGPHOS, termed (S)-I, 
is subject to conventional silica gel flash chromatographic purification,and that use of 
(S)-I purified in this manner enableslow temperature (60 oC) alcohol mediated carbonyl 




The performanceof the chromatographically isolated precatalyst (S)-I was 
evaluated inalcohol mediated carbonyl crotylation, which allows a comparison with 
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results obtained upon generation of (S)-I in situ.3c Whereas reaction temperatures of 90 
oC were necessary using the catalyst generated in situ, use of the chromatographically 
isolated precatalyst (S)-I was possible at 60 oC without extending reaction time. 
Furthermore, use of the chromatographically isolated precatalyst (S)-I led to a 
considerable improvement the level of anti-diastereoselectivity (7:1 – > 20:1 dr), which 
was accompanied by a modest but consistent improvement in enantioselectivity. As 
demonstrated by the conversion of alcohols 4.1.2a-4.1.2i to adducts 4.1.4a-4.1.4i and the 
conversion of aldehydes 4.1.3a-4.1.3i to adducts 4.1.4a-4.1.4i, these favorable trends in 






Table 4.1 Enhanced levels of anti-diastereo- and enantioselectivity in alcohol mediated 




In summary, we reportthat the chromatographically isolated iridium precatalyst 
(S)-I promotes enhanced levels of anti-diastereo- and enantioselectivity in carbonyl 
crotylations from the alcohol or aldehyde oxidation level employing employing α-methyl 
allyl acetate as the crotyl donor.3c Future studies will focus on the development of related 
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C-C bondforming processes that occur in the absence of stoichiometric organometallic 




4.2 DIRECT GENERATION OF POLYPROPIONATE 
STEREOPOLYADS VIA DOUBLE CROTYLATIONS: BEYOND 




The complex issues of stereoselectivity posed by polyketide natural products are 
most often addressed through stepwise carbonyl addition reactions involving use of chiral 
auxiliaries, chiral reagents and premetallated nucleophiles.9,10 In the course of studies on 
hydrogen-mediated C-C bond formation,11 hydrogen exchange between primary alcohols 
and π-unsaturated reactants was found to trigger generation of electrophile-nucleophile 
pairs that combine to form products of carbonyl addition directly from the alcohol 
oxidation level.12,13,14 A significant outcome of this approach resides in the ability to 
rapidly assemble polyacetate substructures through asymmetric double allylations of 1,3-
diols (eqn. 2), as illustrated in dramatically simplified syntheses of the bryostatin A-





Corresponding double crotylations would enable direct generation of pseudo-C2-
symmetric16 polypropionate stereoquintets (eqn. 2), which appear as substructures in 
diverse polyketide natural products, including rifamycin,17 swinholide,18 scytophycin,19 
saliniketal20 and reidispongiolide21 (Figure 4.1). However, attempted double crotylations 
employing the catalyst generated in situ from [Ir(cod)Cl]2, 4-cyano-3-nitrobenzoic acid, 
allyl acetate and (R)-SEGPHOS were unsuccessful. Recently, we observed that 
chromatographic isolation of the iridium precatalyst allows alcohol mediated carbonyl 
crotylations to be conducted at significantly lower temperature, resulting in enhanced 
levels of anti-diastereo- and enantioselectivity.1a More significantly, the 
chromatographically purified precatalyst enables carbonyl crotylations that are not 









Given these findings, the generation of polypropionate stereoquintets using anti-
diastereo- and enantioselective carbonyl double crotylation of 1,3-diols was revisited. 
Here, we report that exposure of α-methyl allyl acetate to 1,3-propanediols 4.2.1a or 
4.2.1b in the presence of the chromatographically purified iridium precatalyst (R)-I 
results in double carbonyl crotylation from the diol oxidation level to deliver the C2-
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symmetric stereopolyads 4.2.2a and 4.2.3a, respectively, with exceptional control of anti-
diastereo- and enantioselectivity. The present double crotylation process has no 
counterpart in conventional crotylmetal chemistry and is unique in its ability to generate 
acyclic stereoquintets from achiral reactants with control of relative and absolute 
stereochemistry.22,23,24 
To illustrate the utility of this methodology vis-à-vis polyketide construction, 
syntheses of key polypropionate substructures were executed with dramatic enhancement 
in step economy. Specifically, the ansa chain of rifamycin S spanning C19-C27 was 
prepared in 8 steps versus 26 steps, as described by Kishi.16c-e Additionally, the 
scyotphycin C19-C25 stereoquintet was prepared 8 steps versus 15 steps, as described by 
Miyashita.18h,i 
 
4.2.2 RESULTS AND DISCUSSION 
 Enantioselective double crotylation of 1,3-propanediol 4.2.1a potentially 
generates as many as ten stereoisomers. Hence, quantitative evaluation of the product 
distribution represents a formidable challenge. A calculation of the theoretical 
distribution of stereoisomers based on a 99:1 enantiomeric ratio and 15:1 diastereomeric 
ratio (anti:syn) predicts a diastereomeric ratio of 6.2:1 dr (4.2.2a versus all other 
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Figure 4.2 Calculated theoretical distribution of stereoisomers obtained in the double 
crotylation of 1,3-propanediol 4.2.1a based on 98% ee for both syn- and anti -crotylation 
events and a 15:1 dr (anti:syn) and observed experimental results. 
 
To quantitatively evaluate product distributions obtained in the course of 
optimization, authentic samples of 4.2.2a, ent-4.2.2a, anti,anti-meso-4.2.2e were 
prepared in a conventional stepwise manner involving successive mono-crotylation.25 
Authentic samples of anti,syn-4.2.2c and rac-iso-anti,syn-4.2.2d were prepared 
conveniently via Mitsunobu inversion of 4.2.2a and anti,anti-meso-4.2.2e, respectively. 
These authentic standards were analyzed by chiral stationary phase GC and a comparison 
to the reaction mixture obtained upon exposure of 1,3-propanediol 4.2.1a to α-methyl 
allyl acetate in the presence of the iridium catalyst derived from [Ir(cod)Cl]2, allyl 
acetate, 4-cyano-3-nitrobenzoic acid, and the chelating phosphine ligand BIPHEP (2,2'-
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bis(diphenylphosphino)biphenyl), as well as the product distribution obtained using the 




For the reaction mixture obtained using the BIPHEP-modified catalyst, chiral 
stationary phase GC analysis reveals ten distinct species, presumably the ten 
stereoisomers indicated in Figure 4.2. Indeed, good correlation in GC retention time is 
observed with the six authentic samples of 4.2.2a, ent-4.2.2a, anti,syn-4.2.2c, anti,anti-
meso-4.2.2e, iso-anti,syn-4.2.2d and ent-iso-anti,syn-4.2.2d. A dramatic simplification in 
product distribution is observed in the enantioselective reaction employing the chiral 
catalyst (R)-I.26 Chiral stationary phase GC and 1H NMR analysis reveal only two 
stereoisomers: the C2-symmetric adduct 4.2.2a and a minor stereoisomer identified as 
iso-anti,syn-4.2.2d. These data are in excellent agreement with the predicted 
stereoisomeric ratios. Isolation by silica gel chromatography delivers 4.2.2a in 76% yield 
as a single enantiomer as a 5:1 mixture of diastereomers. Thus, an acyclic array of four 
stereogenic centers is generated in a single manipulation from achiral reactants with 
control of relative and absolute stereochemistry (Figure 4.3). 
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Figure 4.3 Characterization of the product distribution obtained upon anti-upon diastereo- 
and enantioselective double C-crotylation of 1,3-propanediol 4.2.1a. 
 
Given these favorable results, the double crotylation of 2-methyl-1,3-propanediol 
4.2.1b was explored. Here, generation of the pseudo-C2-symmetric contiguous 
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polypropionate stereoquintet 4.2.3a is potentially achieved in a single manipulation. 
However, sixteen stereoisomeric adducts may arise (Figure 4.4). The calculated 
theoretical distribution of stereoisomers obtained upon use of the chiral catalyst (R)-I 
suggests only three stereoisomers will be generated in significant proportion: the desired 
pseudo-C2-symmetric adduct 4.2.3a (86.1%), s,s,a,a-4.2.3b (5.7%) and s,a,s,a-4.2.3b 
(5.7%). Accordingly, authentic samples of these components and ent-4.2.3a were 
prepared in a conventional stepwise manner involving successive mono-crotylation.24 
 
 
Figure 4.4 Calculated theoretical distribution of stereoisomers obtained in the double 
crotylation of 2-methyl propanediol 4.2.1b based on 98% ee for both syn- and anti -
crotylation events and a 15:1 dr (anti:syn) and observed experimental results. 
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Chiral stationary phase GC analysis of the mixture obtained in the double 
crotylation of 2-methyl-1,3-propanediol 4.2.1b using the BIPHEP-modified catalyst 
reveals over ten distinct species. However, chiral stationary phase GC and 1H NMR 
analysis of the reaction mixture obtained using chiral catalyst (R)-I reveals that the 
desired pseudo-C2-symmetric adduct 4.2.3a is formed predominantly, along with small 
quantities of s,s,a,a-4.2.3b and s,a,s,a-4.2.3b (Figure 4.5). This outcome is in excellent 
agreement with the predicted stereoisomeric ratios. Isolation by silica gel 
chromatography delivers 4.2.3a in 62% yield as a single enantiomer as a 6:1 mixture of 
diastereomers. Thus, a contiguous acyclic array of five stereogenic centers is generated in 
a single manipulation from achiral reactants with control of relative and absolute 
stereochemistry (Figure 4.4). 
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Figure 4.5 Characterization of the product distribution obtained upon anti-upon diastereo- 
and enantioselective double C-crotylation of 2-methyl-1,3-propanediol 4.2.1b. 
 
4.2.3 FORMAL SYNTHESIS OF RIFAMYCIN S AND SYNTHESIS OF THE 
SCYTOPHYCIN STEREOQUINTET 
To explore the utility this methodology in polyketide construction, the product of 
double crotylation 4.2.3a was applied in a synthetic approach to the ansa chain of 
rifamycin S, the C19-C27 stereoheptad. A key objective involves differentiation of the 
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homotopic hydroxyl moieties and olefinic termini of 4.2.3a. Additionally, the latent 
stereocenter residing on the C2-plane must be defined. These goals are achieved in a 
single operation through the conversion of 4.2.3a to iodoether 4.2.4. As corroborated by 
1H NMR analysis of the pyran spin system, the substituents attached to the two newly 




Elaboration of iodoether 4.2.4 to the ansa chain of rifamycin S is accomplished in 
a straightforward manner. Ozonolytic cleavage of iodoether 4.2.4 delivers the aldehyde 
4.2.5, which is subjected to Batey’s crotylation conditions27 to furnish the homoallylic 
alcohol 4.2.6 as a single stereoisomer (>20:1 dr), as determined by 1H NMR analysis. 
Here, synergistic 1,2- and 1,3-asymmetric induction associated with the α- and β-
stereocenters of the aldehyde, as described by the Felkin-Anh28 and Cram-Reetz29 
models, respectively, account for the high level of stereoselectivity.30 Ozonolytic 
cleavage of the terminal olefin followed by NaBH4-mediated reduction of the ozonide 
delivers the primary alcohol 4.2.7 (not shown). Exposure of 4.2.7 to zinc dust in the 
presence of ammonium chloride induces β-iodoether cleavage to reveal the 
polypropionate stereohepted 4.2.8 (not shown). Conversion of tetraol 4.2.8 to the bis-
acetonide 4.2.9 and finally, ozonolytic cleavage of the terminal olefin, again with 
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quenching of the ozonide by NaBH4, delivers the protected C19-C27 stereohepted 4.2.10, 
which is identical in all respects to previously reported material.15 Preparation of the ansa 
chain in this manner constitutes a formal total synthesis of rifamycin S in 8 steps from 2-
methyl-1,3-propanediol 4.2.1b (Scheme 4.1). 
 
 
Scheme 4.1 Formal synthesis of rifamycin S via construction of the C19-C27 
stereoheptad. 
 
To further illustrate the generality of this approach, a synthesis of the scyotphycin 
C C19-C25 stereoquintet was undertaken. Ozonolytic cleavage of the terminal olefin of 
iodoether 4.2.4 with NaBH4-mediated reduction of the ozonide delivers the primary 
alcohol 4.2.11 (not shown), which is converted to the pivalate 4.2.12. Exposure of an 
ethanolic solution of 4.2.12 to zinc dust in the presence of ammonium chloride induces β-
iodoether cleavage to reveal the polypropionate stereoquintet 4.2.13. Conversion of the 
diol to the acetonide followed by ozonolytic cleavage of the terminal olefin, again with 
quenching of the ozonide by NaBH4, delivers the primary alcohol 4.2.15 (not shown), 
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which is converted to the benzylic ether 4.2.16 (Scheme 1). Ether 4.2.16 is identical in all 
respects to previously reported material.17h-i 
 
 
Scheme 4.2 Synthesis of the scytophycin C C19-C25 stereoquintet. 
 
4.2.4 SUMMARY 
In summary, we report a powerful new process for the direct generation of 
polypropionate stereoquintets via iridium catalyzed anti-diastereo- and enantioselective 
carbonyl double crotylation of 1,3-propanediols 4.2.1a and 4.2.1b. Based on this 
methodology, syntheses of the rifamycin S C19-C27 stereoheptad and the scytophycin C 
C19-C25 stereoquintet were executed with dramatic enhancement in step economy. To 
our knowledge, the efficiency associated with the conversion of the achiral/chiral racemic 
materials 4.2.1b and α-methyl allyl acetate to stereoquintet 4.2.3a is without precedent. 
Future studies will focus on the development and application of other alcohol C-C 
couplings of relevance to polyketide construction.  
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All reactions were run under an atmosphere of Argon. Tetrahydrofuran (THF) and 
toluene were obtained from Pure-Solv MD-5 Solvent Purification System (Innovative 
Technology). Anhydrous solvents were transferred by an oven-dried syringe. Sealed 
tubes (13x100 mm) were purchased from Fischer Scientific and were dried in an oven 
overnight and cooled under a stream of nitrogen prior to use. Commercially available 
allyl acetate (Aldrich) was purified by distillation prior to use. Cesium carbonate was 
purchased from Alfa Aesar and was used directly without further purification. 
Isopropanol (Fisher) was purified by distillation prior to use. Analytical thin-layer 
chromatography (TLC) was carried out using 0.2-mm commercial silica gel plates (DC-
Fertigplatten Kieselgel 60 F254). Infrared spectra were recorded on a Perkin-Elmer 1600 
spectrometer. High-resolution mass spectra (HRMS) were obtained on a Karatos MS9 
and are reported as m/z (relative intensity). Accurate masses are reported for the 
molecular ion (M+H, M or M-H) or a suitable fragment ion. Nuclear magnetic resonance 
spectra (1H NMR and 13C NMR) spectra were recorded with a Varian Gemini (400 MHz) 
spectrometer for CDCl3 solutions and chemical shifts are reported as parts per million 
(ppm) relative to residual CHCl3 δH (7.26 ppm) and CDCl3 δC (77.0 ppm), respectively, 
as internal standards. Coupling constants are reported in Hertz (Hz). 
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Preparation of (R)-I 
 
To a mixture of [Ir(cod)Cl]2 (87.3 mg, 0.13 mmol, 100 mol%), (S)-SEGPHOS (159 mg, 
0.26 mmol, 200 mol%), Cs2CO3 (169 mg, 0.52 mmol, 400 mol%), 4-CN-3-NO2BzOH 
(100 mg, 0.52 mmol, 400 mol%) and allyl acetate (65 mg, 0.65 mmol, 500 mol%) in a 
sealed tube under an atmosphere of N2 was added THF (2.6 mL, 0.05 M). The reaction 
mixture was stirred for 30 minutes at ambient temperature and heated for 1.5 hours at 80 
oC. Upon cooling to ambient temperature, the reaction mixture was diluted with CH2Cl2 
(10 mL), filtered through a celite plug, washed with CH2Cl2 (50 mL) and concentrated in 
vacuo. The residue was purified by flash chromatography (SiO2, 20% Et2O/CH2Cl2) and 
concentrated in vacuo. The light yellow gum was dissolved in THF (3 mL). Rapid 
addition of hexanes (50 mL) to the stirred solution resulted in precipitation of a bright 
yellow powder, which was collected by gravity filtration. Removal of trace solvents in 





Preparation of (S)-I 
 
To a mixture of [Ir(cod)Cl]2 (87.3 mg, 0.13 mmol, 100 mol%), (S)-SEGPHOS (159 mg, 
0.26 mmol, 200 mol%), Cs2CO3 (169 mg, 0.52 mmol, 400 mol%), 4-CN-3-NO2BzOH 
(100 mg, 0.52 mmol, 400 mol%) and allyl acetate (65 mg, 0.65 mmol, 500 mol%) in a 
sealed tube under an atmosphere of N2 was added THF (2.6 mL, 0.05 M). The reaction 
mixture was stirred for 30 minutes at ambient temperature and heated for 1.5 hours at 80 
oC. Upon cooling to ambient temperature, the reaction mixture was diluted with CH2Cl2 
(10 mL), filtered through a celite plug, washed with CH2Cl2 (50 mL) and concentrated in 
vacuo. The residue was purified by flash chromatography (SiO2, 20% Et2O/CH2Cl2) and 
concentrated in vacuo. The light yellow gum was dissolved in THF (3 mL). Rapid 
addition of hexanes (50 mL) to the stirred solution resulted in precipitation of a bright 
yellow powder, which was collected by gravity filtration. Removal of trace solvents in 







An oven-dried sealed tube under an atmosphere of N2 was charged with (4-
bromophenyl)methanol 4.1.2a (37.4 mg, 0.20 mmol, 100 mol%), (S)-I (10.3 mg, 0.01 
mmol, 5 mol%), K3PO4 (21.5 mg, 0.10 mmol, 50 mol%), THF (0.1 mL, 2.0 M), and H2O 
(18 μL, 1.0 mmol, 500 mol%). But-3-en-2-yl acetate 4.1 (45.6 mg, 0.40 mmol, 200 
mol%) was added and the mixture was allowed to stir at ambient temperature for 0.5 hr, 
at which point the reaction vessel was placed in an oil bath at 60 oC and was allowed to 
stir for 48 hr. The reaction mixture was concentrated in vacuo. Purification of the residue 
by column chromatography (SiO2; ethyl acetate: hexanes, 1:20 with 0.1% TEA) provided 
4.1.4a (37.6 mg, 0.156 mmol) as a colorless oil in 78% yield (16:1 dr). 
 
TLC (SiO2): Rf = 0.4 (ethyl acetate: hexanes, 1:5). 
 
1H NMR (400 MHz, CDCl3): δ 7.46 (d, J = 8.0 Hz, 2H), 7.18 (d, J = 8.0 Hz, 2H), 5.81-5.71 
(m, 1H), 5.22-5.16 (m, 2H), 4.32 (d, J = 7.6 Hz, 1H), 2.45-2.37 (m, 1H), 2.20 (br s, 1H), 0.87 
(d, J = 6.8 Hz, 3H). 
 
13C NMR (100 MHz, CDCl3): δ141.4, 140.1, 131.3, 128.6, 121.4, 117.3, 77.1, 46.4, 16.4. 
 
HPLC: (Chiralpak AS-H/AS-H column, hexanes:i-PrOH = 98:2, 0.5 mL/min, 230 nm), tminor 














An oven-dried sealed tube under an atmosphere of N2 was charged with (4-
methoxyphenyl)methanol 4.1.2b (27.6 mg, 0.20 mmol, 100 mol%), (S)-I (10.3 mg, 0.01 
mmol, 5 mol%), K3PO4 (21.5 mg, 0.10 mmol, 50 mol%), THF (0.1 mL, 2.0 M), and H2O 
(18 μL, 1.0 mmol, 500 mol%). But-3-en-2-yl acetate (45.6 mg, 0.40 mmol, 200 mol%) 
was added and the mixture was allowed to stir at ambient temperature for 0.5 hr, at which 
point the reaction vessel was placed in an oil bath at 60 oC and was allowed to stir for 48 
hr. The reaction mixture was concentrated in vacuo. Purification of the residue by column 
chromatography (SiO2; ethyl acetate: hexanes, 1:20 with 0.1% TEA) provided 4.1.4b 
(35.0 mg, 0.182 mmol) as a colorless oil in 91% yield (10:1 dr). 
 
TLC (SiO2): Rf = 0.4 (ethyl acetate: hexanes, 1:5). 
 
1H NMR (400 MHz, CDCl3): δ 7.25 (d, J = 8.0 Hz, 2H), 6.87 (d, J = 8.0 Hz, 2H), 5.86-5.76 
(m, 1H), 5.23-5.16 (m, 2H), 4.29 (d, J = 8.4 Hz, 1H), 3.80 (s, 3H), 2.48-2.42 (m, 1H), 2.15 
(br s, 1H), 0.83 (d, J = 6.8 Hz, 3H). 
 
13C NMR (100 MHz, CDCl3): δ159.3, 141.2, 134.8, 128.2, 117.0, 113.9, 77.7, 55.5, 46.7, 
16.8. 
 
HPLC: (Chiralpak AD-H/AD-H column, hexanes:i-PrOH = 95:5, 0.5 mL/min, 230 nm), 















An oven-dried sealed tube under an atmosphere of N2 was charged with methyl 4-
(hydroxymethyl)benzoate 4.1.2c (33.2 mg, 0.20 mmol, 100 mol%), (S)-I (10.3 mg, 0.01 
mmol, 5 mol%), K3PO4 (21.5 mg, 0.10 mmol, 50 mol%), THF (0.1 mL, 2.0 M), and H2O 
(18 μL, 1.0 mmol, 500 mol%). But-3-en-2-yl acetate (45.6 mg, 0.40 mmol, 200 mol%) 
was added and the mixture was allowed to stir at ambient temperature for 0.5 hr, at which 
point the reaction vessel was placed in an oil bath at 60 oC and was allowed to stir for 48 
hr. The reaction mixture was concentrated in vacuo. Purification of the residue by column 
chromatography (SiO2; ethyl acetate: hexanes, 1:20 with 0.1% TEA) provided 4.1.4c 
(34.4 mg, 0.156 mmol) as a colorless oil in 78% yield (11:1 dr). 
 
TLC (SiO2): Rf = 0.4 (ethyl acetate: hexanes, 1:5). 
 
1H NMR (400 MHz, CDCl3): δ 7.97 (d, J = 8.0 Hz, 2H), 7.36 (d, J = 8.0 Hz, 2H), 5.79-5.69 
(m, 1H), 5.17-5.12 (m, 2H), 4.40 (d, J = 7.2 Hz, 1H), 3.88 (s, 3H), 2.49-2.36 (m, 2H), 0.86 
(d, J = 6.8 Hz, 3H). 
 
13C NMR (100 MHz, CDCl3): δ167.2, 147.9, 140.1, 129.7, 129.6, 127.0, 117.5, 77.3, 52.3, 
46.5, 16.6. 
 
HPLC: (Chiralpak AD-H column, hexanes:i-PrOH = 95:5, 0.5 mL/min, 254 nm), tminor = 

















An oven-dried sealed tube under an atmosphere of N2 was charged with (6-bromopyridin-
2-yl)methanol 4.1.2d (37.6 mg, 0.20 mmol, 100 mol%), (S)-I (10.3 mg, 0.01 mmol, 5 
mol%), K3PO4 (21.5 mg, 0.10 mmol, 50 mol%), THF (0.1 mL, 2.0 M), and H2O (18 μL, 
1.0 mmol, 500 mol%). But-3-en-2-yl acetate (45.6 mg, 0.40 mmol, 200 mol%) was added 
and the mixture was allowed to stir at ambient temperature for 0.5 hr, at which point the 
reaction vessel was placed in an oil bath at 60 oC and was allowed to stir for 48 hr. The 
reaction mixture was concentrated in vacuo. Purification of the residue by column 
chromatography (SiO2; ethyl acetate: hexanes, 1:20 with 0.1% TEA) provided 4.1.4d 
(24.2 mg, 0.100 mmol) as a colorless oil in 50% yield (14:1 dr). 
 
TLC (SiO2): Rf = 0.3 (ethyl acetate: hexanes, 1:5). 
 
1H NMR (400 MHz, CDCl3): δ 7.53 (t, J = 7.6 Hz, 1H), 7.38 (d, J = 7.6 Hz, 1H), 7.25 (d, 
J = 8.0 Hz, 1H), 5.73 (dt, J = 17.2, 10.4, 1H), 5.10-4.99 (m, 2H), 4.58 (t, J = 5.2 Hz, 1H), 
3.28 (d, J = 6.0 Hz, 1H), 2.72-2.64 (m, 1H), 1.06 (d, J = 6.8 Hz, 3H). 
 
13C NMR (100 MHz, CDCl3): δ 162.8, 141.0, 138.7, 138.6, 126.7, 120.0, 116.5, 44.6, 
16.1. 
 
HPLC: (Chiralcel OD-H column, hexanes:i-PrOH = 95:5, 0.5 mL/min, 210 nm), tmajor = 














An oven-dried sealed tube under an atmosphere of N2 was charged with (1-methyl-1H-
indol-3-yl)methanol 4.1.2e (32.2 mg, 0.20 mmol, 100 mol%), (S)-I (10.3 mg, 0.01 mmol, 
5 mol%), K3PO4 (21.5 mg, 0.10 mmol, 50 mol%), THF (0.1 mL, 2.0 M), and H2O (18 
μL, 1.0 mmol, 500 mol%). But-3-en-2-yl acetate (45.6 mg, 0.40 mmol, 200 mol%) was 
added and the mixture was allowed to stir at ambient temperature for 0.5 hr, at which 
point the reaction vessel was placed in an oil bath at 60 oC and was allowed to stir for 48 
hr. The reaction mixture was concentrated in vacuo. Purification of the residue by column 
chromatography (SiO2; ethyl acetate: hexanes, 1:20 with 0.1% TEA) provided 4.1.4e 
(32.3 mg, 0.150 mmol) as a colorless oil in 75% yield (7:1 dr). 
 
TLC (SiO2): Rf = 0.4 (ethyl acetate: hexanes, 1:5). 
 
1H NMR (400 MHz, CDCl3): δ 7.62 (d, J = 8.0 Hz, 1H), 7.34 (d, J = 8.4 Hz, 1H), 7.26 (t, J 
= 8.0 Hz, 1H), 7.14 (t, J = 8.0 Hz, 1H), 6.48 (s, 1H), 5.98-5.88 (m, 1H), 5.33-5.25 (m, 2H), 
4.60 (d, J = 8.4 Hz, 1H), 3.81 (s, 3H), 2.86-2.78 (m, 1H), 2.22 (br s, 1H), 1.03 (d, J = 6.8 Hz, 
3H). 
 
13C NMR (100 MHz, CDCl3): δ 140.7, 140.3, 138.2, 127.5, 121.9, 120.9, 119.8, 117.4, 
109.4, 100.8, 71.4, 44.3, 30.7, 17.5. 
 
HPLC: (Chiralcel OJ-H column, hexanes:i-PrOH = 93:7, 0.5 mL/min, 254 nm), tmajor = 53.3 





















An oven-dried sealed tube under an atmosphere of N2 was charged with trans-cinnamyl 
alcohol 4.1.2f (26.8 mg, 0.20 mmol, 100 mol%), (S)-I (10.3 mg, 0.01 mmol, 5 mol%), 
K3PO4 (21.5 mg, 0.10 mmol, 50 mol%), THF (0.1 mL, 2.0 M), and H2O (18 μL, 1.0 
mmol, 500 mol%). But-3-en-2-yl acetate (45.6 mg, 0.40 mmol, 200 mol%) was added 
and the mixture was allowed to stir at ambient temperature for 0.5 hr, at which point the 
reaction vessel was placed in an oil bath at 70 oC and was allowed to stir for 48 hr. The 
reaction mixture was concentrated in vacuo. Purification of the residue by column 
chromatography (SiO2; ethyl acetate: hexanes, 1:20 with 0.1% TEA) provided 4.1.4f 
(27.1 mg, 0.144 mmol) as a colorless oil in 72% yield (10:1 dr). 
 
TLC (SiO2): Rf = 0.3 (ethyl acetate:hexanes, 1:10).  
 
1H NMR (400 MHz, CDCl3): δ 7.41-7.23 (m, 5H), 6.61 (d, J = 16.0 Hz, 1H), 6.21 (dd, J 
= 16.0, 7.2 Hz, 1H), 5.88-5.78 (m, 1H), 5.21-5.16 (m, 2H), 4.06 (t, J = 6.8 Hz, 1H), 2.41-
2.35 (m, 1H), 1.99 (br s, 1H), 1.06 (d, J = 6.8 Hz, 3H).  
 
13C NMR (100 MHz, CDCl3): δ 140.4, 136.9, 132.0, 130.4, 128.8, 127.9, 126.8, 117.0, 
76.4, 44.9, 16.3.  
 
HPLC: (Chiralpak AS-H/AS-H column, hexanes:i-PrOH = 98:2, 0.5 mL/min, 254 nm), 















An oven-dried sealed tube under an atmosphere of N2 was charged with 3-phenylpropan-
1-ol 4.1.2g (27.2 mg, 0.20 mmol, 100 mol%), (S)-I (10.3 mg, 0.01 mmol, 5 mol%), 
K3PO4 (21.5 mg, 0.10 mmol, 50 mol%), THF (0.1 mL, 2.0 M), and H2O (18 μL, 1.0 
mmol, 500 mol%). But-3-en-2-yl acetate (45.6 mg, 0.40 mmol, 200 mol%) was added 
and the mixture was allowed to stir at ambient temperature for 0.5 hr, at which point the 
reaction vessel was placed in an oil bath at 60 oC and was allowed to stir for 48 hr. The 
reaction mixture was concentrated in vacuo. Purification of the residue by column 
chromatography (SiO2; ethyl acetate: hexanes, 1:20 with 0.1% TEA) provided 4.1.4g 
(27.0 mg, 0.142 mmol) as a colorless oil in 71% yield (>20:1 dr). 
 
TLC (SiO2): Rf = 0.4 (ethyl acetate: hexanes, 1:5). 
 
1H NMR (400 MHz, CDCl3): δ 7.31-7.17 (m, 5H), 5.80-5.70 (m, 1H), 5.15-5.10 (m, 2H), 
3.43-3.40 (m, 1H), 2.89-2.81 (m, 1H), 2.72-2.64 (m, 1H), 2.26-2.20 (m, 1H), 1.89-1.80 (m, 
1H), 1.75-1.62 (m, 2H), 1.03 (d, J = 6.8 Hz, 3H). 
 
13C NMR (100 MHz, CDCl3): δ 142.6, 140.4, 128.7, 128.6, 126.0, 116.8, 74.2, 44.6, 36.4, 
32.4, 16.5. 
 
HPLC: (Chiralcel OD-H column, hexanes:i-PrOH = 97:3, 0.7 mL/min, 254 nm), tminor = 11.5 















An oven-dried sealed tube under an atmosphere of N2 was charged with tert-butyl 3-
hydroxypropylcarbamate 4.1.2h (35.0 mg, 0.20 mmol, 100 mol%), (S)-I (10.3 mg, 0.01 
mmol, 5 mol%), K3PO4 (21.5 mg, 0.10 mmol, 50 mol%), THF (0.1 mL, 2.0 M), and H2O 
(18 μL, 1.0 mmol, 500 mol%). But-3-en-2-yl acetate (45.6 mg, 0.40 mmol, 200 mol%) 
was added and the mixture was allowed to stir at ambient temperature for 0.5 hr, at which 
point the reaction vessel was placed in an oil bath at 70 oC and was allowed to stir for 48 
hr. The reaction mixture was concentrated in vacuo. Purification of the residue by column 
chromatography (SiO2; ethyl acetate: hexanes, 1:20 with 0.1% TEA) provided 4.1.4h 
(32.6 mg, 0.142 mmol) as a colorless oil in 71% yield (>20:1 dr). 
 
TLC (SiO2): Rf = 0.5 (ethyl acetate:hexanes, 1:3). 
 
1H NMR (400 MHz, CDCl3): δ 5.76 (dtd, J = 17.2, 10.0, 0.4 Hz, 1H), 5.12-5.05 (m, 2H), 
4.91 (br, 1H), 3.48-3.41 (m, 2H), 3.20-3.11 (m, 1H), 2.58 (d, J = 2.8 Hz, 1H), 2.30-2.17 
(m, 1H), 1.72-1.64 (m, 1H), 1.54-1.45 (m, 1H), 1.44 (s, 9H), 1.03 (d, J = 6.8 Hz,3H). 
 
13C NMR (100 MHz, CDCl3): δ 156.7, 140.4, 116.1, 79.3, 72.6, 44.2, 37.7, 34.2, 28.4, 
16.2. 
 
HPLC: Enantiomeric excess was determined by HPLC analysis of the 4-nitrobenzoate 
derivative of the product (Chiralcel OJ-H column, hexanes:i-PrOH = 98:2, 0.75 mL/min, 
















An oven-dried sealed tube under an atmosphere of N2 was charged with 3-(4-
methoxybenzyloxy)propan-1-ol 4.1.2i (39.2 mg, 0.20 mmol, 100 mol%), (S)-I (10.3 mg, 
0.01 mmol, 5 mol%), K3PO4 (21.5 mg, 0.10 mmol, 50 mol%), THF (0.1 mL, 2.0 M), and 
H2O (18 μL, 1.0 mmol, 500 mol%). But-3-en-2-yl acetate (45.6 mg, 0.40 mmol, 200 
mol%) was added and the mixture was allowed to stir at ambient temperature for 0.5 hr, 
at which point the reaction vessel was placed in an oil bath at 60 oC and was allowed to 
stir for 48 hr. The reaction mixture was concentrated in vacuo. Purification of the residue 
by column chromatography (SiO2; ethyl acetate: hexanes, 1:20 with 0.1% TEA) provided 
4.1.4i (38.1 mg, 0.152 mmol) as a colorless oil in 76% yield (15:1 dr). 
 
TLC (SiO2): Rf = 0.5 (ethyl acetate:hexanes, 1:4). 
 
1H NMR (400 MHz, CDCl3): δ 7.26-7.24 (m, 2H), 6.90-6.86 (m, 2H), 5.80 (dt, J = 17.2, 
10.0 Hz, 1H), 5.09-5.02 (m, 2H), 4.45 (s, 2H), 3.80 (s, 3H), 3.71-3.61 (m, 3H), 2.79 (d, J 
= 2.8, 1H), 2.23 (qt, J = 6.8, 0.8 Hz, 1H), 1.74-1.70 (m, 2H), 1.03 (d, J = 6.8 Hz, 3H). 
 
13C NMR (100 MHz, CDCl3): δ 159.2, 140.5, 130.1, 129.3, 115.4, 113.8, 74.3, 73.0, 
68.9, 55.3, 44.0, 33.5, 15.8. 
 
HPLC: Enantiomeric excess was determined by HPLC analysis of the 4-nitrobenzoate 
derivative of the product (Chiralcel AD-H column, hexanes:i-PrOH = 98:2, 1.0 mL/min, 
















An oven-dried sealed tube under an atmosphere of N2 was charged with 4-
bromobenzaldehyde 4.1.3a (37.0 mg, 0.20 mmol, 100 mol%), (S)-I (10.3 mg, 0.01 mmol, 
5 mol%), K3PO4 (21.5 mg, 0.10 mmol, 50 mol%), THF (0.1 mL, 2.0 M), isopropanol (31 
μL, 0.4 mmol, 200 mol%), and H2O (18 μL, 1.0 mmol, 500 mol%). But-3-en-2-yl acetate 
(45.6 mg, 0.40 mmol, 200 mol%) was added and the mixture was allowed to stir at 
ambient temperature for 0.5 hr, at which point the reaction vessel was placed in an oil 
bath at 60 oC and was allowed to stir for 48 hr. The reaction mixture was concentrated in 
vacuo. Purification of the residue by column chromatography (SiO2; ethyl acetate: 
hexanes, 1:20 with 0.1% TEA) provided 4.1.4a (39.5 mg, 0.164 mmol) as a colorless oil 
in 82% yield (17:1 dr). 
 
HPLC: (Chiralpak AS-H/AS-H column, hexanes:i-PrOH = 98:2, 0.5 mL/min, 230 nm), tminor 











An oven-dried sealed tube under an atmosphere of N2 was charged with 4-
methoxybenzaldehyde 4.1.3b (27.2 mg, 0.20 mmol, 100 mol%), (S)-I (10.3 mg, 0.01 
mmol, 5 mol%), K3PO4 (21.5 mg, 0.10 mmol, 50 mol%), THF (0.1 mL, 2.0 M), 
isopropanol (31 μL, 0.4 mmol, 200 mol%), and H2O (18 μL, 1.0 mmol, 500 mol%). But-
3-en-2-yl acetate 45.6 mg, 0.40 mmol, 200 mol%) was added and the mixture was 
allowed to stir at ambient temperature for 0.5 hr, at which point the reaction vessel was 
placed in an oil bath at 60 oC and was allowed to stir for 48 hr. The reaction mixture was 
concentrated in vacuo. Purification of the residue by column chromatography (SiO2; ethyl 
acetate: hexanes, 1:20 with 0.1% TEA) provided 4.1.4b (34.2 mg, 0.178 mmol) as a 
colorless oil in 89% yield (12:1 dr). 
 
HPLC: (Chiralpak AD-H/AD-H column, hexanes:i-PrOH = 95:5, 0.5 mL/min, 230 nm), 












An oven-dried sealed tube under an atmosphere of N2 was charged with methyl 4-
formylbenzoate 4.1.3c (32.8 mg, 0.20 mmol, 100 mol%), (S)-I (10.3 mg, 0.01 mmol, 5 
mol%), K3PO4 (21.5 mg, 0.10 mmol, 50 mol%), THF (0.1 mL, 2.0 M), isopropanol (31 
μL, 0.4 mmol, 200 mol%), and H2O (18 μL, 1.0 mmol, 500 mol%). But-3-en-2-yl acetate 
(45.6 mg, 0.40 mmol, 200 mol%) was added and the mixture was allowed to stir at 
ambient temperature for 0.5 hr, at which point the reaction vessel was placed in an oil 
bath at 60 oC and was allowed to stir for 48 hr. The reaction mixture was concentrated in 
vacuo. Purification of the residue by column chromatography (SiO2; ethyl acetate: 
hexanes, 1:20 with 0.1% TEA) provided 4.1.4c (35.7 mg, 0.162 mmol) as a colorless oil 
in 81% yield (11:1 dr). 
 
HPLC: (Chiralpak AD-H column, hexanes:i-PrOH = 95:5, 0.5 mL/min, 254 nm), tminor = 












An oven-dried sealed tube under an atmosphere of N2 was charged with 6-
bromopicolinaldehyde 4.1.3d (37.2 mg, 0.20 mmol, 100 mol%), (S)-I (10.3 mg, 0.01 
mmol, 5 mol%), K3PO4 (21.5 mg, 0.10 mmol, 50 mol%), THF (0.1 mL, 2.0 M), 
isopropanol (31 μL, 0.4 mmol, 200 mol%), and H2O (18 μL, 1.0 mmol, 500 mol%). But-
3-en-2-yl acetate (45.6 mg, 0.40 mmol, 200 mol%) was added and the mixture was 
allowed to stir at ambient temperature for 0.5 hr, at which point the reaction vessel was 
placed in an oil bath at 60 oC and was allowed to stir for 48 hr. The reaction mixture was 
concentrated in vacuo. Purification of the residue by column chromatography (SiO2; ethyl 
acetate: hexanes, 1:20 with 0.1% TEA) provided 4.1.4d (36.3 mg, 0.150 mmol) as a 
colorless oil in 75% yield (>20:1 dr). 
 
HPLC: (Chiralcel OD-H column, hexanes:i-PrOH = 95:5, 0.5 mL/min, 210 nm), tmajor = 












An oven-dried sealed tube under an atmosphere of N2 was charged with 1-methyl-1H-
indole-3-carbaldehyde 4.1.3e (31.8 mg, 0.20 mmol, 100 mol%), (S)-I (10.3 mg, 0.01 
mmol, 5 mol%), K3PO4 (21.5 mg, 0.10 mmol, 50 mol%), THF (0.1 mL, 2.0 M), 
isopropanol (31 μL, 0.4 mmol, 200 mol%), and H2O (18 μL, 1.0 mmol, 500 mol%). But-
3-en-2-yl acetate (45.6 mg, 0.40 mmol, 200 mol%) was added and the mixture was 
allowed to stir at ambient temperature for 0.5 hr, at which point the reaction vessel was 
placed in an oil bath at 60 oC and was allowed to stir for 48 hr. The reaction mixture was 
concentrated in vacuo. Purification of the residue by column chromatography (SiO2; ethyl 
acetate: hexanes, 1:20 with 0.1% TEA) provided 4.1.4e (31.9 mg, 0.148 mmol) as a 
colorless oil in 75% yield (10:1 dr). 
 
HPLC: (Chiralcel OJ-H column, hexanes:i-PrOH = 93:7, 0.5 mL/min, 254 nm), tmajor = 53.3 















An oven-dried sealed tube under an atmosphere of N2 was charged with trans-cinnamyl 
aldehyde 4.1.3f (26.4 mg, 0.20 mmol, 100 mol%), (S)-I (10.3 mg, 0.01 mmol, 5 mol%), 
K3PO4 (21.5 mg, 0.10 mmol, 50 mol%), THF (0.1 mL, 2.0 M), isopropanol (31 μL, 0.4 
mmol, 200 mol%), and H2O (18 μL, 1.0 mmol, 500 mol%). But-3-en-2-yl acetate (45.6 
mg, 0.40 mmol, 200 mol%) was added and the mixture was allowed to stir at ambient 
temperature for 0.5 hr, at which point the reaction vessel was placed in an oil bath at 70 
oC and was allowed to stir for 48 hr. The reaction mixture was concentrated in vacuo. 
Purification of the residue by column chromatography (SiO2; ethyl acetate: hexanes, 1:20 
with 0.1% TEA) provided 4.1.4f (29.0 mg, 0.154 mmol) as a colorless oil in 77% yield 
(10:1 dr). 
 
HPLC: (Chiralpak AS-H/AS-H column, hexanes:i-PrOH = 98:2, 0.5 mL/min, 254 nm), 













An oven-dried sealed tube under an atmosphere of N2 was charged with 3-
phenylpropanal 4.1.3g (26.8 mg, 0.20 mmol, 100 mol%), (S)-I (10.3 mg, 0.01 mmol, 5 
mol%), K3PO4 (21.5 mg, 0.10 mmol, 50 mol%), THF (0.1 mL, 2.0 M), isopropanol (31 
μL, 0.4 mmol, 200 mol%), and H2O (18 μL, 1.0 mmol, 500 mol%). But-3-en-2-yl acetate 
(45.6 mg, 0.40 mmol, 200 mol%) was added and the mixture was allowed to stir at 
ambient temperature for 0.5 hr, at which point the reaction vessel was placed in an oil 
bath at 60 oC and was allowed to stir for 48 hr. The reaction mixture was concentrated in 
vacuo. Purification of the residue by column chromatography (SiO2; ethyl acetate: 
hexanes, 1:20 with 0.1% TEA) provided 4.1.4g (27.0 mg, 0.142 mmol) as a colorless oil 
in 71% yield (>20:1 dr). 
 
HPLC: (Chiralcel OD-H column, hexanes:i-PrOH = 97:3, 0.7 mL/min, 254 nm), tminor = 11.2 












An oven-dried sealed tube under an atmosphere of N2 was charged with tert-butyl 3-
oxopropylcarbamate 4.1.3h (34.6 mg, 0.20 mmol, 100 mol%), (S)-I (10.3 mg, 0.01 
mmol, 5 mol%), K3PO4 (21.5 mg, 0.10 mmol, 50 mol%), THF (0.1 mL, 2.0 M), 
isopropanol (31 μL, 0.4 mmol, 200 mol%), and H2O (18 μL, 1.0 mmol, 500 mol%). But-
3-en-2-yl acetate (45.6 mg, 0.40 mmol, 200 mol%) was added and the mixture was 
allowed to stir at ambient temperature for 0.5 hr, at which point the reaction vessel was 
placed in an oil bath at 70 oC and was allowed to stir for 48 hr. The reaction mixture was 
concentrated in vacuo. Purification of the residue by column chromatography (SiO2; ethyl 
acetate: hexanes, 1:20 with 0.1% TEA) provided 4.1.4h (30.3 mg, 0.142 mmol) as a 
colorless oil in 66% yield (>20:1 dr). 
 
HPLC: Enantiomeric excess was determined by HPLC analysis of the 4-nitrobenzoate 
derivative of the product (Chiralcel OJ-H column, hexanes:i-PrOH = 98:2, 0.75 mL/min, 














An oven-dried sealed tube under an atmosphere of N2 was charged with 3-(4-
methoxybenzyloxy)propanal 4.1.3i (38.8 mg, 0.20 mmol, 100 mol%), (S)-I (10.3 mg, 
0.01 mmol, 5 mol%), K3PO4 (21.5 mg, 0.10 mmol, 50 mol%), THF (0.1 mL, 2.0 M), 
isopropanol (31 μL, 0.4 mmol, 200 mol%), and H2O (18 μL, 1.0 mmol, 500 mol%). But-
3-en-2-yl acetate (45.6 mg, 0.40 mmol, 200 mol%) was added and the mixture was 
allowed to stir at ambient temperature for 0.5 hr, at which point the reaction vessel was 
placed in an oil bath at 60 oC and was allowed to stir for 48 hr. The reaction mixture was 
concentrated in vacuo. Purification of the residue by column chromatography (SiO2; ethyl 
acetate: hexanes, 1:20 with 0.1% TEA) provided 4.1.4i (38.1 mg, 0.152 mmol) as a 
colorless oil in 76% yield (>20:1 dr). 
 
HPLC: Enantiomeric excess was determined by HPLC analysis of the 4-nitrobenzoate 
derivative of the product (Chiralcel AD-H column, hexanes:i-PrOH = 98:2, 1.0 mL/min, 























An oven-dried sealed tube under an atmosphere of N2 was charged with1,3-propanediol 
4.2.1a(15.2 mg, 0.20 mmol, 100 mol%),(R)-I(20.7 mg, 0.02 mmol, 10 mol%), Na2CO3 
(42.4 mg, 0.40 mmol, 200 mol%),and THF (0.2 mL, 1.0 M).Freshly distilled α-methyl 
allyl acetate (114 mg, 1.00 mmol, 500 mol%) was added and the mixture was allowed to 
stir at 70oC for 96 hr.The reaction mixture was concentrated in vacuo. Purification of the 
residue by column chromatography (SiO2; ethyl acetate: hexanes, 1:10) provided 
4.2.2a(28.0 mg, 0.152 mmol) as off-white crystalline solid in 76% yield, ≥ 99% ee, 5:1 
dr. 
 
TLC (SiO2): Rf = 0.3 (ethyl acetate:hexanes, 1:3). 
 
1H NMR(400 MHz, CDCl3): δ 5.79-5.67 (m, 2H), 5.11-5.06 (m, 4H), 3.72-3.65 (m, 2H), 
2.61 (br. s, 2H), 2.27-2.18 (m, 2H), 1.57 (dd, J = 6.8, 5.2 Hz, 2H), 0.99 (d, J = 6.8 Hz, 
6H). 
 
13C NMR (100 MHz, CDCl3): δ 140.5, 116.1, 71.6, 44.1, 36.6, 16.0. 
 
GCCyclosil-B: initial temperature 50 °C (1 min hold); final temperature 200 °C; rate = 5 
°C/min; Tmajor product = 22.58 min, Tminor diastereomer = 22.95 min, Tminor enantiomer = 23.03; ee = 
99%, dr = 5:1. 
 
[α]D
27 = +56.0 (c = 1.0, CH2Cl2). 
 
MP = 47–59 oC 
 
FTIR (neat): υ 3329, 2954, 2916, 1641, 1460, 1404, 1376, 1330, 1290, 1239, 1196, 1173, 
1138, 1078, 1032, 1005, 963, 909, 836, 797, 674. 
 
HRMS: (CI) Calcd. for C11H21O2 [M+H]
















































To a solution of (3S,4R,6S,7R)-6-(tert-butyldimethylsilyloxy)-3,7-dimethylnona-1,8-
dien-4-ol (72 mg, 0.24 mmol, 100 mol%) in THF (0.8 mL, 0.25 M) was added TBAF 
(0.29 mL,1M in THF, 0.29 mmol, 120 mol%). The reaction was stirred at ambient 
temperature for 1 hr, concentrated under reduced pressure and the residue was subject to 
flash column chromatography (SiO2: ethyl acetate:hexanes, 1:3) to provide the title 
compound (25 mg, 0.14 mmol) as a white crystalline solid in 77% yield. 
 
TLC(SiO2): Rf = 0.3 (ethyl acetate:hexanes, 1:3). 
 
1H NMR (400 MHz, CDCl3): δ 5.81-5.72 (m, 2H), 5.11-5.06 (m, 4H), 3.67 (ddd, J = 
10.4, 5.6, 2.4 Hz, 2H), 3.12 (br. s, 2H), 2.27-2.18 (m, 2H), 1.63 (dt, J = 14.0, 2.0 Hz, 1H), 
1.45-1.36 (m, 1H), 1.03 (d, J = 6.8 Hz, 6H). 
 
13C NMR (100 MHz, CDCl3): δ 140.1, 116.0, 75.8, 44.5, 36.6. 
 
GCCyclosil-B: initial temperature 50 °C (1 min hold); final temperature 200 °C; rate = 5 
°C/min; Tmajor = 23.02 min. 
 
MP = 70 - 89oC. 
 
FTIR (neat): υ 3354, 2964, 2928, 2873, 1639, 1458, 1420, 1374, 1324, 1248, 1130, 1047, 
1024, 998, 965, 911, 851, 677. 
 
HRMS: (CI) Calcd. for C11H21O2 [M+H]


















A solution of (3R,4S,6R,7S)-3,7-dimethylnona-1,8-diene-4,6-diol (30 mg, 0.16 mmol, 
100 mol%), PPh3 (51 mg, 0.20 mmol, 125 mol%) and 4-nitrobenzoic acid (33 mg, 0.20 
mmol, 125 mol%) in THF (1.6 mL, 0.1 M) was cooled to 0 °C. Diisopropyl 
azodicarboxylate (39 µL, 0.20 mmol, 125 mol%) was added to the reaction mixture 
dropwise. The reaction mixture was stirred at 0 °C for 3 hr, and then allowed to warm to 
room temperature over 1 hr. The reaction mixture was passed through a short plug of 
silica gel with the aid of ethyl acetate, and the resulting liquor was concentrated under 
reduced pressure. The residue was dissolved inmethanol (1.6 mL), K2CO3 (28 mg, 0.20 
mmol, 125 mol%)was added and the reaction mixture was allowed to stir at ambient 
temperature for 16 hr. The reaction mixture was concentrated under reduced pressure, 
and the residue was subjected to flash column chromatography (SiO2: ethyl 
acetate:hexanes, 1:5) to provide the racemic title compound (7.0 mg, 0.04 mmol) as an 
off-white crystalline solid in 23% yield. 
 
TLC(SiO2): Rf = 0.3 (ethyl acetate:hexanes, 1:3). 
 
1H NMR (400 MHz, CDCl3): δ 5.80-5.68 (m, 2H), 5.16-5.05 (m, 4H), 3.78-3.69 (m, 2H), 
2.50 (d, J = 4.0 Hz, 1H), 2.33-2.22 (m, 2H), 2.11 (s, 1H), 1.66-1.57 (m, 2H), 1.07 (d, J = 
6.8 Hz, 3H), 1.00 (d, J = 6.8 Hz, 3H). 
 
13C NMR (100 MHz, CDCl3): δ 140.8, 140.5, 116.9, 115.3, 72.1, 71.9, 44.5, 43.9, 36.6, 
16.2, 15.4. 
 
GCCyclosil-B: initial temperature 50 °C (1 min hold); final temperature 200 °C; rate = 5 
°C/min; T1 = 22.91 min, T2 = 23.28 min. 
 
FTIR (neat): υ 3312, 2979, 2953, 2915, 2866, 1461, 1449, 1405, 1376, 1331, 1097, 1078, 
1055, 1032, 1005, 983, 963, 909, 836, 798, 719, 673. 
 
HRMS: (ESI) Calcd. for C11H20O2Na [M+Na]













A solution of (3R,4S,6S,7R)-3,7-dimethylnona-1,8-diene-4,6-diol (40 mg, 0.22 mmol, 
100 mol%), PPh3 (58 mg, 0.22 mmol, 100 mol%) and 4-nitrobenzoic acid (37 mg, 0.22 
mmol, 100 mol%) in THF (2.2 mL, 0.1 M) was cooled to 0 °C. Diisopropyl 
azodicarboxylate (33 µL, 0.22 mmol, 100 mol%) was added to this reaction mixture 
dropwise. The reaction mixture was stirred at 0 °C for 3 hr, and then allowed to warm to 
room temperature over 1 hr. The reaction mixture was passed through a short plug of 
silica gel with the aid of ethyl acetate, and the resulting liquor was concentrated under 
reduced pressure. The residue was dissolved in methanol (2.2 mL), K2CO3 (46 mg, 0.33 
mmol, 150 mol%) was added, and the reaction mixture was allowed to stir at ambient 
temperature for 16 hr. The mixture was then concentrated under reduced pressure, and 
the residue was subjected to flash column chromatography (SiO2: ethyl acetate:hexanes, 
1:5) to give the title compound (3.0 mg, 0.016 mmol) as an off-white crystalline solid in 
7% yield. 
 
TLC(SiO2): Rf = 0.3 (ethyl acetate:hexanes, 1:3). 
 
1H NMR (400 MHz, CDCl3): δ 5.84-5.70 (m, 2H), 5.13-5.05 (m, 4H), 3.75-3.71 (m, 1H), 
3.68-3.63 (m, 1H), 3.16-2.89 (br. m, 2H), 2.29-2.19 (m, 2H), 1.67 (dt, J = 14.0, 2.4 Hz, 
1H), 1.44-1.36 (m, 1H), 1.05-1.02 (m, 6H). 
 
13C NMR (100 MHz, CDCl3): δ 140.7, 140.0, 116.4, 115.4, 76.1, 75.9, 44.7, 44.0, 36.6, 
15.8, 14.6. 
 
GCCyclosil-B: initial temperature 50 °C (1 min hold); final temperature 200 °C; rate = 5 
°C/min; Tmajor = 23.20 min. 
 
[α]D
27 = -25.0 (c = 0.2, CH2Cl2). 
 
FTIR (neat): υ 3396, 3369, 2970, 2927, 2877, 2370, 1705, 1653, 1640, 1576, 1460, 1418, 
1375, 1108, 1049, 998, 913, 852, 696. 
 
 331
HRMS: (ESI) Calcd. for C11H20O2Na [M+Na]











































An oven-dried sealed tube under an atmosphere of N2 was charged with1,3-propanediol 
4.2.1b(18.0 mg, 0.20 mmol, 100 mol%), (R)-I(20.7 mg, 0.02 mmol, 10 mol%), K3PO4 
(42.4 mg, 0.20 mmol, 100 mol%),and THF:H2O (4:1, 0.125 mL, 1.6 M).Freshly distilled 
crotyl acetate (114 mg, 1.00 mmol, 500 mol%) was added and the mixture was allowed to 
stir at 70oC for 96 hr.The reaction mixture was concentrated in vacuo. Purification of the 
residue by column chromatography (SiO2; ethyl acetate: hexanes, 1:10) provides 
4.2.3a(24.6 mg, 0.124 mmol) as off-white crystalline solid in62% yield, ≥ 99% ee, 5:1 dr. 
 
TLC (SiO2): Rf = 0.3 (ethyl acetate:hexanes, 1:3). 
 
1H NMR(400 MHz, CDCl3): δ5.85-5.73 (m, 2H), 5.15-5.09 (m, 4H), 3.65 (d, J = 9.6 Hz, 
1H), 3.39-3.37 (m, 1H), 2.80 (s, 1H), 2.54 (d, J = 4.0 Hz, 1H), 2.46-2.40 (m, 1H), 2.31-
2.25 (m, 1H), 1.89-1.86 (m, 1H), 1.03 (d, J = 7.2 Hz, 3H), 1.01 (d, J = 6.8 Hz, 1H), 0.94 
(d, J = 6.8 Hz, 3H). 
 
13C NMR (100 MHz, CDCl3): δ142.2, 141.0, 116.5, 116.0, 79.3, 73.9, 42.3, 42.0, 34.8, 
17.2, 16.5, 10.7. 
 
GCCyclosil-B: initial temperature 90 °C (1 min hold); final temperature 140 °C; rate = 1 
°C/min; Tmajor = 43.99 min, Tminor diastereomer-1 = 42.92 min, Tminordiastereomer-2 = 46.16 min, 
Tminorenantiomer = 43.99 min; ee = 99%, dr = 6:1. 
 
[α]D
27 = +18.9 (c = 0.37, CH2Cl2). 
 
MP = 44 - 59oC 
 
FTIR (neat): υ 3389, 2970, 2931, 1638, 1459, 1417, 1376, 1325, 1242, 1130, 1085, 1041, 
994, 971, 911, 812, 720, 674. 
 
HRMS: (CI) Calcd. for C12H23O2 [M+H]













A solution of (2R,3R,4R)-3-(4-methoxybenzyloxy)-2,4-dimethylhex-5-en-1-ol(264.4 mg, 
1.0 mmol, 100 mol%) in DCM (10.0 mL, 0.1 M) was cooled to 0 °C and freshly made 
Dess-Martin periodinane (551 mg, 1.35 mmol, 135 mol%) was added. The reaction was 
stirred for 30 min at 0 °C, at which point the cooling batch was removed. The reaction 
mixture was allowed to stir at ambient temperature for 1 hr, at which point DCM (10 mL) 
and saturated NaHCO3 (10 mL) were added. The reaction mixture was transferred to a 
separatory funnel. The organic layer was separated and aqueous layer was extracted with 
DCM (3 × 15 mL). The combined organic extracts werewashed with saturated aqueous 
NaHCO3 and brine, dried (Na2SO4), filtered and concentrated in vacuo. The crude residue 
was used in the next step without further purification. 
 
To a -78 °C solution of KOtBu (168.3 mg, 1.50 mmol, 150 mol%) in THF (5 mL, 0.2 M) 
was added cis-2-butene (0.45 mL, 4.99 mmol, 500 mol%). After 5 min, nBuLi (0.93 
mL,1.72M in hexanes, 1.6 mmol, 160 mol%) was added dropwise. The reaction mixture 
was stirred at -78 °C for 5 min and then warmed to -45 °C for 20 min, before being re-
cooled to -78 °C. A solution of (+)-(Ipc)2BOMe (506.1 mg, 1.6 mmol, 160 mol%) in 
THF (2 mL) was added dropwise, and the reaction mixture was allowed to stir for 1 hr. 
BF3.OEt2 (0.27 mL, 2.11 mmol, 211 mol%) was added dropwise, followed by the 
addition of crude (2R,3R,4R)-3-(4-methoxybenzyloxy)-2,4-dimethylhex-5-enal as a 
solution in THF (2 mL). The reaction mixture was allowed to stirat -78 °C for 4 hr. To 
the reaction mixture was added aqueous NaOH(1.5 mL, 3M) and H2O2 (0.8 mL, 30% 
solution). The reaction mixture was allowed to reach ambient temperature overnight, at 
which point aqueous HCl (1M) was added and the reaction mixture was transferred to a 
separatory funnel. The aqueous layer extracted with diethyl ether (3 × 20 mL) and the 
combined organic layers were washed with brine, dried (MgSO4), filtered and 
concentrated under reduced pressure. The crude material was used in the next step 
without further purification. 
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To a solution of the crude (3S,4R,5R,6R,7R)-6-(4-methoxybenzyloxy)-3,5,7-
trimethylnona-1,8-dien-4-ol in DCM (10 mL, 0.1 M) was added pH 7.0 phosphate buffer 
(1.0 mL). The solution was cooled to 0 °C and DDQ (340 mg, 1.50 mmol, 150 mol%) 
was added. The reaction was stirred at 0 °C for 2 hr, at which point DCM (20 mL) and 
saturated NaHCO3 (20 mL) were added and the reaction mixture was transferred to a 
separatory funnel. The organic layer was washed with saturated NaHCO3 and brine, dried 
(MgSO4), filtered and concentrated under reduced pressure. The residue was purified by 
flash column chromatography (SiO2: ethyl acetate:hexanes, 1:10) to give the title 
compound as (73.4 mg, 0.37 mmol) a colorless oil in 37% yield after three steps. 
 
 
TLC (SiO2): Rf = 0.3 (ethyl acetate:hexanes, 1:3). 
 
1H NMR(400 MHz, CDCl3): δ 5.65 (ddd, J = 18.0, 9.6, 8.0 Hz,1H), 5.33 (dt, J = 17.2, 
6.0 Hz,1H), 5.08-5.02 (m, 3H), 4.94(dd,J = 10.4, 2.0 Hz, 1H), 3.76 (d, J = 10.4 Hz, 1H), 
3.37 (dt, J = 8.4, 3.6 Hz, 1H), 2.54 (br. s, 1H), 2.50-2.41 (m, 2H), 2.34-2.24 (m, 1H), 
1.91-1.85 (m, 1H), 1.09 (d, J = 6.4 Hz, 3H),1.08 (d, J = 6.8 Hz, 3H), 0.98 (d, J = 7.2 Hz, 
3H). 
 
13C NMR (100 MHz, CDCl3): δ 141.7, 141.6, 117.1, 114.7, 79.4, 73.5, 42.8, 42.6, 34.5, 
16.4, 16.1, 10.5. 
 
GCCyclosil-B: initial temperature 90 °C (1 min hold); final temperature 140 °C; rate = 1 
°C/min; Tmajor = 45.719 min. 
 
[α]D
25 = -9.6 (c = 0.3, CHCl3). 
 
FTIR (neat): υ 3399, 2974, 2934, 1633, 1471, 1422, 1366, 1343, 1241, 1127, 1057, 1001, 
968, 914, 827, 731, 676. 
 
HRMS: (CI) Calcd. for C12H23O2 [M+H]













A solution of (2S,3R,4R)-3-(4-Methoxybenzyloxy)-2,4-dimethylhex-5-en-1-ol(264.4 mg, 
1.0 mmol, 100 mol%) in DCM (10.0 mL, 0.1 M) was cooled to 0 °C and freshly made 
Dess-Martin periodinane (551 mg, 1.35 mmol, 135 mol%) was added. The reaction was 
stirred for 30 min at 0 °C, at which point the cooling batch was removed. The reaction 
mixture was allowed to stir at ambient temperature for 1 hr, at which point DCM (10 mL) 
and saturated NaHCO3 (10 mL) were added. The reaction mixture was transferred to a 
separatory funnel. The organic layer was separated and aqueous layer was extracted with 
DCM (3 × 15 mL). The combined organic extracts werewashed with saturated aqueous 
NaHCO3 and brine, dried (Na2SO4), filtered and concentrated in vacuo. The crude residue 
was used in the next step without further purification. 
 
To a -78 °C solution of KOtBu (168.3 mg, 1.50 mmol, 150 mol%) in THF (5 mL, 0.2 M) 
was added cis-2-butene (0.45 mL, 4.99 mmol, 500 mol%). After 5 min, nBuLi (0.93 
mL,1.72M in hexanes, 1.6 mmol, 160 mol%) was added dropwise. The reaction was 
stirred at -78 °C for 5 min and then warmed to -45 °C for 20 min, before being re-cooled 
to -78 °C. A solution of (+)-(Ipc)2BOMe (506.1 mg, 1.6 mmol, 160 mol%) in THF (2 
mL) was added dropwise, and the reaction mixture was allowed to stir for 1 hr. BF3.OEt2 
(0.27 mL, 2.11 mmol, 211 mol%) was added dropwise, followed by the addition of crude 
(2S,3R,4R)-3-(4-methoxybenzyloxy)-2,4-dimethylhex-5-enal as a solution in THF (2 
mL). The reaction mixture was allowed to stir at -78 °C for 4 hr. To the reaction mixture 
was added aqueous NaOH(1.5 mL, 3M) and H2O2 (0.8 mL, 30% solution). The reaction 
mixture was allowed to reach ambient temperature overnight, at which point aqueous 
HCl (1M) was added and the reaction mixture was transferred to a separatory funnel. The 
aqueous layer extracted with diethyl ether (3 × 20 mL) and the combined organic layers 
were washed with brine, dried (MgSO4), filtered and concentrated under reduced 
pressure. The crude material was used in the next step without further purification. 
 
 345
To a solution of the crude (3S,4R,5S,6R,7R)-6-(4-methoxybenzyloxy)-3,5,7-
trimethylnona-1,8-dien-4-ol in DCM (10 mL, 0.1 M) was added pH 7.0 phosphate buffer 
(1.0 mL). The solution was cooled to 0 °C and DDQ (340 mg, 1.50 mmol, 150 mol%) 
was added. The reaction was stirred at 0 °C for 2 hr, at which point DCM (20 mL) and 
saturated NaHCO3 (20 mL) were added and the reaction mixture was transferred to a 
separatory funnel. The organic layer was washed with saturated NaHCO3 and brine, dried 
(MgSO4), filtered and concentrated under reduced pressure. The residue was purified by 
flash column chromatography (SiO2: ethyl acetate:hexanes, 1:10) to give the title 
compound (59.5 mg, 0.30 mmol) as a colorless oil in 30% yield after three steps. 
 




TLC (SiO2): Rf = 0.3 (ethyl acetate:hexanes, 1:3). 
 
1H NMR (400 MHz, CDCl3): δ 5.78 (ddd, J = 17.2, 9.2, 7.6 Hz, 2H), 5.73-5.62 (m, 1H), 
5.20-4.96 (m, 4H), 3.67 (d, J = 9.6 Hz, 1H), 3.40-3.30 (m, 1H), 3.03 (d, 6.8 Hz, 1H), 
2.46-2.39 (m, 1H), 2.32-2.20 (m, 2H), 1.92-1.86 (m, 1H), 1.11 (d, J = 7.2 Hz, 3H),1.00 
(d, J = 7.2 Hz, 3H), 0.89 (d, J = 6.8 Hz, 3H). 
 
13C NMR (100 MHz, CDCl3): δ 142.0, 140.8, 116.4, 115.8, 79.1, 73.7, 42.1, 41.8, 34.4, 
16.9, 16.3, 10.5. 
 
GCCyclosil-B: initial temperature 90 °C (1 min hold); final temperature 140 °C; rate = 1 
°C/min; Tmajor = 43.702 min; Tminor = 48.800 min. 
 
[α]D
25 = -19.6 (c = 0.31, CHCl3). 
 
FTIR (neat): υ 3399, 2974, 2934, 1633, 1471, 1422, 1366, 1343, 1241, 1127, 1057, 1001, 
968, 914, 827, 731, 676. 
 
HRMS: (CI) Calcd. for C12H23O2 [M+H]







































A solution of (3R,4R,6R,7R)-3,5,7-trimethylnona-1,8-diene-4,6-diol (120 mg, 0.60 mmol, 
100 mol%) and NaHCO3 (150 mg, 1.50 mmol, 250 mol%) in acetonitrile (12.0 mL, 0.05 
M) was cooled to -20 °C. To this solutionwas added iodine (381 mg, 1.80 mmol, 300 
mol%) in one portion. The reaction was stirred at -20 °C for 1 hr. The reaction mixture 
was warmed to 0 °C and was allowed to stir at this temperature for 6 hr. Saturated 
aqueous Na2S2O3was added and the reaction mixture was allowed to stiruntil the solution 
became colorless. The reaction mixture was transferred to a separatory funnel andthe 
aqueous phase was extracted with ethyl acetate (3 × 30 mL). The combined organic 
extracts were dried (MgSO4), filtered and concentrated under reduced pressure. The 
residue was purified by flash column chromatography (SiO2: ethyl acetate:hexanes, 1:10) 
to give the title compound (145.9 mg, 0.45 mmol) as a colorless oil in 75% yield, ≥ 99% 
eeas a single diastereomer. 
 
TLC (SiO2): Rf = 0.5 (ethyl acetate:hexanes, 1:3). 
 
1H NMR(400 MHz, CDCl3): δ 5.87-5.78 (m, 1H), 5.02-4.97 (m, 2H), 3.54-3.50 (m, 1H), 
3.40 (dd, J = 10.8, 4.8 Hz, 1H), 3.25 (dd, J = 10.0, 7.6 Hz, 1H), 3.08 (dd, J = 10.0, 6.0 
Hz, 1H), 2.88 (dd, J = 10.0, 2.0 Hz, 1H), 2.44-2.37 (m, 1H), 2.19-2.13 (m, 1H), 1.56-1.49 
(m, 1H), 1.16 (d, J = 6.8 Hz, 3H), 0.90 (d, J = 6.8 Hz, 3H), 0.80 (d, J = 6.8 Hz, 1H). 
 
13C NMR(100 MHz, CDCl3): δ 139.2, 115.2, 85.1, 78.7, 76.4, 39.9, 38.2, 34.6, 18.8, 
12.2, 6.2, 4.6. 
 
[α]D
25 = -37.1 (c = 0.57, CHCl3). 
 
FTIR (neat): υ3350, 3075, 2963, 2925, 2853, 2362, 1640, 1458, 1416, 1372, 1336, 1300, 
1271, 1242, 1175, 1091, 1070, 1043, 997, 972, 915, 876, 808, 773, 692, 668. 
 
HRMS: (CI) Calcd. for C12H22O2I [M+H]













The assignment of relative stereochemistry of the tetrahydropyran ring system was 
corroborated by analysis of the 1H NMR coupling constants. Also, the assigned 
stereochemistry is consistent with known literature examples. The excellent level of 
stereocontrol might arise from 1,3-diaxial interactions in the transition structure en route 










To a solution of (2R,3S,4S,5S,6R)-2-((R)-but-3-en-2-yl)-6-(iodomethyl)-3,5-
dimethyltetrahydro-2H-pyran-4-ol (58 mg, 0.179 mmol, 100 mol%) in DCM:MeOH (1:1, 
3.6 mL, 0.05 M) at -78 °C was added 3-5 drops of a methanolic solution of Sudan III 
(1.5 nM), which resulted in a light pink coloration. O3 (2.0 L.min
-1, 15 V) was bubbled 
through the solutionuntil the solution became colorless. The reaction mixture was sparged 
with argon and Me2S (0.1 mL) was added. The reaction mixture warmed to 0 °C and was 
allowed to stir overnight. The solvent was removed in vacuo at low temperature, and the 
residue was dried under high vacuum. The crude yellow oil was used in the next step 
without further purification. 
 
To a solution of crude aldehyde in DCM:H2O (1:1, 3.6 mL, 0.05 M) at ambient 
temperature was added Bu4NI (6.4 mg, 0.018mmol, 10mol%) and potassium trans-
crotyltrifluoroborate (43.4 mg, 0.267 mmol, 150 mol%). The reaction mixture was 
allowed to stir overnight. Brine (10 mL) was added and the reaction mixture was 
transferred to a separatory funnel. The aqueous layer was extracted with ethyl acetate (3 
× 15 mL) and the combined organicextracts weredried (MgSO4), filtered and 
concentrated under reduced pressure. The residue was subjected to flash column 
chromatography (SiO2: ethyl acetate:hexanes, 1:15-1:10) to provide the title compound 




TLC (SiO2): Rf = 0.3 (ethyl acetate:hexanes, 1:3). 
 
1H NMR (400 MHz, CDCl3): δ 5.88 (ddd, J = 17.6, 10.4, 8.0 Hz, 1H), 5.12-5.04 (m, 
2H),3.66 (d, J = 9.2 Hz, 1H),3.56 (ddd, J = 8.8, 5.6, 2.0 Hz, 1H), 3.48-3.41 (m, 1H), 3.42 
(br, 1H), 3.21 (dd, J = 10.4, 8.4 Hz, 1H), 3.11 (dd, J = 10.4, 2.0 Hz, 1H), 3.06 (dd, J = 
10.4, 5.6 Hz, 1H), 2.30 (dq, J = 15.2, 6.8 Hz, 1H), 2.24-2.17 (m, 1H), 1.87 (q, J = 7.2 Hz, 
1H), 1.87-1.77 (m, 1H), 1.14 (d, J = 6.8 Hz, 3H), 0.92 (d, J = 6.4 Hz, 3H), 0.91 (d, J = 
6.8 Hz, 3H), 0.88 (d, J = 7.2 Hz, 3H). 
 
13C NMR (100 MHz, CDCl3): δ 142.1, 113.7, 88.0, 79.6, 75.7, 73.7, 41.0, 38.0, 33.5, 
33.4, 16.2, 12.2, 11.2, 4.5, 4.5. 
 
[α]D
25 = -61.9 (c = 1.00, CHCl3). 
 
FTIR (neat): υ3371, 3080, 2961, 2915, 2872, 2350, 1635, 1444, 1426, 1350, 1292, 1242, 
1165, 1077, 1070, 1033, 997, 972, 915, 816, 692, 673. 
 
HRMS: (CI) Calcd. for C15H28O3I [M+H]













To a solution of (2R,3S,4S,5S,6R)-2-((2R,3S,4S)-3-hydroxy-4-methylhex-5-en-2-yl)-6-
(iodomethyl)-3,5-dimethyltetrahydro-2H-pyran-4-ol (76.4 mg, 0.20 mmol, 100 mol%) in 
DCM:MeOH (1:1, 4 mL, 0.05 M) was added 3-5 drops of a methanolic solution of Sudan 
III (1.5 nM), which resulted in a light pink coloration. O3 (2.0 L.min
-1, 15 V) was bubbled 
through the solution until the solution became colorless. The reaction mixture was 
sparged with argon and NaBH4 (75.6 mg, 2.0 mmol, 1000 mol%) was added. The 
reaction mixture warmed to ambient temperature and was allowed to stir overnight. Brine 
(60 mL) was added and the reaction mixture was transferred to a separatory funnel. The 
aqueous layer was extracted with ethyl acetate (3 × 30 mL) and the combined organic 
phases were dried (MgSO4), filtered and concentrated under reduced pressure. The 
residue was subjected to flash column chromatography (SiO2: ethyl ether:DCM, 1:5-1:1) 
to provide the title compound (64.5 mg, 0.167 mmol) as a colorless oil in 84% yield. 
 
TLC (SiO2): Rf = 0.2 (ether:DCM, 1:2). 
 
1H NMR (400 MHz, DMSO): δ 3.81 (dd, J = 10.4, 1.6 Hz, 1H), 3.69-3.57 (m, 2H), 3.49-
3.41 (m, 2H), 3.23 (dd, J = 10.4, 8.0 Hz, 1H), 3.09 (dd, J = 10.4, 1.6 Hz, 1H), 3.03 (dd, J 
= 10.4, 6.0 Hz, 1H), 2.30-2.21 (m, 1H), 2.03-1.94 (m, 1H), 1.71-1.54 (m, 2H), 1.22 (d, J 
= 7.2 Hz, 3H), 0.97 (d, J = 8.0 Hz, 3H), 0.93 (d, J = 7.2 Hz, 3H), 0.68 (d, J = 7.2 Hz, 3H). 
 
13C NMR (100 MHz, DMSO): δ 90.7, 80.0, 75.3, 73.9, 61.6, 37.9, 35.0, 33.8, 32.9, 16.3, 
13.4, 9.9, 5.2, 5.2. 
 
[α]D
26 = +37.7 (c = 1.00, CHCl3). 
 
FTIR (neat): υ 3630, 2988, 2923, 2892, 2369, 1624, 1432, 1429, 1334, 1283, 1174, 1107, 
1070, 933, 928, 815, 700, 679. 
 
HRMS: (CI) Calcd. for C14H27O4I [M]












To a solution of (2S,3S,4R)-4-((2R,3S,4S,5S,6R)-4-hydroxy-6-(iodomethyl)-3,5-
dimethyltetrahydro-2H-pyran-2-yl)-2-methylpentane-1,3-diol (33.0 mg, 0.085 mmol, 100 
mol%) in EtOH (0.85 mL, 0.1 M) was added activated Zn (83.5 mg, 1.28 mmol, 1500 
mol%) and NH4Cl (45.5 mg, 0.85 mmol, 1000 mol%). The reaction mixture was allowed 
to stir overnight under reflux. Then the reaction mixture was filtered through a short plug 
of silica gel with the aid of ethyl acetate. The resulting liquor was concentrated under 
reduced pressure and dried under high vacuum. The crude yellow oil was used in the next 
step without further purification. 
 
To a solution of crude tetraol in acetone (1.24 mL, 0.05 M) was added 2-methoxyprop-1-
ene (44.7 mg, 0.62 mmol, 1000 mol%) and PPTS (0.5 mg, 0.01 mmol, 20 mmol%). The 
reaction mixture was stirred under ambient temperature and monitored by TLC. After 30 
mins, saturated NaHCO3 (5 mL) was added and the reaction mixture was transferred to a 
separatory funnel. The aqueous layer was extracted with ethyl acetate (3 × 15 mL) and 
the combined organicextracts were dried (MgSO4), filtered and concentrated under 
reduced pressure. The residue was subjected to flash column chromatography (SiO2: 
ethyl acetate:hexanes, 1:100) to give the title compound (20.1 mg, 0.059 mmol) as a 





TLC (SiO2): Rf = 0.4 (ethyl acetate:hexanes, 2:98). 
 
1H NMR (400 MHz, CDCl3): δ 5.88 (ddd, J = 17.2, 10.4, 6.4 Hz, 1H), 5.07-4.97 (m, 2H), 
3.85 (dd, J = 10.8, 2.0 Hz, 1H),3.68 (dd, J = 10.8, 5.2 Hz, 1H),3.51 (t, J = 11.2 Hz, 1H), 
3.46 (dd, J = 10.4, 3.6 Hz, 1H), 3.27 (dd, J = 9.2, 6.4 Hz, 1H), 2.31-2.22 (m, 1H), 1.88-
1.70 (m, 3H), 1.38 (s, 3H), 1.34 (s, 3H), 1.29 (s, 3H), 1.26 (s, 3H), 0.92 (d, J = 6.4 Hz, 
6H), 0.87 (d, J = 7.2 Hz, 3H), 0.69 (d, J = 6.8 Hz, 3H). 
 
13C NMR(100 MHz, CDCl3): δ142.4, 113.3, 100.3, 98.0, 74.1, 73.2, 72.8, 66.6, 39.2, 
36.8, 36.7, 30.4, 29.8, 25.7, 23.5, 19.0, 15.6, 12.9, 12.1, 7.7. 
 
[α]D
25 = +0.4 (c = 1.17, CHCl3). 
 
FTIR (neat): υ3073, 2978, 2935, 1842, 1640, 1431, 1378, 1359, 1171, 1119, 1111, 1013, 
1000, 979,833, 851, 637. 
 
HRMS: (CI) Calcd. for C20H37O4 [M+H]














To a solution of (4R,5S,6S)-4-((R)-but-3-en-2-yl)-2,2,5-trimethyl-6-((R)-1-((4S,5S)-2,2,5-
trimethyl-1,3-dioxan-4-yl)ethyl)-1,3-dioxane (20.1 mg, 0.059 mmol, 100 mol%) in 
DCM:MeOH (1:1, 1.2 mL, 0.05 M) was added 3-5 drops of a methanolic solution of 
Sudan III (1.5 nM), which resulted in a light pink coloration. O3 (2.0 L.min
-1, 15 V) was 
bubbled through the solution until the color changed from pink to colorless. The reaction 
mixture was purged with argon, and NaBH4 (22.3 mg, 0.59 mmol, 1000 mol%) was 
added. The reaction warmed to ambient temperature and was allowed to stir overnight. 
Brine (10 mL) was added and the reaction mixture was transferred to a separatory funnel. 
The aqueous layer was extracted with DCM (3 × 15 mL) and the combined organic 
phases were dried (MgSO4), filtered and concentrated under reduced pressure. 
Purification by flash column chromatography (SiO2: ethyl acetate:hexanes, 1:10) gave the 





TLC (SiO2): Rf = 0.3 (ethyl acetate:hexanes, 1:3). 
 
1H NMR (400 MHz, CDCl3): δ 3.83 (dd, J = 10.4, 1.6 Hz, 1H), 3.71-3.66 (m, 2H), 3.59-
3.48 (m, 3H), 3.30-3.28 (m, 2H),1.95-1.81 (m, 2H), 1.77-1.70 (m, 2H), 1.38 (s, 3H), 1.37 
(s, 3H), 1.34 (s, 3H), 1.30 (s, 3H), 0.93 (d, J = 6.8 Hz, 3H), 0.87 (d, J = 7.2 Hz, 3H), 0.76 
(d, J = 6.8 Hz, 3H), 0.69 (d, J = 6.8 Hz, 3H). 
 
13C NMR(100 MHz, CDCl3): δ100.5, 98.0, 76.2, 74.0, 72.7, 69.4, 66.6, 39.2, 36.7, 34.8, 
30.3, 29.8, 26.1, 23.4, 19.0, 13.0, 12.6, 12.1, 7.7. 
 
[α]D
25 = -5.2 (c = 0.75, CHCl3). 
 
FTIR (neat): υ3473, 2999, 2945, 2879, 1454, 1441, 1416, 1381, 1290, 1223, 1164, 1145, 
1077,994, 973, 902, 877. 
 
HRMS: (CI) Calcd. for C19H35O5 [M-H]
+: 343.2485, Found: 343.2489. 
 
The spectroscopic properties of this compound and corrosponding acetate were consistent 












To a solution of (R)-2-((4R,5S,6S)-2,2,5-trimethyl-6-((R)-1-((4S,5S)-2,2,5-trimethyl-1,3-
dioxan-4-yl)ethyl)-1,3-dioxan-4-yl)propan-1-ol(19.5 mg, 0.057 mmol, 100 mol%) in 
DCM (1.2 mL, 0.05 M) was added triethylamine (17.3 mg, 0.171 mmol, 300 mol%) and 
acetic anhydride (11.6 mg, 0.114, 200 mol%). The reaction mixture was stirred for 3 hr 
under ambient temperature. Saturated NaHCO3 (5 mL) was added and the reaction 
misture was transferred to a separatory funnel. The aqueous layer was extracted with 
DCM (3 × 5 mL) and the combined organic phases were dried (MgSO4) and concentrated 
under reduced pressure. Purification by flash column chromatography (SiO2: ethyl 
acetate:hexanes, 1:15) gave the title compound (19.8 mg, 0.051 mmol) as a colorless oil 
in 90% yield. 
 
 
TLC (SiO2): Rf = 0.6 (ethyl acetate:hexanes, 1:4). 
 
1H NMR (400 MHz, CDCl3): δ 4.16 (dd, J = 10.4, 2.8 Hz, 1H), 4.06 (dd, J = 10.4, 6.0 
Hz, 1H), 3.84 (dd, J = 10.4, 2.0 Hz, 1H), 3.68 (dd, J = 11.6, 5.2 Hz, 1H),3.61 (dd, J = 
10.0, 3.6 Hz, 1H), 3.51 (t, J = 11.2 Hz, 1H), 3.27 (dd, J = 9.6, 6.4 Hz, 1H),2.05 
(s,3H),1.93-1.80 (m, 2H), 1.79-1.69 (m, 2H), 1.38 (s, 3H), 1.34 (s, 3H), 1.27 (s, 3H), 1.25 
(s, 3H), 0.91 (d, J = 6.4 Hz, 3H), 0.90 (d, J = 6.8 Hz, 3H), 0.87 (d, J = 6.8 Hz, 3H), 0.69 
(d, J = 6.8 Hz, 3H). 
 
13C NMR(100 MHz, CDCl3): δ171.3, 100.4, 98.0, 74.1, 72.7, 69.7, 66.6, 66.6, 39.2, 36.4, 
32.5, 30.4, 29.8, 25.6, 23.4, 21.0, 19.0, 12.9, 12.7, 12.1, 7.8. 
 
[α]D
25 = +16.2 (c = 1.07, CHCl3). 
 
FTIR (neat): υ3413, 3094, 2955, 2833, 2357, 1400, 1372, 1334, 1300, 1271, 1205, 1175, 
1025, 999, 987, 692, 668. 
 
HRMS: (CI) Calcd. for C21H38O6 [M]














A solution of (2R,3S,4S,5S,6R)-2-((R)-but-3-en-2-yl)-6-(iodomethyl)-3,5-
dimethyltetrahydro-2H-pyran-4-ol (162.1 mg, 0.50 mmol, 100 mol%) in DCM:MeOH 
(1:1, 10 mL, 0.05 M) was added 3-5 drops of a methanolic solution of Sudan III (1.5 
nM), which resulted in a light pink coloration. O3 (2.0 L.min
-1, 15 V) was bubbled 
through the solution until the color changed from pink to colorless. The reaction mixture 
was purged with argon, and NaBH4 (189.2 mg, 5.0 mmol, 1000 mol%) was added. The 
reaction warmed to ambient temperature and was allowed to stir overnight. Brine (30 
mL) was added and the reaction mixture was transferred to a separatory funnel. The 
aqueous layer was extracted with DCM (3 × 15 mL) and the combined organic phases 
were dried (MgSO4) and concentrated under reduced pressure. Purification by flash 
column chromatography (SiO2: ethyl acetate:hexanes, 1:1) gave the title compound 
(131.3 mg, 0.40 mmol) as a colorless oil in 80% yield. 
 
TLC (SiO2): Rf = 0.5 (ethyl acetate:hexanes, 1:1). 
 
1H NMR(400 MHz, CDCl3): δ 3.90 (dd, J = 10.8, 2.8 Hz, 1H), 3.58-3.51 (m, 2H), 3.44-
3.40 (m, 1H), 3.24 (dd, J = 10.0, 8.0 Hz, 1H), 3.10-3.05 (m, 2H), 2.45 (d, J = 7.6 Hz, 
1H), 2.23-2.17 (m, 1H), 1.93-1.86 (m, 1H), 1.79-1.72 (m, 1H), 1.67 (br. s, 1H), 1.22 (d, J 
= 7.2 Hz, 3H), 0.94 (d, J = 6.8 Hz, 3H), 0.87 (d, J = 6.8 Hz, 3H). 
 




27 = +62 (c = 0.6, CH2Cl2). 
 
FTIR (neat): υ 3352, 2965, 2927, 1458, 1415, 1389, 1266, 1180, 1131, 1097, 1059, 1038, 
1009, 983, 967, 937, 890, 803, 736, 697. 
 
HRMS: (CI) Calcd. for C11H22O3I [M+H]














A solution of (2R,3S,4S,5S,6R)-2-((R)-1-hydroxypropan-2-yl)-6-(iodomethyl)-3,5-
dimethyltetrahydro-2H-pyran-4-ol (100 mg, 0.30 mmol, 100 mol%) in DCM (0.6 mL, 0.5 
M) was added pyridine (47.5 mg, 0.60 mmol, 200 mol%) and pivaloyl chloride (43.4 mg, 
0.36 mmol, 120 mol%). The reaction mixture was stirred overnight under ambient 
temperature. Saturated NH4Cl (5 mL) was added, and the reaction mixture wastransferred 
to a separatory funnel. The aqueous layer was extracted with DCM (3 ×5 mL) and the 
combined organic phases were dried (MgSO4), filtered and concentrated under reduced 
pressure. Purification by flash column chromatography (SiO2: ethyl acetate:hexanes, 
1:10) gave the title compound (108.8 mg, 0.26 mmol) as a colorless oil in 88% yield. 
 
TLC (SiO2): Rf = 0.7 (ethyl acetate:hexanes, 1:10). 
 
1H NMR (400 MHz, CDCl3): δ 4.25 (dd, J = 10.8, 5.6 Hz, 1H), 3.91 (dd, J = 10.8, 8.0 
Hz, 1H), 3.56-3.52 (m, 1H), 3.39-3.35 (m, 1H), 3.23 (dd, J = 10.0, 8.0 Hz, 1H),3.07 (dd, 
J = 10.0, 5.6 Hz, 1H),2.93 (dd, J = 10.0, 2.0 Hz, 1H), 2.20-2.11 (m, 2H), 1.76-1.67 (m, 
1H), 1.20 (s, 9H), 1.12 (d, J = 7.2 Hz, 3H), 0.97 (d, J = 6.4 Hz, 3H), 0.82 (d, J = 6.8 Hz, 
3H). 
 
13C NMR(100 MHz, CDCl3): δ 178.6, 84.7, 79.1, 76.6, 65.1, 38.7, 38.2, 34.4, 33.4, 27.2, 
16.3, 12.7, 5.9, 4.6. 
 
[α]D
26 = +27.1 (c = 1.20, CHCl3). 
 
FTIR (neat): υ 3052, 2965, 2927, 1734, 1485, 1400, 1134, 1111, 1080, 1056, 998, 985, 
967, 934, 899, 740. 
 
HRMS: (CI) Calcd. for C16H29O4I [M]













A solution of (R)-2-((2R,3S,4S,5S,6R)-4-hydroxy-6-(iodomethyl)-3,5-dimethyltetrahydro-
2H-pyran-2-yl)propyl pivalate (85.9 mg, 0.30 mmol, 100 mol%) in EtOH (3 mL, 0.1 M) 
was added activated Zn (294.3 mg, 4.50 mmol, 1500 mol%) and NH4Cl (160.5 mg, 3.00 
mmol, 1000 mol%). The reaction mixture was heated under refluxing and was allowed to 
stir overnight. The crude reaction mixture was diluted with ethyl acetate (15 mL) and 
filtered through a silica plug. The filtrate was concentrated under reduced pressure. 
Purification by flash column chromatography (SiO2: ethyl acetate:hexanes, 1:5) gave the 
title compound (68.7 mg, 0.24 mmol) as a colorless oil in 80% yield. 
 
TLC (SiO2): Rf = 0.3 (ethyl acetate:hexanes, 1:3). 
 
1H NMR (400 MHz, CDCl3): δ 5.69 (dt, J = 18.0, 9.2 Hz, 1H), 5.19-5.14 (m, 2H), 4.29-
4.20 (m, 2H), 3.61 (d, J = 9.2 Hz, 1H), 3.38-3.35 (m, 2H), 2.52 (br, 1H), 2.33-2.23 (m, 
1H), 2.07-2.01 (m, 1H),1.95-1.89 (m, 1H), 1.79-1.72 (m, 1H), 1.21 (s, 9H), 1.07 (d, J = 
7.2 Hz, 3H), 0.95 (d, J = 6.4 Hz, 3H), 0.92 (d, J = 6.8 Hz, 3H). 
 
13C NMR(100 MHz, CDCl3): δ 178.9, 141.4, 116.9, 78.0, 73.6, 67.0, 42.5, 38.9, 36.8, 
33.5, 27.2, 16.2, 14.1, 10.7. 
 
[α]D
25 = -0.4 (c = 1.00, CHCl3). 
 
FTIR (neat): υ 3652, 3314, 2965, 2927, 1750, 1479, 1414, 1389, 1266, 1180, 1091, 1079, 
1042, 1000, 993, 812, 735, 679. 
 
HRMS: (CI) Calcd. for C16H29O4I [M-H]














A solution of (2R,3R,4S,5R,6R)-3,5-dihydroxy-2,4,6-trimethyloct-7-enyl pivalate (28.6 
mg, 0.10 mmol, 100 mol%) in DCM (2.0 mL, 0.05 M) was added 2,2-dimethoxypropane 
(104.2 mg, 1.0 mmol, 1000 mol%) and PPTS (5.0 mg, 0.02 mmol, 20 mol%). The 
reaction mixture was stirred overnight under ambient temperature. Saturated NaHCO3 (5 
mL) was added, and the reaction mixture was transferred to a separatory funnel. The 
aqueous layer was extracted with DCM (3 ×5 mL) and the combined organic phases were 
dried (MgSO4), filtered and concentrated under reduced pressure. Purification by flash 
column chromatography (SiO2: ethyl acetate:hexanes, 1:20) gave the title compound 
(31.7 mg, 0.10 mmol) as a colorless oil in 97% yield. 
 
TLC (SiO2): Rf = 0.6 (ethyl acetate:hexanes, 1:20). 
 
1H NMR (400 MHz, CDCl3): δ 5.85 (ddd, J = 17.2, 10.4, 7.2 Hz, 1H), 5.04 (dt, J = 17.2, 
1.6 Hz, 1H), 4.98 (dt, J = 10.4, 1.6 Hz, 1H), 4.15 (dd, J = 10.8, 4.4 Hz, 1H), 3.99 (dd, J = 
10.8, 7.2 Hz, 1H), 3.43 (dd, J = 10.8, 4.0 Hz, 1H), 3.21 (t, J = 7.6 Hz, 1H), 2.30-2.21 (m, 
1H), 1.99-1.85 (m, 2H), 1.29 (s, 3H), 1.25 (s, 3H), 1.20 (s, 9H), 1.01 (d, J = 6.8 Hz, 3H), 
0.92 (d, J = 6.8 Hz, 3H), 0.91 (d, J = 6.8 Hz, 3H). 
 
13C NMR(100 MHz, CDCl3): δ 178.6, 142.1, 113.5, 100.6, 76.2, 73.1, 66.0, 38.8, 37.3, 
36.9, 35.6, 27.2, 25.1, 23.3, 15.7, 13.8, 12.5. 
 
[α]D
25 = -7.2 (c = 0.71, CHCl3). 
 
FTIR (neat): υ 3030, 2965, 2927, 1744, 1458, 1415, 1389, 1266, 1180, 1131, 1097, 1059, 
1038, 1009, 983, 967, 937, 890, 803, 736, 697. 
 
HRMS: (CI) Calcd. for C19H34O4I [M]











yl)propyl pivalate 4.2.15 
 
 
A solution of (R)-2-((4R,5S,6R)-6-((R)-but-3-en-2-yl)-2,2,5-trimethyl-1,3-dioxan-4-
yl)propyl pivalate (49.0 mg, 0.15 mmol, 100 mol%) in DCM:MeOH (1:1, 3.0 mL, 0.05 
M) was added 3-5 drops of a methanolic solution of Sudan III (1.5 nM), which resulted in 
a light pink coloration. O3 (2.0 L.min
-1, 15 V) was bubbled through the solution until the 
color changed from pink to colorless. The reaction mixture was purged with argon, and 
NaBH4 (56.8 mg, 1.5 mmol, 1000 mol%) was added. The reaction warmed to ambient 
temperature and was allowed to stir overnight. Brine (5 mL) was added and the reaction 
mixture was transferred to a separatory funnel. The aqueous layer was extracted with 
DCM (3 × 15 mL) and the combined organic phases were dried (MgSO4) and 
concentrated under reduced pressure. Purification by flash column chromatography 
(SiO2: ethyl acetate:hexanes, 1:1) gave the title compound (44.6 mg, 0.14 mmol) as a 
colorless oil in 90% yield. 
 
TLC (SiO2): Rf = 0.5 (ethyl acetate:hexanes, 1:3). 
 
1H NMR (400 MHz, CDCl3): δ 4.15 (dd, J = 10.8, 4.4 Hz, 1H), 3.99 (dd, J = 10.8, 6.8 
Hz, 1H), 3.64 (dd, J = 10.4, 4.0 Hz, 1H), 3.61-3.49 (m, 2H), 3.23 (dd, J = 6.8, 6.0 Hz, 
1H), 3.18 (dd, J = 10.0, 2.0 Hz, 1H), 1.98-1.84 (m, 3H), 1.36 (s, 3H), 1.30 (s, 3H), 1.20 
(s, 9H), 1.01 (d, J = 6.8 Hz, 3H), 0.92 (d, J = 6.8 Hz, 3H), 0.91 (d, J = 7.2 Hz, 3H). 
 
13C NMR(100 MHz, CDCl3): δ 178.5, 100.7, 76.2, 76.0, 69.1, 65.8, 38.8, 37.2, 35.5, 
34.9, 27.2, 25.4, 23.3, 13.7, 12.6, 12.5. 
 
[α]D
25 = -6.2 (c = 0.75, CHCl3). 
 
FTIR (neat): υ 3500, 3033, 2927, 2845, 1744, 1312, 1270, 1164, 1025, 1001, 894, 732, 
697. 
 
HRMS: (CI) Calcd. for C18H35O5I [M+H]










yl)propyl pivalate (Scytophycin C C19-C25 Fragment) 4.2.16 
 
A solution of (R)-2-((4R,5S,6R)-6-((R)-1-hydroxypropan-2-yl)-2,2,5-trimethyl-1,3-
dioxan-4-yl)propyl pivalate (14.5 mg, 0.04 mmol, 100 mol%) in DCM (2.0 mL, 0.02 M) 
was added freshly made benzyl 2,2,2-trichloroacetimidate (30.3 mg, 0.12 mmol, 300 
mol%) and camphorsulfonic acid (1.0 mg, 0.004 mmol, 10 mol%). The reaction mixture 
was stirred overnight under ambient temperature. Saturated NaHCO3 (5 mL) was added, 
and the reaction mixture was transferred to a separatory funnel. The aqueous layer was 
extracted with diethyl ether (3 ×5 mL) and the combined organic phases were dried 
(MgSO4), filtered and concentrated under reduced pressure. Purification by flash column 
chromatography (SiO2: ethyl acetate:hexanes, 1:15) gave the title compound (13.1 mg, 
0.03 mmol) as a colorless oil in 78% yield. 
 
TLC (SiO2): Rf = 0.5 (ethyl acetate:hexanes, 1:20). 
 
1H NMR (400 MHz, CDCl3): δ 7.24-7.25 (m, 5H), 4.48 (s, 2H), 4.16 (dd, J = 10.8, 4.4 
Hz, 1H), 3.99 (dd, J = 10.8, 6.8 Hz, 1H),3.62 (dd, J = 10.8, 4.4 Hz, 1H),3.57 (dd, J = 8.8, 
2.8 Hz, 1H), 3.20 (t, J = 6.4 Hz, 1H), 1.94 (qddd, J = 6.8, 6.8, 6.8, 4.4 Hz, 1H), 1.86 (qdd, 
J = 6.8, 6.8, 4.4 Hz, 1H), 1.84 (dqdd, J = 10.8, 6.8, 6.8, 2.2 Hz, 1H), 1.29 (s, 3H), 1.25 (s, 
3H), 1.20 (s, 9H), 1.00 (d, J = 6.8 Hz, 3H ), 0.95 (d, J = 6.8 Hz, 3H), 0.89 (d, J = 6.8 Hz, 
3H). 
 
13C NMR(100 MHz, CDCl3): δ 178.6, 138.9, 128.2, 127.5, 127.3, 100.5, 76.4, 73.2, 72.5, 
70.0, 66.0, 38.8, 37.3, 35.3, 33.7, 27.2, 25.1, 23.3, 13.8, 13.4, 12.4. 
 
[α]D
26 = -2.0 (c = 1.1, CHCl3). 
 
FTIR (neat): υ 3034, 2973, 2855, 1737, 1160, 1026, 999, 748, 699. 
 
HRMS: (CI) Calcd. for C25H41O3I [M+H]
+: 421.2955, Found: 421.2955. 
 











CHAPTER 5: TOTAL SYNTHESIS OF 6-
DEOXYERYTHRONOLIDE B VIA C-C BOND-FORMING 





In 1952, the pharmaceutical company Eli Lily commercialized the first macrolide 
antibiotic, erythromycin A.2 Beyond its impact on human medicine, the challenges in 
chemical synthesis posed by erythromycin A and related polyketides propelled advances 
in acyclic stereocontrol via carbonyl addition, especially aldol bond constructions and 
crotylation methods.3 Perhaps fueled further by Woodward’s dim assessment of the 
prospect of accessing erythromycin A through chemical synthesis,4 the erythromycins 
have become inextricably tied to the evolution of synthetic organic chemistry and their 
total syntheses are widely regarded as benchmarks for the state-of-the-art. As illustrated 
in total syntheses of erythromycin A5 and B6, erythronolide A7 and B8, (9S)-
dihydroerythronolide A9 and their biogenic precursor 6-deoxyerythronolide B10, 
tremendous strides have been made over the past 30 years. However, all reported 
syntheses remain well over 20 steps in length, suggesting the influence of the 
erythromycins on chemical synthesis will persist into the future (Figure 1.1.3). 
In the course of exploring C-C bond forming hydrogenations and transfer 
hydrogenations beyond hydroformylation,11 our laboratory developed a suite of methods 
for stereoselective polyketide construction, including methods for carbonyl crotylation 
via redox triggered C-C coupling of primary alcohols and α-methyl allyl acetate 5.5 or 
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butadiene using iridium12 and ruthenium13 catalysts, respectively. These studies evoked 
an exceptionally powerful transformation that has no counterpart in conventional 
allylmetal chemistry:3 the anti-diastereo- and enantioselective iridium catalyzed double 
crotylation of 2-methyl-1,3-propanediol 5.6 to form polypropionate stereoquintets.12c To 
benchmark the utility of this method vis-à-vis polyketide construction, it was applied to 
the preparation of 6-deoxyerythronolide B. This undertaking has resulted in the most 
concise route to any erythronolide reported, to date.2,5-10 
Before we started investigated our effort into current synthetic route, several 
failed attempts had also been carried out by our lab. The methyl group on C10 
significantly decreased the reactivity of this type of substrate; hence introducing the 









5.2 RETROSYNTHETIC ANALYSIS 
Retrosynthetically, a convergent assembly of 6-deoxyerythronolide B from 
Fragments 5A and 5B was envisioned through esterification followed by ring-closing 
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enyne metathesis to form the 14-membered macrolide.14 Fragment 5A is prepared in 6 
steps from n-propanol 5.1 through successive introduction of propionate subunits via 
ruthenium catalyzed butadiene mediated syn-crotylation13d followed by substrate directed 
syn-aldol addition15 to form thiol ester 5.3, which incorporates the 4 contiguous 
stereogenic centers spanning C10-C13. Fragment 5B, which incorporates the 5-
contiguous stereogenic centers spanning C2-C6, is prepared in 8 steps from 2-methyl-1,3-
propane diol 5.6 via iridium catalyzed double crotylation followed by iodoetherification 
and alkene oxidative cleavage to form the carboxylic acid (Scheme 5.1).12c 
 
 
Scheme 5.1 Retrosynthetic analysis of deoxyerythronolide B highlighting C-C bonds 
formed via hydrogenative coupling. 
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5.3 FRAGMENTS SYNTHESIS 
 
5.3.1 ALCOHOL FRAGMENT 5A SYNTHESIS 
The synthesis of Fragment 5A begins with the butadiene mediated 
hydrohydroxyalkylation of n-propanol 5.1 to form the product of syn-crotylation (Scheme 
5.2).13d As the resulting secondary alcohol is quite volatile, reagents promoting formation 
of the TBS ether 5.2 were added to the reaction mixture after the C-C coupling was 
complete, enabling direct acquisition of TBS ether 5.2 from n-propanol in 59% isolated 
yield with 5:1 syn-diastereoselectivity and 98% enantiomeric excess.13d,16 Oxidative 
cleavage of the terminal olefin followed by treatment of the resulting aldehyde with the 
(E)-boron enolate derived from S-phenyl propanethioate delivered the product of syn-
aldol addition 5.3 with only trace quantities of the anti-diastereomer detected by 1H NMR 
analysis.15 The thiol ester 5.3 was converted to the β-hydroxy aldehyde,17 which was 
exposed to the Ohira-Bestmann reagent to form the homopropargyl alcohol 5.4 without 
protection of the hydroxyl moiety.18 Finally, benzylation of homopropargyl alcohol 5.4 
accompanied by acidic hydrolysis of the TBS ether in the course of isolation provides 
Fragment 5A. An even more concise route to Fragment 5A potentially involves 1,3-enyne 
hydrohydroxyalkylation to form the C10-C11 bond with concomitant installation of the 
alkyne, however, this chemistry has not yet been adapted to the use of chiral β-
stereogenic alcohols (Scheme 5.2).19 
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Scheme 5.2 Alcohol fragment 5A synthesis. 
 
5.3.2 ACID FRAGMENT 5B SYNTHESIS 
The synthesis of Fragment 5B begins with the anti-diastereo- and enantioselective 
iridium catalyzed double crotylation of 2-methyl-1,3-propanediol 6 to furnish the pseudo-
C2-symmetric diol 5.7 (Scheme 5.3).
12c The diol 5.7 is produced as a single enantiomer as 
determined by GC, as the minor enantiomer of the mono-adduct is converted to the 
pseudo-meso-diastereomer.20 Iodoetherification of 5.7, which differentiates the alkene 
termini and diol moieties and defines the nonstereogenic chirotopic center at C4, 
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followed by benzylation delivers pyran 5.8. Osmium catalyzed oxidative cleavage of the 
olefin to form the carboxylic acid21 followed by zinc mediated reductive cleavage of the 
iodoether provides the β-hydroxy required. To this end, conversion of 5.9 to the β-lactone 
5.10 was attempted under Mitsunobu conditions, however, decarboxylative Grob type 
elimination to the cis-alkene was formed in over 70% yield.22 Treatment of the dianion of 
5.9 with methanesulfonyl chloride23 delivered the β-lactone 5.10 in 15-20% yield along 
with recovered β-hydroxy acid 5.9, suggesting a more electrophilic sulfonylchloride was 
required. Indeed, use of chloromethanesulfonyl chloride led to the formation of β-lactone 
5.10 in 72% yield. It was our hope to directly exploit β-lactone 5.10 in the acylation of 
Fragment 5A. However, although related β-lactone ring openings are known,24 as we 
learned, cis-disubstituted β-lactones are recalcitrant acylating agents,24b and so β-lactone 
5.10 was converted to the carboxylic acid Fragment 5B (Scheme 5.3). 
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Scheme 5.3 Acid fragment 5B synthesis. 
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5.4 FRAGMENTS UNION & END GAME 
The convergent assembly of Fragments 5A and 5B is achieved through 
esterification under Yamaguchi’s conditions to form the tethered enyne 5.11 (Scheme 
5.4).25 Initial attempts at ring-closing enyne metathesis14 in the absence of ethylene led to 
isomerization of the terminal olefin. Under an atmosphere of ethylene at 80 oC the 
terminal alkyne is converted to the conjugated diene in nearly quantitative yield, but 
macrocyclization is not observed. Hence, upon complete conversion to the conjugated 
diene at 80 oC, the reaction vessel was purged with nitrogen and the reaction temperature 
was increased to 110 oC, which induced formation of the 14-membered macrolide 5.12 as 
a single regioisomer in a remarkable 89% yield. Osmium catalyzed oxidative cleavage of 
the C9 methylidene residue provides the conjugated enone 5.13.21 Reductive methylation 
of enone 5.13 to form ketone 5.14 under the conditions of dissolving metal reduction or 
through the agency of arene anion radicals was explored.26 Although efficient reductive 
alkylation was achieved in a model system (4,4-dimethylcyclohexenone), enone 5.13 
underwent benzyl cleavage or decomposed upon exposure to dissolving metal conditions, 
and upon treatment with arene anion radicals enone 5.13 was converted to the product of 
enone 1,2-reduction. Consequently, the conversion of enone 5.13 to ketone 5.14 was 
accomplished by P2-nickel catalyzed hydrogenation27 followed by conventional enolate 
methylation. Interestingly, highly variable levels of diastereoselectivity were associated 
with the newly formed C8-stereocenter of ketone 5.14, suggesting facile epimerization at 
this position. Indeed, irrespective of the diastereomeric ratio at C8, exposure of ketone 
5.14 to the slightly acidic conditions of palladium catalyzed homogenous hydrogen 
provides 6- deoxyerythronlide B in 93% isolated yield as a single diastereomer. Thus, 6-
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deoxyerythronlide B is prepared in 14 steps (longest linear sequence) and 20 total steps, 
representing the most concise route to any erythromycin family member reported, to date. 
 
Scheme 5.4 Fragments union and end game. 
 
5.5 SUMMARY 
New reactivity is the principal basis for new functional group interconversions 
and, hence, new strategies that can shift the retrosynthetic paradigm, ultimately 
simplifying longstanding challenges in chemical synthesis. Successfully utilizing double 
crotylation strategy and syn-crotylation mediated by 1,3-butadiene, our lab has 
established the most concise assembly of 6-deoxyerythronolide B. This work also 








All reactions were run under an atmosphere of Argon. Tetrahydrofuran (THF) and 
toluene were obtained from Pure-Solv MD-5 Solvent Purification System (Innovative 
Technology). Anhydrous solvents were transferred by an oven-dried syringe. Sealed 
tubes (13x100 mm) were purchased from Fischer Scientific and were dried in an oven 
overnight and cooled under a stream of nitrogen prior to use. Commercially available 
allyl acetate (Aldrich) was purified by distillation prior to use. Cesium carbonate was 
purchased from Alfa Aesar and was used directly without further purification. 
Isopropanol (Fisher) was purified by distillation prior to use. Analytical thin-layer 
chromatography (TLC) was carried out using 0.2-mm commercial silica gel plates (DC-
Fertigplatten Kieselgel 60 F254). Infrared spectra were recorded on a Perkin-Elmer 1600 
spectrometer. High-resolution mass spectra (HRMS) were obtained on a Karatos MS9 
and are reported as m/z (relative intensity). Accurate masses are reported for the 
molecular ion (M+H, M or M-H) or a suitable fragment ion. Nuclear magnetic resonance 
spectra (1H NMR and 13C NMR) spectra were recorded with a Varian Gemini (400 MHz) 
spectrometer for CDCl3 solutions and chemical shifts are reported as parts per million 
(ppm) relative to residual CHCl3 δH (7.26 ppm) and CDCl3 δC (77.0 ppm), respectively, 







A solution of (2S,3R,4R,5R,6S)-2-((S)-but-3-en-2-yl)-6-(iodomethyl)-3,5-
dimethyltetrahydro-2H-pyran-4-ol (628 mg, 2.00 mmol, 100 mol%) and PMB-imidate 
(2825.5 mg, 10.00 mmol, 500 mol%) in diethyl ether (6.7 mL, 0.30 M) was heated to 30 
°C. To this solution was added camphorsulfonic acid (46.5 mg, 0.2 mmol, 10 mol%) in 
one portion. The reaction was stirred at 30 °C overnight. Saturated aqueous NaHCO3 was 
added and the reaction mixture was transferred to a separatory funnel. The aqueous phase 
was extracted with DCM (3 × 30 mL). The combined organic extracts were dried 
(MgSO4), filtered and concentrated under reduced pressure. The residue was purified by 
flash column chromatography (SiO2: ethyl acetate:hexanes, 1:20) to give the title 
compound (702.1 mg, 1.58 mmol) as a colorless oil in 79% yield. 
 
TLC (SiO2): Rf = 0.72 (ethyl acetate:hexanes, 1:3). 
 
1H NMR(400 MHz, CDCl3): δ 7.28-7.26 (m, 2H), 6.89-6.86 (m, 2H), 5.81 (dt, J = 18.0, 
9.2 Hz, 1H), 4.99-4.95 (m, 2H), 4.56 (d, J = 11.2 Hz, 1H), 4.28 (d, J = 11.2 Hz, 1H), 3.81 
(s, 3H), 3.47 (ddd, J = 8.0, 6.0, 2.0 Hz, 1H), 3.27 (dd, J = 10.0, 8.0 Hz, 1H), 3.11 (dd, J = 
10.0, 6.4 Hz, 1H), 2.87 (dd, J = 10.4, 2.0 Hz, 1H), 2.43-2.32 (m, 2H), 1.70-1.60 (m, 1H), 
1.15 (d, J = 7.2 Hz, 3H), 0.86 (d, J = 6.4 Hz, 3H), 0.81 (d, J = 6.8 Hz, 3H). 
 
13C NMR(100 MHz, CDCl3): δ 159.2, 139.2, 130.5, 129.4, 115.2, 113.8, 85.4, 82.9, 78.6, 
69.7, 55.3, 39.9, 33.8, 32.2, 18.7, 12.6, 6.6, 4.9. 
 
[α]D
25 = +51.2 (c = 0.58, CHCl3). 
 
FTIR (neat): υ3100, 2977, 2952, 2332, 1638, 1458, 1455, 1350, 1324, 1212, 1155, 1082, 
967, 958, 773, 699, 650. 
 
HRMS: (CI) Calcd. for C20H30O3I [M+H]









A solution of 5.8 in DMF (15.0 mL, 0.05 M) was added stock solution of OsO4 in t-
butanol (128.7 mg, 4% in H2O, 0.02 mmol, 3 mol%). After 5 min stirring under room 
temperature, solid Oxone (1.660 g, 2.7 mmol, 400 mol%) was added to this solution in 
one portion. The reaction was stirred at room temperature for 6 hr. The reaction mixture 
was warmed to 0 °C and was allowed to stir at this temperature for 6 hr. Saturated 
aqueous Na2S2O3 was added and the reaction mixture was stirred vigorously for 15 min. 
The reaction mixture was acidified with pH = 4.00 buffer solution and transferred to a 
separatory funnel. The aqueous phase was extracted with ethyl acetate (3 × 30 mL). The 
combined organic extracts were dried (MgSO4), filtered and concentrated under reduced 
pressure. The residue was purified by flash column chromatography (SiO2: ethyl 
acetate:hexanes, 1:10) to give the title compound (274.6 mg, 0.594 mmol) as a colorless 
oil in 88% yield. 
 
TLC (SiO2): Rf = 0.39 (ethyl acetate:hexanes, 1:2). 
1H NMR(400 MHz, CDCl3): δ 7.28-7.26 (m, 2H), 6.89-6.87 (m, 2H), 4.58 (d, J = 11.2 
Hz, 1H), 4.29 (d, J = 11.2 Hz, 1H), 3.81 (s, 3H), 3.57-3.53 (m, 1H), 3.27 (dd, J = 10.0, 
7.6 Hz, 1H), 3.16 (dd, J = 10.4, 2.4 Hz, 1H), 3.13-3.09 (m, 2H), 2.82 (td, J = 7.2, 2.4 Hz, 
1H), 2.41-2.36 (m, 1H), 1.98-1.88 (m, 1H), 1.30 (d, J = 7.2 Hz, 3H), 0.94 (d, J = 6.8 Hz, 
3H), 0.83 (d, J = 6.8 Hz, 3H). 
13C NMR(100 MHz, CDCl3): δ 177.7, 159.2, 130.1, 129.4, 113.8, 83.7, 82.3, 79.3, 69.8, 
55.3, 41.5, 33.7, 33.4, 13.9, 12.8, 5.4, 4.9. 
[α]D
25 = +45.9 (c = 0.55, CHCl3). 
FTIR (neat): υ 3500, 3348, 3150, 3000, 2976, 2951, 1705, 1620, 1543, 1243, 1175, 1067, 
922, 878, 842, 773, 692, 668. 
HRMS: (CI) Calcd. for C19H28O5I [M+H]











A solution of (R)-2-((2R,3R,4R,5R,6S)-6-(iodomethyl)-4-((4-methoxybenzyl)oxy)-3,5-
dimethyltetrahydro-2H-pyran-2-yl)propanoic acid (137.1 mg, 0.297 mmol, 100 mol%) in 
EtOH (3 mL, 0.1 M) was added activated Zn (289.6 mg, 4.455 mmol, 1500 mol%) and 
NH4Cl (158.9 mg, 2.97 mmol, 1000 mol%). The reaction mixture was heated under 
refluxing for 1 hr. The crude reaction mixture was diluted with ethyl acetate (15 mL) and 
HCl in THF (1 mL, 1.0M) and filtered through a silica plug. The filtrate was concentrated 
under reduced pressure. Purification by flash column chromatography (SiO2: ethyl 
acetate:hexanes, 1:3) gave the title compound (91.9 mg, 0.273 mmol) as a colorless oil in 
92% yield. 
 
TLC (SiO2): Rf = 0.45 (methanol:DCM, 1:9). 
 
1H NMR(400 MHz, CDCl3): δ 7.26-7.24 (m, 2H), 6.89-6.87 (m, 2H), 5.97 (ddd, J = 17.2, 
10.0, 8.0 Hz, 1H), 5.14 (dt, J = 17.2, 1.6 Hz, 1H), 5.07 (dd, J = 10.0, 1.6 Hz, 1H), 4.60 (d, 
J = 10.8 Hz, 1H), 4.49 (d, J = 10.8 Hz, 1H), 3.80 (s, 3H), 3.74 (dd, J = 8.0, 4.8 Hz, 1H), 
3.58 (dd, J = 6.0, 2.8 Hz, 1H), 2.67-2.53 (m, 2H), 2.08-1.99 (m, 1H), 1.27 (d, J = 7.2 Hz, 
3H), 1.03 (d, J = 7.2 Hz, 3H), 1.00 (d, J = 7.2 Hz, 3H). 
 
13C NMR(100 MHz, CDCl3): δ 177.4, 159.5, 141.0, 129.8, 129.6, 115.2, 114.0, 84.0, 
76.3, 73.1, 55.3, 42.4, 40.1, 37.1, 18.3, 14.8, 12.2. 
 
[α]D
25 = -21.7 (c = 0.58, CHCl3). 
 
 
FTIR (neat): υ3500, 3428, 3050, 3044, 2984, 2941, 1705, 1616, 1533, 1249, 1170, 1060, 
922, 878, 842. 
 
 
HRMS: (CI) Calcd. for C19H29O5 [M+H]









A solution of 5.9 (34 mg, 0.1 mmol, 100 mol%) in THF:HMPA (0.5, 1:1, 0.20 M) was 
cooled to -78 °C. To this solution was added s-butyl lithium (0.26 mL, 1.4 M, 0.35 mmol, 
350 mol%) dropwise. The reaction was warmed to -20 °C and stirred for 2 hr. 
Chloromethanesulfonyl chloride (52.2 mg, 0.35 mmol, 350 mol%) in THF (0.1 mL) was 
added to the reaction mixture and stirring was continued for another 2 hr. Pyridine:H2O 
(15 mL, 40:1) was added and the reaction mixture was allowed to stir under 35 °C 
overnight. The reaction mixture was diluted with ethyl acetate (100 mL) and transferred 
to a separatory funnel. The organic phase was washed with CuSO4 (30 mL), water (30 
mL) and brine (30 mL). The organic extracts were dried (MgSO4), filtered and 
concentrated under reduced pressure. The residue was purified by flash column 
chromatography (SiO2: ethyl acetate:hexanes, 1:20) to give the title compound (22.9 mg, 
0.072 mmol) as a colorless oil in 72% yield. 
 
TLC (SiO2): Rf = 0.73 (ethyl acetate:hexanes, 1:2). 
1H NMR(400 MHz, CDCl3): δ 7.24-7.22 (m, 2H), 6.89-6.87 (m, 2H), 5.91 (ddd, J = 18.0, 
10.4, 8.0 Hz, 1H), 5.15 (dd, J = 18.0, 1.2 Hz, 1H), 5.09 (dd, J = 10.4, 1.2 Hz, 1H), 4.60 
(d, J = 11.6 Hz, 1H), 4.30 (dd, J = 10.8, 6.4 Hz, 1H), 4.25 (d, J = 11.6 Hz, 1H), 3.81 (s, 
3H), 3.19 (qd, J = 8.0, 6.0 Hz, 1H), 3.08 (dd, J = 8.0, 1.6 Hz, 1H), 2.56 (qd, J = 14.8, 6.8 
Hz, 1H), 2.06 (dqd, J = 13.6, 6.8, 1.6 Hz, 1H), 1.20 (d, J = 8.0 Hz, 3H), 1.07 (d, J = 6.8 
Hz, 3H), 1.02 (d, J = 6.8 Hz, 3H). 
13C NMR(100 MHz, CDCl3): δ 172.7, 159.4, 141.2, 130.1, 129.9, 115.2, 113.8, 80.4, 
77.6, 73.3, 55.3, 46.4, 41.0, 35.6, 16.7, 9.4, 9.0. 
[α]D
25 = -20.1 (c = 0.34, CHCl3). 
FTIR (neat): υ3300, 3080, 2963, 2925, 1821, 1466, 1377, 1128, 1043, 1000, 970, 923, 
888, 842, 761, 731. 
HRMS: (CI) Calcd. for C19H26O4 [M]










The NOE experiment shows clearly the NOE interaction between aH and bH, while aH 
and dH shows no NOE interaction towards each other. This data suggest a syn 







A solution of (3R,4S)-4-((2R,3S,4S)-3-((4-methoxybenzyl)oxy)-4-methylhex-5-en-2-yl)-
3-methyloxetan-2-one (200 mg, 0.63 mmol, 100 mol%) in dioxane:H2O (12.6 mL, 1:1, 
0.05 M) was added LiOH monohydrate (52.9 mg, 1.26 mmol, 200 mol%) in one portion. 
The reaction was stirred overnight. pH = 4 buffer solution (15 mL) was added and the 
reaction mixture was transferred to a separatory funnel. The aqueous phase was extracted 
with ethyl acetate (3 × 30 mL). The combined organic extracts were dried (MgSO4), 
filtered and concentrated under reduced pressure. The residue was purified by flash 
column chromatography (SiO2: ethyl acetate:hexanes, 1:3) to give the title compound 
(148.4 mg, 0.441 mmol) as a colorless oil in 70% yield. 
 
TLC (SiO2): Rf = 0.32 (ethyl acetate:hexanes, 1:1). 
 
1H NMR(400 MHz, CDCl3): δ 7.26-7.24 (m, 2H), 6.89-6.86 (m, 2H), 5.92 (ddd, J = 17.6, 
10.4, 8.4 Hz, 1H), 5.15 (dt, J = 17.2, 1.6 Hz, 1H), 5.08 (ddd, J = 10.4, 2.0, 0.8 Hz, 1H), 
4.70 (d, J = 10.4 Hz, 1H), 4.38 (d, J = 10.4 Hz, 1H), 3.95 (dd, J = 7.6, 2.0 Hz, 1H), 3.80 
(s, 3H), 3.40 (dd, J = 7.6, 3.2 Hz, 1H), 2.72-2.65 (m, 1H), 2.62-2.53 (m, 1H), 1.88 (qdd, J 
= 8.4, 7.2, 4.0 Hz, 1H), 1.24 (d, J = 7.2 Hz, 3H), 1.01 (d, J = 6.8 Hz, 3H), 0.97 (d, J = 7.2 
Hz, 3H). 
 
13C NMR(100 MHz, CDCl3): δ 178.6, 159.4, 141.3, 129.8, 129.6, 115.2, 113.9, 87.5, 
76.0, 73.6, 55.3, 42.6, 41.1, 36.6, 16.9, 13.2, 6.9. 
 
[α]D
25 = -47.2 (c = 0.83, CHCl3). 
 
FTIR (neat): υ3478, 3409, 3081, 3068, 2974, 2938, 1707, 1613, 1514, 1459, 1249, 1175, 
1035, 916, 820. 
 
HRMS: (CI) Calcd. for C19H29O5 [M+H]











A solution of (2R,3S,4S,5S,6S)-3-hydroxy-5-((4-methoxybenzyl)oxy)-2,4,6-trimethyloct-
7-enoic acid (148.4 mg, 0.441 mmol, 100 mol%) and 4Å molecular sieves (480.5 mg) in 
DCM (8.82 mL, 0.05 M) was cooled to 0 °C. To this solution was added DDQ (120.1 
mg, 0.529 mmol, 120 mol%) in three portions. The reaction was stirred at 0 °C for 1 hr. 
The reaction mixture was loaded on to the column directly. Purification by column 
chromatography (SiO2; ethyl acetate: hexanes, 1:3) gave the title compound (118.0 mg, 
0.353 mmol) as a colorless oil in 80% yield. 
 
TLC (SiO2): Rf = 0.69 (ethyl acetate:hexanes, 1:1). 
 
1H NMR(400 MHz, CDCl3): δ 7.42-7.40 (m, 2H), 6.90-6.88 (m, 2H), 5.97 (ddd, J = 17.2, 
10.4, 6.4 Hz, 1H), 5.48 (s, 1H), 5.08 (dt, J = 17.2, 1.6 Hz, 1H), 5.03 (dt, J = 10.4, 1.6 Hz, 
1H), 3.88 (dd, J = 10.0, 2.0 Hz, 1H), 3.80 (s, 3H), 3.50 (dd, J = 10.0, 2.0 Hz, 1H), 2.85 
(qdd, J = 6.8, 6.4, 2.0 Hz, 1H), 2.44 (qd, J = 6.8, 3.2 Hz, 1H), 1.80 (qd, J = 6.8, 2.0 Hz, 
1H), 1.38 (d, J = 6.8 Hz, 3H), 1.02 (d, J = 6.8 Hz, 3H), 0.97 (d, J = 6.8 Hz, 3H). 
 
13C NMR(100 MHz, CDCl3): δ 178.7, 159.9, 141.6, 131.1, 127.2, 114.0, 113.5, 101.3, 
84.5, 81.8, 55.3, 41.7, 38.3, 29.7, 14.9, 14.3, 6.0. 
 
[α]D
25 = -90.2 (c = 0.36, CH2Cl2). 
 
 
FTIR (neat): υ3334, 3255, 2970, 2922, 2852, 1737, 1645, 1557, 1517, 1375, 1302, 1170, 
1132, 1104, 1033, 1011, 976, 914, 828, 668. 
 
 
HRMS: (CI) Calcd. for C19H27O5 [M+H]








To a resealable pressure tube equipped with a magnetic stir bar was added 
RuH2(CO)(PPh3)3 (321.5 mg, 0.35 mmol, 7 mol%), (S)‐SEGPHOS (213.5 mg, 0.35 
mmol, 7 mol%), TADDOL‐phosphoric acid (488 mg, 0.7 mmol, 14 mol%). The tube was 
sealed with a rubber septum and purged with argon. Propanol (382.5 μL, 5. 0 mmol, 100 
mol%) and acetone (5. 0 mL, 1.0 M concentration with respect to alcohol) were added 
and the solution was cooled to ‐78 °C. Butadiene (1.69 mL, 20.0 mmol, 400 mol%) was 
quickly added and the rubber septum was quickly replaced with a screw cap. The mixture 
was heated at 95 °C (oil bath temperature) for 3 days, at which point the reaction mixture 
was allowed to cool to ambient temperature. TBSCl (1.507 g, 10.0 mmol, 200 mol%) and 
imidazole (0.851 g, 12.5 mmol, 250 mol%) were added and the reaction mixture was 
diluted with DMF (25 mL) and stirred under 70 °C for another 15 hours. Aqueous CuSO4 
solution was added and the reaction mixture was extract with ether (20 mL × 3). 
Combined organic layer was dried in vacuo and purified by flash column 
chromatography (SiO2; hexanes) to furnish the title compound (673.9 mg, 2.95 mmol, 
syn:anti = 4.7:1, 98% ee) as a colorless oil in 59% yield. 
 
TLC (SiO2): Rf = 0.64 (hexanes). 
1H NMR(400 MHz, CDCl3): δ5.83 (ddd, J = 17.6, 10.4, 7.2 Hz, 1H), 5.02-4.96 (m, 2H), 
3.51-3.44 (m, 1H), 2.35-2.26 (m, 1H), 1.46-1.37 (m, 2H), 0.96 (d, J = 7.2 Hz, 1H), 0.90 
(s, 9H), 0.86 (t, J = 7.2 Hz, 1H), 0.04 (s, 6H). 
13C NMR (100 MHz, CDCl3): δ141.8, 113.6, 76.7, 42.3, 26.5, 25.9, 15.0, 9.5, -4.3, -4.4. 
FTIR (neat): υ2956, 2927, 1462, 1251, 771. 
[α]D
25 = +20.8 (c = 1.1, CH2Cl2). 
HPLC Enantiomeric excess was determined by HPLC analysis of the 4-nitrobenzoate 
derivative of the product (Chiralcel AD-H column, hexanes:i-PrOH = 99:1, 0.5 mL/min, 


















An oven-dried round bottom flask under an atmosphere of N2 was charged with tert-
Butyldimethyl(((3R,4R)-4-methylhex-5-en-3-yl)oxy)silane (290 mg, 1.27 mmol, 100 
mol%), 2,6-lutidine (271.9 mg, 2.54 mmol, 200 mol%), and THF:H2O (12.7 mL, 3:1, 0.1 
M). OsO4 in t-butanol (0.76 mL, 0.05M, 0.038 mmol, 3 mol%) was added under 0 
oC. 
After being stirring for 5 min, solid NaIO4 (542.9 mg, 2.54 mmol, 200 mol%) was added 
in one portion. Stirring was continued for another 12 hr fallowed by saturated aqueous 
Na2S2O3 (20 mL) was added. The reaction mixture was stirred vigorously for 15 min and 
then transferred to a separatory funnel. The aqueous phase was extracted with ethyl 
acetate (3 × 30 mL). The combined organic extracts were dried (MgSO4), filtered and 
concentrated under reduced pressure. The residue was run through a silica plug to give 
the title compound (262 mg, 0.977 mmol) as a colorless oil in 77% yield and used in the 
next step without further purification. 
 
TLC (SiO2): Rf = 0.63 (hexanes:ethyl acetate, 10:1). 
 
1H NMR(400 MHz, CDCl3): δ 9.77 (d, J = 0.8 Hz, 1H), 4.03 (ddd, J = 10.4, 7.2, 3.6 Hz, 
1H), 2.47 (qdd, J = 7.2, 3.6, 0.8 Hz, 1H), 1.60-1.47 (m, 3H), 1.05 (d, J = 7.2 Hz, 3H), 
0.89 (t, J = 7.2 Hz, 3H), 0.86 (s, 9H), 0.06 (s, 3H), 0.04 (s, 3H). 
 











An oven-dried round bottom flask under an atmosphere of N2 was charged with S-phenyl 
propanethioate (170 mg, 1.0 mmol, 150 mol%) and ether (0.5 mL). 9-BBNOTf solution 
(2.0 mL, 0.5 M, 150 mol%) was added under 0 oC followed by triethylamine (0.186 mL, 
1.2 mmol, 180 mol%). The bright yellow reaction mixture was stirred under room 
temperature for 30 min, and then cooled to -78 oC. (2S,3R)-3-((tert-
butyldimethylsilyl)oxy)-2-methylpentanal (154 mg, 0.67 mmol, 100 mol%) in ether (0.5 
mL, 0.7 M) was added to the reaction mixture. Stirring was continued for 1 hr then pH = 
7 buffer (2 mL) was added. The layer was separated and the aqueous layer was extract 
with DCM (10 mL × 3). Combined organic layer was dried in vacuo and purified by flash 
column chromatography (SiO2; hexanes:ether = 11:1-8:1) to furnish the title compound 
(207.3 mg, 0.52 mmol) as a colorless oil in 78% yield. 
 
TLC (SiO2): Rf = 0.42 (ethyl acetate:hexanes, 1:9). 
 
1H NMR(400 MHz, CDCl3): δ 7.43-7.39 (m, 5H), 4.10-4.08 (m, 1H), 3.94-3.90 (m, 1H), 
3.76 (br, 1H), 2.87 (qd, J = 7.8, 3.2 Hz, 1H), 1.83-1.75 (m. 1H), 1.66-1.51 (m, 3H), 1.28 
(d, J = 7.2 Hz, 3H), 0.91 (t, J = 6.4 Hz, 3H), 0.90 (s, 9H), 0.12 (s, 3H), 0.09 (s, 3H). 
 
13C NMR(100 MHz, CDCl3): δ 201.2, 134.6, 129.3, 129.1, 127.6, 76.5, 74.2, 51.1, 38.7, 
25.9, 25.8, 18.0, 11.5, 10.9, 10.2, -4.2, -4.5. 
 
[α]D
25 = -28.8 (c = 0.55, CH2Cl2). 
 
 
FTIR (neat): υ2928, 2858, 1714, 1457, 1252, 1217, 1003, 954, 834, 774, 744, 688, 668. 
 
 
HRMS: (CI) Calcd. for C21H37O3SSi [M+H]










An oven-dried round bottom flask under an atmosphere of N2 was charged with 
(2R,3S,4R,5R)-S-phenyl 5-((tert-butyldimethylsilyl)oxy)-3-hydroxy-2,4-
dimethylheptanethioate (230 mg, 0.58 mmol, 100 mol%), 10% Pd/C (31 mg, 0.029 
mmol, 5 mol%), and acetone (11.6 mL, 0.05M). Triethylsilane (0.930 mL, 5.8 mmol, 
1000 mol%) was added in ten portions and the mixture was allowed to stir at room 
temperature until all starting material was consumed. The reaction mixture was run 
through a silica plug and concentrated in vacuo to give the title compound (142.2 mg, 
0.49 mmol) as a colorless oil in 85% yield and used in the next step without further 
purification. 
 
TLC (SiO2): Rf = 0.42 (ethyl acetate:hexanes, 1:9). 
 
1H NMR(400 MHz, CDCl3): δ9.77 (d, J = 0.4 Hz, 1H), 4.31 (dd, J = 10.0, 2.4 Hz, 1H), 
4.27 (s, 1H), 3.72 (dt, J = 8.8, 3.2 Hz, 1H), 3.34 (qd, J = 6.8, 2.0 Hz, 1H), 1.91 (dqd, J = 
8.8, 7.2, 2.8 Hz, 1H), 1.68-1.52 (m, 2H), 1.12 (d, J = 7.2 Hz, 3H), 0.96 (t, J = 7.6 Hz, 
3H), 0.90 (s, 9H), 0.79 (d, J = 7.2 Hz, 3H), 0.12 (s, 3H), 0.09 (s, 3H). 
 













An oven-dried round bottom flask under an atmosphere of N2 was charged with Ohira-
Bestmann reagent (119.9 mg, 0.62 mmol, 300 mol%) and methanol (6 mL, 0.1 M). Solid 
K2CO3 (86.2 mg, 0.62 mmol, 300 mol%) was added in one portion and the mixture was 
allowed to stir at room temperature for 30 min. The clear solution was transferred via 
syringe to another reaction flask with (2R,3S,4R,5R)-5-((tert-butyldimethylsilyl)oxy)-3-
hydroxy-2,4-dimethylheptanal (60 mg, 0.21 mmol, 100 mol%) in THF (4.2 mL, 0.05 M) 
under 0 oC. The reaction was stirred for 1 hr and pH = 7 buffer (20 mL) was added. The 
layer was separated and the aqueous layer was extract with DCM (20 mL × 3). Combined 
organic layer was dried in vacuo and purified by flash column chromatography (SiO2; 
hexanes:ether = 9:1) to furnish the title compound (52.7 mg, 0.19 mmol) as a colorless oil 
in 89% yield. 
 
TLC (SiO2): Rf = 0.62 (ethyl acetate:hexanes, 1:9). 
 
1H NMR(400 MHz, CDCl3): δ 3.90 (d, J = 4.0 Hz, 1H), 3.86 (td, J = 7.2, 2.0 Hz, 1H), 
3.65 (p, J = 4.0 Hz, 1H), 2.58 (qdd, J = 7.2, 5.2, 2.4 Hz, 1H), 2.09 (d, J = 2.4 Hz, 1H), 
1.93 (pd, J = 10.8, 2.4 Hz, 1H), 1.63-1.48 (m, 2H), 1.22 (d, J = 6.8 Hz, 3H), 0.89 (t, J = 
6.4 Hz, 3H), 0.88 (s, 9H), 0.85 (d, J = 6.8 Hz, 3H), 0.10 (s, 3H), 0.09 (s, 3H). 
 
13C NMR(100 MHz, CDCl3): δ 87.3, 77.3, 76.6, 69.2, 37.7, 29.9, 25.8, 25.6, 17.9, 14.4, 
11.8, 10.8, -4.1, -4.6. 
 
[α]D
25 = -6.1 (c = 0.33, CH2Cl2). 
 
 
FTIR (neat): υ 2928, 2858, 1714, 1457, 1252, 1217, 1003, 954, 834, 774, 744, 688, 668. 
 
 
HRMS: (CI) Calcd. for C16H32O2Si [M]









An oven-dried sealed tube under an atmosphere of N2 was charged with (3S,4R,5R,6R)-6-
((tert-butyldimethylsilyl)oxy)-3,5-dimethyloct-1-yn-4-ol (350 mg, 1.23 mmol, 100 
mol%), Ag2O (855 mg, 3.69 mmol, 300 mol%) and benzyl bromide (2.104 g, 12.3 mmol, 
1000 mol%). The mixture was allowed to stir at 50 oC for 24 hr. Methanol (5 mL) was 
added to the reaction mixture and the reaction was acidified by conc. HCl (~0.5 mL). 
After stirring for 30 min under room temperature, pH = 7 buffer (10 mL) was added and 
the mixture was transferred to a separatory funnel. The aqueous layer was extract with 
DCM (20 mL × 3). Combined organic layer was dried in vacuo and purified by flash 
column chromatography (SiO2; hexanes:ether = 9:1) to furnish the title compound (230.6 
mg, 0.886 mmol) as a colorless oil in 72% yield. 
 
TLC (SiO2): Rf = 0.48 (ethyl acetate:hexanes, 1:9). 
 
1H NMR(400 MHz, CDCl3): δ 7.35-7.28 (m, 5H), 4.76 (d, J = 10.8 Hz, 1H), 4.65 (d, J = 
10.8 Hz, 1H), 3.96-3.93 (m, 1H), 3.49 (dd, J = 8.0, 3.6 Hz, 1H), 3.07 (d, J = 1.6 Hz, 1H), 
2.87 (dqd, J = 10.0, 6.8, 2.8 Hz, 1H), 2.13 (d, J = 2.8 Hz, 1H), 2.11 (qdd, J = 6.8, 4.0, 1.6 
Hz, 1H), 1.62-1.51 (m, 1H), 1.43-1.32 (m, 1H), 1.34 (d, J = 6.8 Hz, 3H), 1.05 (d, J = 7.2 
Hz, 3H), 0.93 (t, J = 7.6 Hz, 3H). 
 
13C NMR(100 MHz, CDCl3): δ 137.6, 128.5, 128.0, 127.9, 88.2, 86.3, 76.0, 72.1, 70.5, 
38.2, 29.4, 27.3, 17.3, 11.4, 10.6. 
 
[α]D
25 = -9.3 (c = 0.22, CH2Cl2). 
 
 




HRMS: (CI) Calcd. for C17H25O2 [M+H]










An oven-dried round bottom flask under an atmosphere of N2 was charged with acid 
fragment (77.1 mg, 0.23 mmol, 100 mol%), triethylamine (64.3 µL, 0.46 mmol, 200 
mol%) and THF (2.3 mL, 0.1 M). 2,4,6-Trichlorobenzoyl chloride (72 µL, 0.46 mmol, 
200 mol%) was added and the mixture was allowed to stir at room temperature for 3 hr. 
The reaction mixture was filtered through a Celite plug and concentrated in vacuo. The 
residue was dissolved in toluene (1.5 mL) and added to a mixture of alcohol fragment 
(60.0 mg, 0.23 mmol, 100 mol%), DMAP (112.6 mg, 0.92 mmol, 400 mol%) and toluene 
(2.3 mL, 0.1 M). The reaction mixture was stirred at room temperature overnight, and 
loaded on to column directly. Purification by column chromatography (SiO2; ethyl 
acetate: hexanes, 1:20) provides the title compound (90.6 g, 0.16 mmol) as a colorless oil 
in 70% yield. 
 
TLC (SiO2): Rf = 0.59 (ethyl acetate:hexanes, 1:9). 
 
1H NMR(400 MHz, CDCl3): δ 7.47-7.28 (m, 7H), 6.90-6.88 (m, 2H), 5.96 (ddd, J = 17.2, 
10.4, 6.8 Hz, 1H), 5.48 (s, 1H), 5.41 (td, J = 8.4, 2.4 Hz, 1H), 5.08-5.00 (m, 2H), 4.97 (d, 
J = 10.0, 1H), 4.54 (d, J = 10.0, 1H), 3.90 (dd, J = 10.4, 2.0 Hz, 1H), 3.80 (s, 3H), 3.50 
(dd, J = 10.0, 2.0 Hz, 1H), 3.36 (dd, J = 10.8, 2.8 Hz, 1H), 2.87-2.75 (m, 2H), 2.41 (qd, J 
= 6.8, 1.6 Hz, 1H), 2.11 (d, J = 2.4 Hz, 1H), 1.86-1.80 (m, 2H), 1.74-1.67 (m, 1H), 1.55-
1.49 (m, 1H), 1.37 (d, J = 6.8 Hz, 3H), 1.24 (d, J = 7.2 Hz, 3H), 1.04 (d, J = 6.8 Hz, 3H), 
0.94 (d, J = 7.2 Hz, 3H), 0.89 (d, J = 6.8 Hz, 3H), 0.98 (t, J = 7.6 Hz, 3H). 
 
 438
13C NMR (100 MHz, CDCl3): δ 174.2, 159.7, 141.6, 138.4, 131.3, 128.3, 128.3, 127.7, 
127.1, 113.9, 113.5, 101.2, 87.8, 84.5, 82.2, 82.1, 74.8, 74.5, 69.8, 55.3, 42.6, 38.9, 38.1, 
31.4, 27.6, 25.7, 15.7, 14.4, 14.3, 10.2, 10.2, 6.2. 
 
[α]D
27 = -14.4 (c = 0.44, CH2Cl2). 
 




HRMS: (CI) Calcd. for C36H47O6 [M-H]













An oven-dried round bottom flask under an atmosphere of ethylene (balloon pressure) 
was charged with (R)-(3R,4S,5R,6S)-5-(benzyloxy)-4,6-dimethyloct-7-yn-3-yl-2-
((2S,4S,5R,6S)-6-((S)-but-3-en-2-yl)-2-(4-methoxyphenyl)-5-methyl-1,3-dioxan-4-
yl)propanoate (105.2 mg, 0.18 mmol, 100 mol%), Hoveyda-Grubbs 2nd generation 
catalyst (34.3 mg, 0.60 mmol, 30 mol%) and toluene (182.4 mL, 0.001 M). The mixture 
was allowed to stir at 80 oC overnight. Blowing nitrogen through the reaction system to 
remove the ethylene and the reaction mixture was allowed to stir at 110 oC for another 24 
hr followed by loading on to column directly. Purification by column chromatography 
(SiO2; ethyl acetate: hexanes, 1:20) provides the title compound (93.6 mg, 0.16 mmol) as 
a colorless viscous oil in 89% yield. 
 
TLC (SiO2): Rf = 0.62 (ethyl acetate:hexanes, 1:9). 
 
1H NMR(400 MHz, CDCl3): δ 7.49-7.46 (m, 2H), 7.39-7.27 (m, 5H), 6.94-6.90 (m, 2H), 
6.22 (d, J = 16.0 Hz, 1H), 5.65 (dd, J = 16.0, 9.6 Hz, 1H), 5.60 (s, 1H), 5.47 (dd, J = 8.4, 
5.6 Hz, 1H), 5.23 (s, 1H), 5.16 (s, 1H), 4.46 (d, J = 9.2 Hz, 1H), 4.33 (d, J = 9.2 Hz, 1H), 
3.83-3.80 (m, 1H), 3.82 (s, 3H), 3.65 (dd, J = 11.2, 1.2 Hz, 1H), 3.49 (d, J = 10.0 Hz, 
1H), 2.96-2.80 (m, 3H), 2.17 (q, J = 6.8 Hz, 1H), 1.81-1.66 (m, 1H), 1.54-1.45 (m, 1H), 
1.26 (d, J = 6.4 Hz, 3H), 1.24 (d, J = 6.4 Hz, 3H), 1.23 (d, J = 7.2 Hz, 3H), 1.14 (d, J = 
6.8 Hz, 3H), 1.01 (d, J = 7.2 Hz, 3H), 0.86 (t, J = 7.6 Hz, 3H). 
 
 442
13C NMR (100 MHz, CDCl3): δ 174.7, 160.0, 148.7, 138.7, 132.8, 132.7, 131.2, 128.4, 
128.3, 127.6, 127.5, 115.7, 113.6, 102.6, 84.5, 83.7, 80.0, 76.0, 75.1, 55.3, 41.6, 40.2, 
40.1, 35.5, 33.4, 26.5, 14.1, 13.0, 10.6, 9.9, 9.9, 9.4. 
 
[α]D
27 = -19.9 (c = 0.58, CH2Cl2). 
 
 
FTIR (neat): υ 2972, 2936, 2880, 1723, 1616, 1518, 1458, 1385, 1302, 1249, 1174, 1153, 
1096, 1071, 1030, 1005, 891, 829, 755, 733, 699. 
 
HRMS: (CI) Calcd. for C36H48O6 [M]













An oven-dried round bottom flask under an atmosphere of N2 was charged with 
(1S,2R,5R,6S,7R,8S,12S,13S,15S,17R,E)-7-(benzyloxy)-5-ethyl-15-(4-methoxyphenyl)-
2,6,8,12,17-pentamethyl-9-methylene-4,14,16-trioxabicyclo[11.3.1]heptadec-10-en-3-one 
(33.0 mg, 0.0607 mmol, 100 mol%) and THF:H2O (3.0 mL, 1:1, 0.02 M). OsO4 in t-
butanol (0.303 mL, 0.02M, 0.00607 mmol, 10 mol%) was added under 0 oC and NMO 
(27.1 g, 0.200 mmol, 300 mol%) was added in one portion. The reaction mixture was 
stirred overnight, and solid NaIO4 (66.5 mg, 0.243 mmol, 400 mol%) was added in one 
portion. Stirring was continued for another 12 hr fallowed by saturated aqueous Na2S2O3 
(8 mL) was added. The reaction mixture was stirred vigorously for 15 min and then 
transferred to a separatory funnel. The aqueous phase was extracted with ethyl acetate (3 
× 30 mL). The combined organic extracts were dried (MgSO4), filtered and concentrated 
under reduced pressure. The residue was purified by flash column chromatography (SiO2: 
ethyl acetate:hexanes, 1:20) to give the title compound (19.3 mg, 0.0334 mmol) as a 
colorless oil in 55% yield. 
 
TLC (SiO2): Rf = 0.33 (ethyl acetate:hexanes, 1:9). 
 
1H NMR(400 MHz, CDCl3): δ 7.48-7.45 (m, 2H), 7.41-7.28 (m, 5H), 6.93-6.91 (m, 2H), 
6.59 (dd, J = 16.4, 9.6 Hz, 1H), 6.10 (dd, J = 16.4 Hz, 1H), 5.61 (s, 1H), 5.51 (dd, J = 8.8, 
5.6 Hz, 1H), 4.26-4.20 (m, 2H), 3.87 (dd, J = 7.6, 1.2 Hz, 1H), 3.82 (s, 3H), 3.75 (d, J = 
10.0 Hz, 1H), 3.66 (d, J = 10.0 Hz, 1H), 3.27 (q, J = 6.4 Hz, 1H), 3.08-2.99 (m, 1H), 
2.95-2.87 (m, 1H), 2.07-2.02 (m, 1H), 1.85-1.68 (m, 2H), 1.63-1.45 (m, 1H), 1.30 (d, J = 
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6.8 Hz, 3H), 1.28 (d, J = 7.2 Hz, 3H), 1.26 (d, J = 6.8 Hz, 3H), 1.14 (d, J = 6.8 Hz, 3H), 
1.05 (d, J = 7.2 Hz, 3H), 0.87 (t, J = 7.6 Hz, 3H). 
 
13C NMR (100 MHz, CDCl3): δ 204.4, 174.5, 160.0, 147.4, 137.5, 131.6, 130.8, 128.8, 
128.4, 127.9, 127.5, 113.6, 102.7, 84.2, 82.4, 80.9, 75.7, 73.7, 55.3, 43.8, 41.6, 40.2, 40.0, 
33.6, 26.4, 13.5, 13.1, 10.5, 10.1, 9.5, 6.7. 
 
[α]D
27 = -33.7 (c = 0.21, CH2Cl2). 
 
 
FTIR (neat): υ 3477, 2930, 1734, 1628, 1455, 1377, 1247, 1188, 1099, 1022, 808, 630. 
 
 
HRMS: (CI) Calcd. for C35H47O7 [M+H]











A solution of 5.13 (12.3 mg, 0.0213 mmol, 100 mol%) in THF:MeOH (0.9 mL, 1:1, 
0.025 M) was cooled to 0 °C. To this solution was added NiCl2 hexahydrate (2.5 mg, 
0.0106 mmol, 50 mol%) in one portion. The reaction was stirred at 0 °C for 10 min, and 
NaBH4 (1.6 mg, 0.0425 mmol, 200 mol%) was added in three portions. The reaction 
mixture was stirred for another 1 hr. Purification by column chromatography (SiO2; ethyl 
acetate: hexanes, 1:20) gave the title compound (11.1 mg, 0.0191 mmol) as a colorless oil 
in 90% yield, > 10:1 regioselectivity. 
 
TLC (SiO2): Rf = 0.31 (ethyl acetate:hexanes, 1:9). 
 
1H NMR(400 MHz, CDCl3): δ 7.47-7.45 (m, 2H), 7.41-7.28 (m, 5H), 6.93-6.90 (m, 2H), 
5.64-5.61 (m, 2H), 4.34 (d, J = 9.2 Hz, 1H), 4.23 (d, J = 9.2 Hz, 1H), 3.97 (d, J = 6.4 Hz, 
1H), 3.82 (s, 3H), 3.81-3.78 (m, 2H), 3.00-2.92 (m, 1H), 2.90-2.80 (m, 2H), 2.41-2.33 
(m, 1H), 2.26-2.19 (m, 1H), 2.01 (q, J = 6.8 Hz, 1H), 1.87-1.69 (m, 2H), 1.56-1.46 (m, 
1H), 1.29 (d, J = 6.8 Hz, 3H), 1.27 (d, J = 7.2 Hz, 3H), 1.11 (d, J = 7.2 Hz, 3H), 1.07 (d, 
J = 6.8 Hz, 3H), 1.02 (d, J = 7.2 Hz, 3H), 0.89 (t, J = 7.2 Hz, 3H). 
 
13C NMR (100 MHz, CDCl3): δ 213.4, 175.2, 160.0, 137.5, 131.0, 128.6, 128.4, 127.9, 
127.5, 113.6, 102.7, 84.3, 80.9, 80.2, 75.9, 72.8, 55.3, 44.9, 41.6, 40.8, 39.5, 35.0, 32.5, 
30.3, 26.2, 15.8, 13.4, 10.5, 10.1, 9.2, 6.5. 
 
[α]D
27 = -39.0 (c = 0.16, CH2Cl2). 
 
FTIR (neat): υ 2972, 2940, 2923, 1730, 1717, 1366, 1214, 1099, 765, 729, 663. 
 
HRMS: (CI) Calcd. for C35H48O7 [M]











A solution of (1S,2R,5R,6S,7S,8R,12S,13S,15S,17R)-7-(benzyloxy)-5-ethyl-15-(4-
methoxyphenyl)-2,6,8,12,17-pentamethyl-4,14,16-trioxabicyclo[11.3.1]heptadecane-3,9-
dione (16.5 mg, 0.0284 mmol, 100 mol%) in THF (0.8 mL, 0.05 M) was cooled to -78 
°C. To this solution was added LHMDS (0.071 mL, 1.0 M, 0.071 mmol, 250 mol%) 
dropwise. The reaction was stirred at -40 °C for 30 min, and recooled to -78 °C. Freshly 
distilled MeI (20.2 mg, 0.142 mmol, 500 mol%) was added to the reaction and the 
mixture was warmed to room temperature slowly. pH = 7 buffer solution was added and 
the mixture was extracted with ethyl ether (3 × 3 mL). The combined organic extracts 
were dried (MgSO4), filtered and concentrated under reduced pressure. The residue was 
purified by flash column chromatography (SiO2: ethyl acetate:hexanes, 1:15) to give the 
title compound (14.4 mg, 0.024 mmol) as a colorless oil in 85% yield, mixture of 
diastereomers. 
 
TLC (SiO2): Rf = 0.40 (ethyl acetate:hexanes, 1:9). 
 
FTIR (neat): υ 2971, 2934, 2034, 1701, 1618, 1518, 1454, 1305, 1248, 1173, 983, 891, 
830, 809, 726, 719, 667. 
 
HRMS: (CI) Calcd. for C36H51O7 [M+H]













An oven-dried sealed tube under an atmosphere of H2 was charged with 
(1S,2R,5R,6S,7S,8R,10R,12S,13S,15S,17R)-7-(benzyloxy)-5-ethyl-15-(4-
methoxyphenyl)-2,6,8,10,12,17-hexamethyl-4,14,16-trioxabicyclo[11.3.1]heptadecane-
3,9-dione (15 mg, 0.025 mmol, 100 mol%), Pd(OAc)2 (2.3 mg, 0.010 mmol, 40 mol%) 
and i-propanol (0.5 mL, 0.05 M). The mixture was allowed to stir at room temperature 
under balloon pressure of H2 overnight. Hexane was added when reaction was finished. 
Purification of the residue by column chromatography (SiO2; ethyl acetate: hexanes, 1:5) 
provides the title compound (9.0 mg, 0.0233 mmol) as a colorless viscous oil which 
solidified on standing in 93% yield. 
 
TLC (SiO2): Rf = 0.34 (ethyl acetate:hexanes, 1:3). 
 
1H NMR(500 MHz, CDCl3): δ 5.15 (ddd, J = 9.5, 4.0, 1.5 Hz, 1H), 4.02-4.00 (m, 1H), 
3.93 (dd, J = 10.5, 3.0 Hz, 1H), 3.86 (dd, J = 4.5, 1.0 Hz, 1H), 3.68 (ddd, J = 10.5, 5.0, 
2.5 Hz, 1H), 2.84 (d, J = 3.0 Hz, 1H), 2.82-2.74 (m, 1H), 2.66-2.50 (m, 1H), 2.08-2.00 
(m, 1H), 2.01 (d, J = 3.5 Hz, 1H), 1.86 (qd, J = 6.5, 1.5 Hz, 1H), 1.84-1.79 (m, 1H), 1.74-
1.72 (m, 1H), 1.70-1.65 (m, 1H), 1.55-1.50 (m, 1H), 1.30 (d, J = 7.0 Hz, 3H), 1.28-1.21 
(m, 1H), 1.07 (d, J = 7.0 Hz, 3H), 1.06 (d, J = 6.5 Hz, 3H), 1.05 (d, J = 7.0 Hz, 3H), 1.02 
(d, J = 6.5 Hz, 1H), 0.94 (t, J = 7.5 Hz, 3H), 0.89 (d, J = 7.0 Hz, 3H). 
 
13C NMR (125 MHz, CDCl3): δ 213.4, 178.4, 79.5, 76.5, 76.3, 70.9, 44.0, 43.4, 40.6, 




22 = -34.1 (c = 0.41, CH2Cl2). 
. 
 
FTIR (neat): υ3363, 2973, 1700, 1640, 1458, 1373, 1185, 1097, 940, 905, 727, 580. 
 
HRMS: (CI) Calcd. for C21H38O6Na [M+Na]
+: 409.25606, Found: 409.25614. 
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